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CIRCADIAN DISRUPTION IN WOMEN WITH BREAST CANCER 
Eric Dedert 
October 22, 2007 
 Cancer patients show circadian disruption that increases as disease progresses. 
Disrupted endocrine and activity rhythms predict early metastatic cancer mortality. 
Effects of psychological versus biological factors on rhythms are unknown, as are 
potential links between endocrine and sleep disruption, and relevance of disruption in 
early stage cancer. This study sought to examine the associations of cancer-related 
intrusions and avoidant coping with circadian cortisol rhythms, assessed with saliva 
samples, and rest/activity rhythms, assessed with actigraphy. Participants were women 
who had been recently diagnosed with breast cancer, meaning participants provided data 
at similar points in the course of diagnosis and treatment of cancer. 
 Between diagnosis and surgical treatment, 45 women with breast cancer 
completed four days of data collection including daily reports on intrusions (IES intrusion 
scale) and avoidant coping (Brief COPE avoidant coping subscales), 12 saliva samples 
(waking, +30 minutes, 16:00 hours, bedtime), and actigraphy recordings. Mean intrusion 
and avoidant coping scores were calculated. Cortisol EIA assay results were examined 
for outliers and log-transformed prior to calculation of the diurnal slope. Actigraphy 
yielded the activity rhythm (autocorrelation coefficient), activity while in bed and out of 

































explore circadian disruption through collection of multiple measures of circadian  
 
rhythmicity and daily reports of breast cancer-related intrusions and avoidant coping while 
 
patients adjusted to diagnosis and anticipated treatment.
 
           Hierarchal regression analyses adjusted for relevant demographic and medical 
 
variables. Intrusions and avoidant coping were independently related to activity rhythm 
 
disruption (R2 change = .146 and .098, p = .008 and .034, respectively). Avoidant coping 
 
was associated with higher activity while in bed (R2 change = .168, p = .006). Circadian 
 
rhythm measures, diurnal cortisol slope and autocorrelation, were significantly associated 
 
in the predicted direction (r = -.613, p < .001). Higher autocorrelation was related to 
 
higher waking, and lower bedtime cortisol (r = -.459, p = .003). Breast cancer-related 
 
intrusions and avoidant coping may influence circadian rest/activity with possible 
 
implications for clinical intervention.
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Breast cancer currently has the highest incidence of any cancer experienced by 
women. Estimates indicate approximately 213,000 women will be diagnosed with breast 
cancer in the United States in 2006 (National Cancer Institute [NCI], 2005). Breast 
cancer accounts for an estimated 30.7% of all newly diagnosed cancers in women in the 
United States (NCI, 2005). Breast cancer also accounts for 15.7% of cancer-related death 
in American women, trailing only lung cancer (NCI, 2005). While breast cancer mortality 
rates have declined in the United States in recent years, incidence rates have remained 
stable, and breast cancer is expected to continue to afflict many women. An estimated 
12.67% of women born in the United States today are expected to develop breast cancer 
at some point, with an estimated 2.96% dying of breast cancer (NCI, 2006). An estimated 
$8.1 billion are spent annually on treatment of domestic breast cancer (NCI, 2005). 
 
Breast Cancer Staging 
 At the time they are informed of a diagnosis of breast cancer, women may also 
receive information about their disease stage, a grouping of patients by the extent of 
tumor spread. Cancer that originates in the breast, as opposed to spreading from another 
part of the body, is referred to as primary breast cancer. Primary breast cancer can be 
staged between 0 and IV according to the staging system developed by the American 
Joint Committee on Cancer (2006). According to this system, staging is determined by 




from its primary site. Cancer that has spread from its primary site and invaded other sites 
in the body is termed metastatic. 
 
 Treatments 
Women diagnosed with early stage breast cancer, typically less than stage III, are 
often given surgical treatment options that include total mastectomy, a removal of the 
entire breast, or partial mastectomy, removal of the cancerous portion of the breast as 
well as some of the healthy tissue around it. These surgeries are often accompanied by 
breast reconstruction surgery. Patients are also often given the option of breast-
conserving surgery, called a lumpectomy, which removes the cancer and a minimal 
amount of tissue surrounding it, but leaves most of the breast intact. Existing research 
suggests that when breast-conserving surgery is paired with radiation that kills cancer 
cells, survival is similar to that of women receiving a mastectomy (NCI, 2004). In 
addition, a six-year follow-up study found no differences in psychological adjustment 
between women undergoing breast-conserving surgery and those receiving mastectomy 
(Omne-Ponten, Holmberg, & Sjoden,1994). Mastectomy is still chosen by some women 
to avoid undergoing radiation or reduce the chance of recurrence in the same breast 
(Molenaar, et al., 2001). Of women diagnosed with early stage breast cancer, an 
estimated 41% receive mastectomy, 37% receive breast-conserving surgery paired with 
radiation, and 19% receive breast-conserving surgery without radiation (National Institute 
of Health [NIH], 2005) 
For patients whose primary breast cancer has spread to their lymph nodes, 
chemotherapy is generally recommended. Chemotherapy uses drugs to target and kill 
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rapidly-growing tumor cells. Chemotherapy drugs are taken orally, injected 
intravenously, or placed near the cancer site. An estimated 69% of patients with cancer 
metastasis to lymph nodes receive chemotherapy (NIH, 2005). 
Some hormones, particularly estrogen and progesterone, are capable of 
stimulating the multiplication of cancer cells. Consequently, hormone therapies (e.g. 
tamoxifen, aromatase inhibitors) aim to block the activity of hormones that stimulate 
cancer cells. Hormone therapy offers potential benefits only for tumors with estrogen or 
progesterone receptors.  
 
Symptoms Associated with Diagnosis 
The course of breast cancer is frequently marked by manifestations of 
psychological distress including depression, anxiety, disrupted social and sexual 
functioning, self-image changes, fears of recurrence (Northouse, Templin, Mood, & 
Oberst, 1998; Rowland & Massie, 1998; Yurke, Farrar, & Anderson, 2000), as well as 
pain, hot flashes, weight gain, and vaginal discharge and dryness (Avis, Crawford, & 
Manuel, 2005). Quality of life studies support the notion that the period immediately 
following diagnosis, and including treatment, is the most troublesome for patients with 
breast cancer (Knobf, 2007). A recent review reported as much as 30% of patients 
develop an anxiety or depressive disorder within the first year after diagnosis (Edwards, 
Hailey, & Maxwell, 2004). Additionally, patients report more distress during the pre-
treatment period than during the post-treatment period (Culver, Arena, Antoni, & Carver, 
2002;  Northouse, 1989). Patients also report elevated symptom distress related to 
insomnia, loss of concentration, and fatigue during the pre-treatment period (Cimprich, 
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1999). In candidates for surgical treatment, part of this distress could be due to the 
decision between mastectomy and breast-conserving surgery. Patients are generally 
interested in participating in this decision (Degner et al., 1997), but the acquisition of 
complex information and weighing of risks and benefits, in addition to adjusting to the 
diagnosis itself, is taxing for many patients. While distress is primarily evident prior to 
treatment, significant long-term distress has been noted in 18% of patients in a study of 
patients 20 years after diagnosis (Kornblith et al., 2003). In addition to the burden of 
distress experienced pre-treatment, this distress has been associated with post-treatment 
pain, nausea, fatigue, and discomfort in at least one sample of patients with breast cancer 
(Montgomery, & Bovbjerg, 2004). 
 
Distress, Psychiatric Morbidity, and Quality of Life 
While many studies have documented the difficulty of psychological adjustment 
to breast cancer, the prevalence of these difficulties are unclear due to inconsistent 
findings. For example, prevalence reports regarding depression in women with breast 
cancer have ranged from 1.5% to 50% (Rowland & Massie, 1998). Disparities in reports 
of psychological disorders in these patients have numerous explanations. Because a 
number of instruments for measuring depressive symptoms are available, depression 
research can be used as an example of the effect of methodology on estimates of 
prevalence rates in patients with breast cancer. The Diagnostic and Statistical Manual of 
Mental Disorders – Fourth Edition (APA, 1994) specifies criteria for a Depressive 
Episode that have substantial overlap with the consequences of illness and medical 
treatments such as chemotherapy. Anhedonia, decreased appetite, sleep disturbance, 
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reduced psychomotor activity, and fatigue might all be secondary to cancer and its 
treatment, confounding even a skilled assessment.  
Differences between studies in the methods of addressing this issue likely account 
for some of the variance in reports of depressive symptomatology (Trask, 2004). For 
example, some studies have measured and used all symptoms of depression regardless of 
whether they are caused by a general medical condition (Rifkin et al., 1985). This 
approach maximizes sensitivity for detecting symptoms of depression but decreases 
specificity. A likely result is that depression estimates using this method are inflated. 
Conversely, fatigue and appetite/weight changes, two symptoms often confounded with 
medical conditions, have been eliminated from assessments of depression in samples of 
patients with a medical condition (Bukberg, Penman, & Holland, 1984). This method 
maximizes specificity at the expense of sensitivity and likely underestimates symptoms 
of depression. Alternatively, a symptom of depression has sometimes been counted only 
if it is clearly not attributable to a general medical condition as determined by the 
interviewer or investigator (Rodin, Craven, & Littlefield, 1991). To the extent that the 
etiology can be determined, this method is useful, but determinations regarding symptom 
etiology can be challenging, even for skilled interviewers (Trask, 2004). Some 
researchers have addressed this issue by distinguishing between somatically and 
cognitively focused symptoms such as helplessness, hopelessness, indecisiveness, or 
pessimism (Endicott, 1984). This method matches the assessment to the specific medical 
population, but there is no consensus regarding which symptoms are most appropriate to 
use (Trask, 2004) and how well the resulting depression estimates compare to estimates 
using formal criteria for a depressive disorder.  
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Confusion regarding symptom etiology is not the only potential confound 
contributing to variability in estimates of psychiatric morbidity in patients with breast 
cancer. Studies use both interview and written self-report measures to assess 
psychological disorders and symptomatology. While a diagnostic interview is preferable 
for establishing the presence of a psychological disorder, self-report questionnaires are 
frequently more feasible. Studies using a self-report questionnaire sometimes employ a 
cutoff score to indicate which patients are likely suffering from clinically significant 
depression, but these measures tend to yield a high number of false positive diagnoses 
(Lynch, 1995). 
Variability in the assessment of psychological disorders can also be derived from 
differences in who assesses the patient. Routine screening for depression often does not 
exist, and research suggests a minority of patients are likely to report symptoms of 
depression to nonpsychiatric hospital staff (Koller et al., 1996; Passik et al., 1998). As a 
result, archival studies of depressive symptoms may underestimate the prevalence of 
depression in patients with breast cancer.  
Finally, the symptomatology of many psychological disorders, especially 
depression and anxiety disorders, may worsen and remit throughout the diagnostic and 
treatment processes (Trask, 2004), so the time of assessment could also contribute to 
variability in prevalence estimates. Existing research suggests the first 13 months after 
diagnosis produce the most distress, with decreasing levels thereafter (Helgeson, Snyder, 
& Seltman, 2004). Long-term studies suggest that after this period, psychiatric disorder 
prevalence rates of women that were diagnosed with breast cancer approach those of the 
general population (Coyne, Benazon, Gaba, Calzone, & Weber, 2000). While the rates of 
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psychiatric disorders for women that are more than one year post-diagnosis may be only 
mildly elevated relative to the general population, subclinical distress and impairment in 
excess of average rates are evident (Rowland & Massie, 1998). These considerations are 
in addition to those of age, race, subculture, and differences between self-report measures 
that typically contribute to variability.  
Elevated levels of depressive and anxious symptomatology have consistently been 
reported by patients with newly diagnosed breast cancer on self-report measures 
(Cimprich, 1999; Compas & Luecken, 2002). For example, a large survey reported that 
33% of patients with breast cancer suffered from significant distress (Zabora, 
Brinzenhofeszoc, Curbow, Hooker, & Piantodosi, 2001). However, studies investigating 
the prevalence of psychological disorders in these patients have yielded conflicting 
results. In a recent study using a semi-structured diagnostic interview that followed 
patients longitudinally, at least borderline criteria for a depression or anxiety disorder as 
listed in the Diagnostic and Statistical Manual of Mental Disorders – Third Edition  
(DSM-III; APA, 1987) were endorsed by 33% of patients at diagnosis, 24% at three 
months after diagnosis, and 15% one year after diagnosis (Burgess et al., 2005). 
However, another study of newly diagnosed patients using a semi-structured interview 
found the prevalence of psychiatric disorders to be 18%, similar to that of community 
epidemiological surveys (Dausch et al., 2004). It should be noted that the latter study was 
comprised of psychosocial treatment-seeking individuals and excluded patients with a 
history of a psychotic psychiatric disorder or current metastatic disease. These differences 
could account for the discrepancy between the two studies. 
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Studies of psychological well-being, specifically, have been supplemented by 
studies of the broader quality of life concept. The term quality of life is multidimensional 
(Aaronson, Bullinger, & Ahmedzai, 1988; Cella, 1994), and its measurement typically 
assesses social, emotional, physical, and functional well-being and may also include 
spiritual, financial, and sexual well-being (McQuellon, Kimmick, & Hurt, 1997). Several 
studies have noted improved quality of life within the first year after completing 
treatment (Land et al., 2004; Stanton, Danoff-Burg, & Huggins, 2002). Still, the research 
literature contains several reports of elevated symptomatology years after diagnosis or 
treatment, including increased fatigue (Bower et al., 2000). 
The abundance of methodological issues complicating assessment of psychiatric 
morbidity and quality of life in patients with breast cancer explain the strikingly disparate 
estimates sometimes found in the literature. In evaluating these estimates, the 
appropriateness of existing criteria, assessment methods and interviewers to the patient 
population should be considered. The patient’s place in the course of diagnosis and 
treatment should also be considered. 
Clearly, methodological differences contribute to significant variability in 
psychiatric morbidity and quality of life in patients with breast cancer, but some patterns 
have emerged. Generally, the available literature suggests that women who are diagnosed 
with breast cancer experience increased distress and impaired quality of life for at least 
the first year after diagnosis. However, it appears that despite the continued presence of 
some residual symptoms resulting from breast cancer diagnosis and treatment, long-term 
psychological morbidity prevalence rates and quality of life improve following successful 




Intrusions are defined as “unwanted thoughts and images related to the stressor” 
(Antoni, Wimberly, et al., 2006, p. 1793). Intrusions have also been defined as 
“intrusively experienced ideas, images, feelings, or bad dreams” (Zilberg, Weiss, & 
Horowitz, 1982, p. 407). They can be elicited by environmental stimuli associated with 
the stressor or internal stimuli such as thoughts associated with the stressor.  
Intrusions related to a stressor are, in addition to being unwanted, typically 
distressing to the individual. As reactions to a stressor, intrusions are categorized as a 
type of psychological distress (Horowitz, & Wilner, 1979). As a type of distress, 
intrusions compromise emotional well-being, a component of the patient’s quality of life. 
Surprisingly, intrusions do not always correlate highly with generalized distress. Cancer-
related intrusions and distress were only mildly associated with each other (r = .34) in a 
study of patients that had been recently diagnosed with cancer at several different sites, 
with the most prevalent being breast cancer (37%; Epping-Jordan, Compas, & Howell, 
1994). Patients in this study varied with respect to cancer site, with breast cancer being 
the most common diagnosis. Different results were found in a study of people who were 
registered as outpatients at an oncology department and had immigrated to Israel from 
Russia between the years of 1989 and 1992. These patients also had varied cancer sites, 
with breast cancer being the most common (44%). Cancer-related intrusions and distress 
were more strongly correlated (r = .64) among the women in this study (Baider, 
Kaufman, Ever Hadani, & Kaplan De-Nour, 1996), though this could be influenced by 
the stress of immigration. 
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Although it was initially developed to study individuals during bereavement, the 
Impact of Event Scale (IES) has frequently been employed to measure reactions to 
trauma (Sundin & Horowitz, 2002). The IES measures two aspects of trauma: intrusions 
and avoidance. Diagnostic criteria for Posttraumatic Stress Disorder (PTSD) include re-
experiencing of the traumatic event and avoidance of event-specific cues as symptoms of 
the disorder. The re-experiencing criterion includes intrusions, as well as other 
manifestations such as dreams of the event or feeling as though one is reliving the event. 
A diagnosis of PTSD requires that the reaction be in response to a traumatic event, so 
intrusions are consistent with psychiatric morbidity that is tied to the original stressor. As 
a result, intrusions are an indicator of continued distress or impairment related to a 
stressful event. However, as persisting cues to think about a stressor, intrusions can 
prompt continuing stress for the individual. Consistent with this idea, intrusions have 
been conceptualized as efforts to process new information (Park & Folkman, 1997), 
suggesting that processing is necessary to resolve these thoughts. Ehlers and Steil (1995) 
proposed a model of intrusive memories and thoughts asserting that when intrusions are 
assigned a negative meaning, the individual is more likely to engage in avoidance, which 
increases the frequency of intrusions. This model suggests that intrusions will recur, 
especially when an individual engages in avoidant coping. 
Intrusions related to breast cancer are prevalent, with 35% of patients endorsing 
“repeated, disturbing memories of cancer treatment or your experience with cancer” in 
one study of women who were primarily more than one year post-diagnosis (Jacobsen et 
al., 1998). Scores of 20 or more on the Intrusions subscale of the Impact of Event Scale 
(IES) are considered indications of a stress response syndrome (Bleiker, Pouwer, van der 
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Ploeg, Leer, & Ader, 2000; Horowitz, & Wilner, 1979). High levels of cancer-related 
intrusions associated with a score of 20 or more on the IES intrusions subscale have been 
observed in 16% of patients two months after surgery, while scores in the moderate range 
of 9-19 in IES intrusions were observed in 30% of the same patients two months after 
surgery. Of the patients endorsing high levels of intrusions, 60% continued to report high 
intrusions 21 months after surgery, suggesting temporally stable distress resulting from 
the diagnosis (Bleiker et al., 2000). Intrusions are likely to be associated with other 
psychological morbidity and have been related to anxiety and depression at the time of 
diagnosis and 3 months post-diagnosis in a sample of patients with cancer at varying sites 
(Epping-Jordan et al., 1994) and at 6 months post-diagnosis in a sample consisting 
entirely of patients with breast cancer (Primo et al., 2000). 
The relationship between intrusions and endocrine alterations in people who have 
endured a traumatic event (Yehuda, 2002), the high prevalence of intrusions in patients 
with breast cancer, and the prominence of PTSD among mental disorders observed in 
women recently diagnosed with breast cancer (Dausch et al., 2004) suggest that cancer-
related intrusions may be a more sensitive index of a patient’s response to breast cancer 
than are general measures of stress or distress. Consequently, intrusions present an 
intriguing psychological variable with respect to physical health. Research on this 
relationship is not extensive, but cancer-related distress, as measured by the sum of all 
intrusion and avoidance items on the IES (Horowitz, & Wilner, 1979), has been related to 
several indicators of immunosuppression in women who had received surgical treatment 
for breast cancer in the past four months and had not yet begun adjuvant treatment. 
Overall cancer-specific distress was associated with impaired ability of natural killer 
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(NK) cells to attack target cells, decreased proliferative response to T-cell receptors, and 
decreased response to mitogens (Andersen et al., 1998). 
Because cancer-related intrusions are a significant and common problem for 
patients with breast cancer, a cognitive-behavioral intervention has been designed to 
target these intrusions and has demonstrated evidence of efficacy in women receiving 
surgical treatment for breast cancer (Antoni, Wimberly, et al., 2006). A supportive-
expressive therapy trial targeted and reduced overall traumatic stress symptoms in 
women with metastatic breast cancer (Classen et al., 2001). In addition, patients with 
high overall cancer-specific distress, which includes an intrusion subscale, have realized 
greater mood improvement from psychological intervention (Andersen et al., 2004).  
 
Diagnosis of Cancer as a Trauma 
A breast cancer diagnosis has been shown to produce symptoms consistent with 
those used to determine a diagnosis of Posttraumatic Stress Disorder (PTSD) diagnosis in 
some patients (Andrykowski, Cordova, Studts, & Miller, 1998). These findings are 
mirrored by an inclusion of life-threatening illness among the Criterion A events that can 
potentially precipitate PTSD in the DSM-IV (APA, 1994). Symptoms consistent with 
PTSD must be present for at least one month to meet criteria for a diagnosis of PTSD. 
Prior to that time, trauma-related symptoms may meet criteria for Acute Stress Disorder, 
though more dissociative symptoms are required for diagnosis of Acute Stress Disorder, 
as opposed to PTSD (APA, 1994). One study of patients in remission and six or more 
months removed from treatment found that 6% of patients met criteria for PTSD 
(Andrykowski et al., 1998). Another study assessed women 3-6 weeks after diagnosis and 
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found that while only 18% of the sample met criteria for a mood, anxiety, or adjustment 
disorder, 8% of these diagnoses were for PTSD or Acute Stress Disorder (Dausch et al., 
2004). In women responding to self-report questionnaires 6-60 months after completing 
treatment for early stage breast cancer, 5-10% responded in a way suggestive of a 
diagnosis of PTSD (Cordova et al., 1995). A study of women who were 4-12 months 
post-treatment for early stage breast cancer found that 3% of women met strict current or 
past criteria for PTSD based on the cancer diagnosis as the traumatic event, but 
subsyndromal PTSD symptoms were commonly reported. Cancer-related intrusive 
thoughts were reported by 36% of these patients, 48% met the re-experiencing criterion, 
and 36% endorsed three or more symptoms of PTSD (Green et al., 1998).  
At first glance, the disparity between intrusions and PTSD diagnoses may be 
surprising because intrusions are part of the diagnosis of PTSD. Some of this disparity 
could be attributed to methodological differences between measurement of intrusions, 
which are often assessed using self-report measures, and PTSD diagnoses assessed by 
interview. Further, although it is clear that intrusions are present to a significant degree in 
women diagnosed with breast cancer (Butler, Koopman, Classen, & Spiegel, 1999), 
PTSD is only an appropriate diagnostic category for a subset of these women. PTSD 
criteria specify that intrusions consist of recollections, dreams, or re-experiencing of the 
traumatic event, but intrusive thoughts reported by women with breast cancer may consist 
of future-oriented worry about treatment, cancer progression, recurrence or death that are 
not truly intrusions and does not fit PTSD criteria (Green et al., 1998). Existing research 
on traumatic reactions is consistent with findings regarding other psychiatric diagnoses in 
that the primary elevations in the prevalence of PTSD occur shortly after diagnosis. 
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In addition to being linked with general distress, intrusions may influence 
physiology. Intrusions have demonstrated relationships with impaired immune responses 
(Andersen et al., 1998). Intrusions have also been linked with immunosuppression in 
students anticipating an examination (Workman & La Via, 1987). In addition, in men 
undergoing testing for HIV, intrusions were correlated with increased cortisol at 1 week, 
3 weeks, and 5 weeks after being informed of test results (Antoni et al., 1990). 
 
HPA axis description 
 A model of HPA axis activation is presented in Figure 1 below. Human 
physiological responses to stress appraisals have consistently demonstrated activation of 
a specific pathway beginning with the hypothalamus (corresponding to arrow A in the 
model depicted in Figure 1) (McEwen, 1998), which secretes corticotropin-releasing 
hormone (CRH) (arrow B). CRH triggers the pituitary gland to secrete 
adrenocorticotropic hormone (ACTH) (arrow C), causing the adrenal cortex to secrete 
cortisol (arrow D). Cortisol produces metabolic changes, mobilizing energy by promoting 
the conversion of protein and lipids to usable carbohydrates, providing the organism with 
the energy resources to confront a stressor (McEwen, 2004) and ideally alter 
characteristics of the stressor to make it less stressful. The neurohormonal cascade 
resulting in cortisol secretion is a physiological negative feedback loop, with cortisol 
actively inhibiting subsequent activation of this system (arrow E). As a result of 
heightened secretion under stress, cortisol presents one means of assessing the effects of 
psychosocial stress on physiological functioning. The neurohormonal pathway described 
above is collectively referred to as the Hypothalamic-Pituitary-Adrenal (HPA) axis.  
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Figure 1 illustrates stress-related activation of the hypothalamic-pituitary-adrenal (HPA) 
axis. The arrows represent different phases of the HPA activation process A) Appraisals 
of stress stimulate the hypothalamus; B) The hypothalamus secretes corticotropin-
releasing hormone (CRH); C) CRH stimulates the pituitary gland to secrete 
adrenocorticotropic hormone (ACTH); D) ACTH stimulates the adrenal gland to secrete 
cortisol; and E) Cortisol inhibits subsequent activation of the HPA axis. 
 
 
Changes in HPA axis reactivity have been reported in association with chronic 
stressors such as anxiety (McEwen, 1998), early childhood trauma (Heim, Ehlert, & 
Hellhammer, 2000), socioeconomic status (Brandtstadter, Baltes-Gotz, Kirschbaum, & 
Hellhammer, 1991), and depression (Heim et al., 2002). HPA axis reactivity has also 
been evident in response to short-term distress (Seeman, Burton, Rowe, Horwitz, & 
McEwen, 1997), including completion of a mammogram (Porter et al., 2003) and 
laboratory stressors including a public speaking task (Kirschbaum, Wust, & Hellhammer, 
1992) and a distress-inducing vigilance task in healthy adults (Lundberg & Frankhaeuser, 
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1980). Taken together, these studies support the notion that distress is associated with 
increased cortisol production and argue for the usefulness of cortisol as a physiological 
measure of stress reactivity. 
 The physiological responses to acute stressors aimed at short-term adaptation have 
been termed allostasis, meaning “the ability to achieve stability through change” 
(McEwen, 1998, p. 171). Allostasis incorporates responses from several systems in the 
body, including the HPA axis, the autonomic nervous system, and the cardiovascular, 
metabolic, and immune systems. Stress-related activation of the HPA axis as part of 
allostasis results in cortisol secretion and the associated mobilization of energy through 
the availability of carbohydrates (McEwen, 2004). Once a stressor is removed, allostatic 
responses aimed at addressing acute stressors are generally inactivated, returning HPA 
axis activity to its baseline state.  
 Although the adaptation promoted by allostasis is critical, accommodations to stress 
can exact a toll on the body over time due to chronic underactivation or overactivation of 
bodily systems influenced by allostasis. The wear and tear on the body associated with 
repeated stress or insufficient deactivation of allostatic responses has been termed 
allostatic load (McEwen & Stellar, 1993). Allostatic load can develop due to exposure to 
frequent and varied stressors, failure to adapt to repeated stressors of the same type, or 
failure of stress responsive systems to return to baseline following the removal of the 
stressor (McEwen, 1998). In these instances, chronic overexposure to stress hormones 
such as cortisol can bring about pathophysiologic consequences. For example, chronic 
overactivation of the HPA axis can lead to disruption of circadian physiological rhythms, 
which may be linked with suppressed immune function, sleep disruption, and increased 
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cancer incidence and progression (Sephton & Spiegel, 2003). Continued overactivation of 
the HPA axis has also been associated with varying conditions including memory 
impairment, hypertension, osteoporosis, insulin resistance, and cardiovascular disease 
(Chrousos & Gold, 1998). Among the effects of HPA axis activation on the body are 
alterations of the immune system. End-products of the HPA axis such as cortisol inhibit 
cytotoxicity, the ability of some types of immune cells to destroy target cells. Stress 
responses can also reduce availability in the body of immune cells such as lymphocytes 
and affect secretion of cytokines such as interleukin-2 (essential to fighting infection) and 
interferon-γ, which has anti-tumor properties (Elenkov & Chrousos, 1999). 
 Just as overexposure to stress hormones can be problematic, hyporesponsivity of the 
HPA axis can also lead to allostatic load. The immune system component of allostasis is 
typically regulated by glucocorticoids such as cortisol. When cortisol levels are 
insufficient for inactivation of the immune response following removal of the stressor, 
the organism is at increased risk of autoimmune or inflammatory disturbances associated 
with a sustained exposure to inflammatory cytokines (McEwen, 1998). 
 
Transactional Model 
The transactional model of stress, coping, and adaptation originally proposed by 
Lazarus and Folkman (1984) asserts that the person and his or her environment are in a 
“dynamic, mutually reciprocal, bidirectional relationship” (p. 293). Stress is defined in 
this model as “a relationship between the person and the environment that is appraised by 
the person as taxing or exceeding his or her resources and endangering his or her well-
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being” (Lazarus & Folkman, 1984, p. 21). Figure 2 illustrates the transactional model of 
stress and coping. 
In this model, an individual engages in a primary appraisal evaluating whether, 
and to what extent, an encounter is challenging, threatening or harmful (i.e. stress). If an 
encounter is deemed stressful, the person then engages in secondary appraisal, an 
evaluation of the availability of coping options, the effectiveness of available coping 
options, and the person’s ability to enact these coping options. Secondary appraisals and 
primary appraisals work together to determine the precise degree of stress perceived by 
the individual. Plentiful availability of easily enacted coping strategies that are expected 
to be effective in reducing or ameliorating the stressor are likely to reduce a person’s 
perception that the encounter is stressful. Conversely, the absence of cognitively 
available coping options, ineffectiveness of available coping options, or a person’s doubt 
in their ability to successfully enact coping responses may increase stress appraisals. It 
should be noted that stress appraisals may not be significantly altered by secondary 
appraisals. For example, this may be true for encounters in which a person appraises the 
outcome stakes to be particularly high. 
Following the appraisal process, coping efforts are employed. The outcome of the 
coping process continues to work together with primary and secondary appraisals to 
shape a person’s experience of an encounter as stressful. These relationships are complex 
and likely to vary considerably between individuals, but discussion of ways in which 
primary and secondary appraisals and coping could work together may illustrate their 
conceptual relationships. For instance, if coping successfully reduces the threat or harm 
produced by the stressor or ameliorates the effects of the stressor on the person’s 
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emotional well-being, the encounter may be appraised as being less stressful. 
Unsuccessful coping, in contrast, may modify secondary appraisals, lessening the 
person’s perceptions that effective coping responses are available. This may influence 
primary appraisals, strengthening the person’s conviction that an encounter is threatening 
or harmful. 
Figure 2. The transactional model of stress and coping 
Figure 2 depicts the transactional model of stress, coping, and adaptation. When an event  
occurs, appraisal determines whether the event is threatening, challenging, or harmful. In  
addition, Coping efforts are consciously employed, and if the event is not favorably  
resolved, distress results. Model adapted from: Folkman, S. (1997). Positive  
psychological states and coping with severe stress. Social Science & Medicine, 45(8),  
1207-1221. 
 
According to the transactional model, characteristics of the person, stressor, and 
situation influence how people appraise and cope with a potential stressor (p.147) 
(Lazarus & Folkman, 1984). The implications of the dynamic features of the transactional 
model are that it is desirable to specify relevant characteristics of a stressful encounter to 





 Coping is most commonly defined as “constantly changing cognitive and 
behavioral efforts to manage specific external and/or internal demands that are appraised 
as taxing or exceeding the resources of the person” (Lazarus, & Folkman, 1984, p. 141). 
While stressors are often associated with physiological arousal, the relationship between 
stressful events and an individual’s physiology and physical health is complex, and the 
relationship is likely modified by coping strategies (Taylor, Repetti, & Seeman, 1997). 
Research on physiological adaptation to stressors has noted that exposure to stressors can 
lead to positive physiological changes and that these physiological changes are 
influenced by the psychological responses of the individual including appraisals and 
perceptions of control (Epel & McEwen 1998). As a result, the way in which coping 
influences physiological adaptation to stressors has been investigated. Researchers have 
used observational studies as one way to investigate the relationships of coping with 
distress, physiological variables, and health outcomes, as reviewed below. 
 
Active coping 
 Coping strategies have been categorized as either active or avoidant and outcomes 
for the two types of coping strategies have been contrasted. Active coping is defined as 
“the process of taking active steps to try to remove or circumvent the stressor or to 
ameliorate its effects” (Carver, Scheier, & Weintraub, 1989, p. 268). Evidence indicates 
that an active coping style, as opposed to an avoidant coping style, has generally been 
associated with enhanced psychological adjustment (Luecken & Compas, 2002). Active 
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coping has been found to predict better long-term psychological adjustment in women 
with breast cancer (Epping-Jordan et al., 1999; Stanton, Danoff-Burg, & Huggins, 2002). 
In addition, in women undergoing breast biopsy, patients who utilized coping efforts 
characterized by actively confronting their illness reported less psychiatric morbidity 
(Chen et al., 1996). Several studies have documented a possible relationship between 
emotional expression, rather than inhibition of emotional responses, and slowed 
progression of cancer (Gross, 1989). Although opinions on the effects of active coping on 
survival differ (Faller, 2001; Petticrew, Bell, & Hunter, 2002), interview ratings of active 
coping in patients with lung cancer have been related to increased survival (Faller, 2001). 
Strategies for addressing or ameliorating the stressor, or problem-focuses coping 
strategies, have also been studied in patients with breast cancer. Information seeking 
shortly after being informed of a breast cancer diagnosis has predicted subsequent 
improved physical quality of life six month post-diagnosis (Ransom, Jacobsen, Schmidt, 
& Andrykowski, 2005). The mechanism of the effects of problem-solving coping on 
physical health outcomes has not been established, but constructs such as information 
seeking incorporate openness to different treatments (Ray et al., 1993). Improved health 
behavior such as adherence to medical regimen, increased exercise, improved nutrition, 
and decreased smoking are also possible consequences of problem-focused coping that 
could improve physical health outcomes (Ransom et al., 2005).  
 Additionally, emotionally expressive coping, defined as the utilization of emotional 
outlets as a means of intentionally focusing on the individual’s reaction to the stressor, 
has predicted better quality of life, enhanced physical health, decreased psychological 
distress and fewer medical appointments in HIV-infected men (Mulder, Antoni, 
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Duivenvoorden, Kauffman, & Goodkin, 1995).  
 Watson et al. (1988) developed the Mental Adjustment to Cancer (MAC) scale to 
measure a person’s mental adjustment to cancer, but it has since come to be used as a 
measure of coping. Nevertheless, examination of the items on the MAC reveal that the 
original conceptualization is likely more accurate. Although some items seem to assess 
coping efforts or resources, most items assess psychological reactions more consistent 
with distress, specifically depression and anxiety. Among the responses assessed is 
hopelessness/helplessness, a psychological reaction characteristic of depression that 
incorporates low expectation for future paired with a sense of inability to influence the 
future. This subscale is assessed with questions such as “I think it is the end of the world” 
and “I feel like giving up” (Watson et al., 1988). The disengagement that typically 
accompanies feelings of helplessness is characteristic of avoidant coping. The MAC also 
measured anxious preoccupation, which seemed to be a composite of anxiety and 
generalized distress. This subscale included questions such as “I suffer great anxiety 
about it” and “It is a devastating feeling” (Watson et al., 1994). Fatalism, another 
subscale of the MAC, seemed to target acceptance with limited hope for the future and 
used items such as “I’ve had a good life; what’s left is a bonus” and “I count my 
blessings” (Watson et al., 1994). Finally, the MAC assessed fighting spirit, a construct 
that is the polar opposite to hopelessness/helplessness and consists of “regarding cancer 
as a challenge and adopting a positive attitude” (Greer, 2000, p. 847) and was measured 
using items like “I am very optimistic” and “I am determined to beat this disease” 
(Watson et al., 1994).  
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Some inconsistencies exist regarding the relationship between cancer stage and 
coping strategies employed. Patients do not restrict themselves to one type of coping 
strategy. Patients may employ multiple strategies over time, and the coping strategy 
employed could vary depending on the stage of the disease. A change from one strategy 
to another may be in response to a perception that initial strategies have been 
unsuccessful. The use of both active and avoidant coping concurrently may be adaptive 
for individuals faced with different types of stressors. Some evidence suggests that active 
coping strategies are used more often by women with early stage breast cancer (Schnoll, 
Harlow, Stolbach, & Brandt, 1998) and advanced stage has been linked with increased 
use of hopelessness/helplessness, anxious preoccupation, and fatalism (Schnoll et al., 
1998). Studies have observed associations between advanced stage and both increased 
use of avoidant coping (Sandgren & McCaul, 2007) and decreased use of avoidant coping 
(Reynolds et al., 2000). Earlier stage has been associated with an elevated “fighting 
spirit” orientation to the disease (Lilja, 2003; Schnoll et al., 1998) and more problem-
focused coping strategies (Cohen, 2002). 
  
Avoidant coping 
Horowitz and Wilner (1979, p. 210) characterized avoidance as involving 
“ideational constriction, denial of meanings and consequences of the event, blunted 
sensation, behavioral inhibition or counter-phobic activity, and awareness of emotional 
numbness.” Avoidant coping is defined here as reducing one’s cognitive and behavioral 
efforts to deal with the stressor (Carver, Scheier, & Weintraub, 1989). Consistent with its 
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definition, avoidant coping has generally been associated with findings opposite to those 
of active coping (Stowell, Kiecolt-Glaser, & Glaser, 2001). 
Some evidence suggests a positive influence of avoidant coping, as one study 
found that women awaiting mastectomy who were judged by interviewers to be using 
denial coping strategies also report lower mood disturbance and state anxiety (Watson, 
Greer, Blake, & Shrapnell, 1984), but other research has generally observed a robust 
negative relationship between avoidant coping and psychological adjustment (Luecken & 
Compas, 2002; McCaul et al., 1999; Montgomery et al., 2003; Shapiro et al., 1997; 
Stanton & Snider, 1993; Wade, Nehmy, & Koczwara, 2005; Watson et al., 1991). 
Avoidant coping at the time of diagnosis has been shown to be predictive of increased 
distress as long as three years post-diagnosis (Hack & Degner, 2004). In breast cancer 
patients, avoidant coping has been associated with increased distress in women with early 
stage breast cancer (Carver et al., 1993) and increased fear of recurrence one year after 
diagnosis (Stanton, Danoff-Burg, & Huggins, 2002). An association between increased 
distress and avoidant coping in cross-sectional studies may seem counterintuitive, or at 
least paradoxical, given the definition of avoidant coping as a collection of consciousness 
lowering processes. It might be expected that avoidant coping would, by definition, be 
associated with reduced self-reported short-term distress. To explain these findings, it is 
necessary to draw on the distinction made by the transactional model of stress between 
coping functions and coping outcomes. This means that a person may engage in avoidant 
coping functionally without achieving or experiencing that outcome (Lazarus & 
Folkman, 1984).  
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 In addition to effects on distress, avoidant coping has been researched as it relates 
to physical and physiological outcomes. This research has included repression, a concept 
that is similar to avoidant coping. Repression has been conceptualized as “a class of 
consciousness-lowering processes” (Erdelyi, 2006), and this process is consistent with 
reduction of efforts to deal with a stressor characteristic of avoidant coping (Brown et al., 
1996). An association of repression with increased basal cortisol levels has been observed 
in college undergraduates (Brown et al., 1996). In a study of metastatic breast cancer 
patients, repression was directly associated with a flatter diurnal cortisol slope (Giese-
Davis, Sephton, Abercrombie, Duran, & Spiegel, 2004), a variable previously found to be 
predictive of survival in the same sample (Sephton, Sapolsky, Kraemer, & Spiegel, 
2000). An association has also been noted between repression and cancer progression in 
patients with breast cancer (Jensen, 1987).  
In addition to the literature on the physiological effects of coping efforts on 
patients with breast cancer, there is evidence of significant relationships in other 
populations. Avoidant behavior marked by low exploration of novel environments and 
situations was related to elevated morning cortisol levels in children (Kagan, Reznick, & 
Snidman, 1988). Reaction formation, behaving a way opposite to something the 
individual wishes to avoid, has been conceptualized as an avoidant response (Prins & 
Beaudet, 1980) and has been associated with increased cortisol in non-swimming military 
recruits taking a swimming test (Vaernes, Ursin, Darragh, & Lambe, 1982). Rhesus 
monkeys that are slow to explore novel environments have been noted to have increased 
cortisol levels in response to separation from the mother (Suomi, 1987). This finding 
supports the notion of a contrast between active and avoidant coping and suggests that 
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avoidant coping is associated with poorer psychological and physical adaptation. It is 
noteworthy that harm avoidance, as a personality trait, has been linked with diminished 
ambulatory measured motor activity throughout the day. Personality traits differ from 
coping processes, but people high in Harm Avoidance have been described as having 
learned to “inhibit behavior to avoid punishment, novelty, and nonreward” (Volkers et 
al., 2002). This conceptualization suggests that individuals high in Harm Avoidance are 
likely to exhibit avoidance behavior as a means of coping with stressors.  
Coping has also been a significant variable in a number of studies of immunity, 
suggesting that a person’s response to a stressor can influence the physiological impact of 
stressors and the resulting distress. In HIV-positive men, active coping has been 
positively associated with improved immunity marked by natural killer cell cytotoxicity 
(Goodkin, Blaney, et al., 1992), lymphocyte proliferative response (Goodkin et al., 1996), 
leukocyte proliferative response, and  slower  clinical progression (Mulder, Antoni, 
Duivenvoorden, Kauffman, & Goodkin, 1995). Conversely, avoidant coping has been 
associated with poorer immune function in HIV patients (Goodkin, Fuchs, Feaster, 
Leeka, & Rishel, 1992) and  reduced effectiveness of NK cells in patients with malignant 
melanoma (Fawzy et al., 1990). Similarly, in a sample of patients with various cancer 
sites, avoidance predicted disease status one year later (Epping-Jordan et al., 1994).  
Existing literature on the HPA axis also suggests the distress associated with 
medical problems is related to greater physiological disturbance when people utilize 
avoidant coping. Research on avoidant coping and the HPA axis has noted increased 
cortisol output following arthroscopic knee surgery (Rosenberger, Ickovics, Epel, 
D'Entremont, & Jokl, 2004) and suppression of immune function in partners of patients 
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receiving bone marrow transplants (Futterman, Wellisch, Zighelboim, Luna-Raines, & 
Weiner, 1996). In addition to naturalistic studies of the HPA axis, the induction of stress 
in a laboratory setting has proven to be a useful tool. The most common lab stressor used 
is the Trier Social Stress Test, a task in which participants are asked to give a videotaped 
mock job interview speech before a panel of judges for five minutes. After the speech is 
completed, participants are then asked to serially subtract 13 from an initial value of 
1,022 for 5 minutes (Young, Lopez, Murphy-Weinberg, Watson, & Akil, 2000). This task 
induces a mild to moderate increase in psychosocial stress and cortisol in most 
individuals (Kirschbaum, Pirke, & Hellhammer, 1993). As a result, this task can be used 
to investigate the responsiveness of the HPA axis to a psychosocial stressor.  
The relationship between coping and physiological variables could be complex 
and may involve an interaction between stress, coping, and distress. Conceptualized 
within the framework of the transactional model of stress and coping, the effect of a 
stressor on outcomes may be influenced by coping. This relationship may be such that 
stress is associated with undesirable outcomes only when maladaptive coping is high, or 
adaptive coping is low. For example, there is variability in the ways in which individuals 
respond to the Trier Social Stress Test (Young et al., 2000), suggesting a possible 
influence of coping on the relationship between the stress induced in the laboratory and 
the individual’s physiological response. Avoidant coping has been researched in people 
with schizophrenia using the Trier Social Stress Test. Results from this study suggested a 
blunted HPA axis response to the task in people reporting more avoidant coping (Jansen, 
Wied, & Kahn, 2000). Similarly, an investigation of this relationship in caregivers of 
family member with dementia noted that the interaction of perceived stress and avoidant 
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coping was generally, though not always, related to poorer leukocyte proliferative 
response to mitogens (Stowell et al., 2001). 
Avoidant coping may influence the effect of stress or distress, specifically 
intrusions, on physiological outcomes as discussed in the previous paragraph. Avoidant 
coping may also directly influence physical or physiological outcomes, independently of 
the level of stress or intrusions present. The former relationship is one in which research 
asks “under which conditions does avoidant coping influence physiology?”, while the 
latter relationship asks whether a simple influence of avoidant coping on physiology 
exists. The majority of the studies reviewed above have investigated and reported direct 
effects of avoidant coping on outcomes, with promising results. Consequently, direct 
effects of avoidant coping on physiology are of interest. Still, research on direct effects of 
avoidant coping may benefit from extension to the former question of identifying 
conditions under which a given coping strategy is helpful or harmful. 
Based on the existing literature reviewed above, avoidant coping strategies appear 
to be an important component of response to breast cancer diagnosis and treatment with 
potential negative effects on psychological adjustment, activity levels, immunity, and 
cancer progression. Additionally, avoidant coping may be associated with increased 
cortisol output in response to acute stressors and disrupted circadian cortisol profiles.  
 
Self-Distraction 
 The avoidant coping category subsumes several more specific coping efforts. One 
of these subtypes of avoidant coping, self-distraction, has also been referred to as mental 
disengagement (Carver et al., 1989). This coping effort includes activities to reduce 
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awareness of goals with which the stressor interferes (Carver et al., 1989) and typically 
takes the form of engaging in thoughts or activities that absorb the person’s attention, 
successfully distracting from thoughts about the stressor. Previous research on this self-
distraction suggests this construct is correlated with decreased optimism and perceived 
control, as well as increased anxiety (Carver et al., 1989). In women with gynecological 
cancer, pre-operative self-distraction predicted increased post-operative pain, presenting 
evidence of a direct negative effect of self-distraction on long-term physical adaptation 
(Cohen, Fouladi, & Katz, 2005). Self-distraction may be adaptive in preventing short-
term distress, as a study of women within three months of breast cancer diagnosis or six 
months of completing treatment found that those high in self-distraction were less likely 
to report problems interacting with health care providers (Collie et al., 2005). 
Nevertheless, longitudinal research has reported no association of self-distraction and 
distress in the pre-surgical period, but noted that post-surgical self-distraction was related 
to increased distress as long as twelve months post-surgery (Culver et al., 2002). It is 
possible that self-distraction cannot be sustained long-term and prevents the development 
of other coping strategies. 
 
Denial 
 A second avoidant coping subtype of interest to this study is denial. A number of 
conceptualizations of denial exist, but the operational definition for this study is “reports 
of refusal to believe that the stressor exists or of trying to act as though the stressor is not 
real” (Carver, Scheier, & Weintraub, 1989, p. 270). Because self-reports of coping efforts 
were employed in this study, it is crucial to note that the conceptualization of denial 
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utilized in this study relies on reports of denial. Denial, when operationally defined as it 
is in this study, has correlated with decreased self-esteem, stress hardiness, optimism, and 
control, and increased anxiety (Carver, Scheier, & Weintraub, 1989). The use of denial as 
a coping strategy, as well as increased serum cortisol, has shown to be predictive of 
quicker progression from HIV to AIDS (Leserman et al., 2001). Limited research also 
suggests that denial is associated with an exaggerated cortisol response (Frecska et al., 
1988), though the precise relationship is unclear because just as denial may alter cortisol 
levels, increased cortisol may inhibit attention to stressors (Frecska et al., 1988).  
 As a form of avoidant coping, it is perhaps unsurprising that findings similar to 
those observed in women exhibiting self-distraction coping have also been observed in 
women using denial coping efforts. The degree to which women report using denial 
immediately after breast cancer surgery has been shown to be predictive of health worries 
12 weeks post-surgery (Wade, Nehmy, & Koczwara, 2005). Exploratory research has 
yielded denial themes regarding physical symptoms and and medical care in women who 
have presented with locally advanced breast cancer, a indication of a delay between 
initial symptoms and the seeking of medical care (Mohamed, Williams, Tamburrino, 
Wyrobeck, & Carter, 2005). 
 
Behavioral Disengagement 
 A third subtype of avoidant coping is behavioral disengagement. Behavioral 
disengagement includes reduction of efforts to deal with the stressor and efforts to 
achieve goals with which the stressor is interfering, a behavior pattern that is consistent 
with helplessness (Carver et al., 1989). It is when behavioral disengagement is not 
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available that strategies such as self-distraction are often utilized. Relationships have 
been observed between behavioral disengagement, and decreased self-esteem, stress 
hardiness, type A personality traits, monitoring, social desirability, optimism, and control, 
and increased anxiety (Carver et al., 1989).  
 Behavioral disengagement coping is of interest in people with chronic illness 
partly due to the possible implications for behavioral health. In women diagnosed with 
breast cancer, behavioral disengagement was related to impaired ability to interact with 
medical professionals, a finding that suggests the behavioral health of women exhibiting 
behavioral disengagement could be impaired, as meaningful interaction with medical 
professional is likely beneficial to adherence to the patient’s medical regimen (Collie et 
al., 2005). Effects of behavioral disengagement on patient symptoms have not been 
extensively researched, but behavioral disengagement coping was predictive of increased 
fatigue in a sample of patients with chronic fatigue syndrome, a finding the authors 
argued as supportive of the need for increased activity levels in these patients (Ray, 
Jefferies, & Weir, 1997). In a sample of oncological inpatients, behavioral disengagement 
was among several variables related to impaired performance status, a rating of overall 
functional impairment (Perez-Aranibar, C., Cordova, H., & Espinoza, M., 2002). 
Behavioral disengagement may be related to physiological outcomes as well. In 
adolescents with type one diabetes, behavioral disengagement was related to elevated 
hemoglobin A1c levels, an indication of sustained harmful elevations in blood glucose 
levels (Graue, Wentzel-Larsen, Bru, Hanestad, & Sovik, 2004).  
 Self-Distraction, Denial, and Behavioral Disengagement clustered together in a 
factor analysis conducted by the author of the Brief COPE in a psychometric study of 
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these constructs (Carver et al., 1989), lending support to the notion that they are part of a 
larger avoidant coping category. In all, limited research on the three aspects of avoidant 
coping of interest to this study indicates that if there is a relationship between each of 
them and outcomes such as distress, physical symptoms and physiological outcomes, 
aspects of avoidant coping are generally related to negative outcomes. 
 
Avoidant coping and survival 
 Some coping strategies that have been investigated as predictors of survival in 
cancer patients can be categorized, to varying degrees, as avoidant coping strategies. 
Denial has been defined as “reports of refusal to believe that the stressor exists or of 
trying to act as though the stressor is not real” (Carver et al., 1989, p. 270). This 
definition aligns closely with the operationalization of avoidant coping as reducing 
cognitive and behavioral efforts to deal with the stressor. Use of denial, or of a fighting 
spirit, as a coping strategy three months post-surgery has been reported to be predictive 
of increased 10-year survival (Pettingale, 1984), while denial was reported to be 
predictive of decreased 3-year survival in another study (Achte, Vuhkonen, & Achte, 
1979).  
A more recent and larger study aimed at replicating Pettingale’s (1984) study 
found that helplessness/hopelessness was predictive of decreased 5-year survival, and no 
effect of fighting spirit was observed (Watson, Haviland, Greer, Davidson, & Bliss, 
1999). However, because these two constructs are conceived by at least one author as 
bipolar ends of a single continuum, the absence of an association between fighting spirit 
and survival in this study has been questioned (Greer, 2000). It is interesting to note an 
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effect of helplessness/hopelessness, a psychological reaction that is consistent with 
avoidant coping, on survival in a larger and more recent study. Nevertheless, there is no 
consensus on this issue, and the existing research is not extensive and is likely 
insufficient to determine the predictive value of self-reported coping and psychological 
reactions on cancer survival. 
 
Psychosocial Factors and Cancer Incidence 
A number of psychosocial variables have been explored as predictors of cancer 
incidence. Psychosocial factors including marital disruption by divorce, separation, and 
widowhood have been associated with increased breast cancer incidence (Lillberg et al., 
2003). However, several large studies have yielded no effect of psychosocial factors on 
breast cancer incidence (Lillberg et al., 2001), and one study has found stress to be 
related to decreased breast cancer incidence (Nielsen et al., 2005). A recent meta-analysis 
attributed positive findings to statistical evidence of publication bias and concluded that 
only death of a spouse was substantially related to subsequent cancer incidence 
independent of publication bias (Duijts, Zeegers, & Borne, 2003).  
 
Psychosocial Factors and Cancer Progression/Survival 
Psychosocial factors have also been of interest to researchers investigating 
survival in patients diagnosed with cancer. In observational studies, longer survival has 
been linked to social involvement or social support (Hislop, Waxler, Coldman, Elwood, 
& Kan, 1987; House, Landis, & Umberson, 1988; Maunsell, Brisson, & Deschens, 1995; 
Reynolds & Kaplan, 1990; Weihs et al., 2005 ), active coping (Faller, Bulzebruck, 
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Drings, & Lang, 1999), a “fighting spirit” coping style (Greer, Morris, Pettingale, & 
Haybittle, 1990), suggesting that psychosocial resources may be involved with disease 
progression. Other psychosocial factors, including depression (Brown, Levy, Rosberger, 
& Edgar, 2003), helplessness/hopelessness (Greer, Morris, & Pettingale, 1979) emotional 
suppression (Reynolds, et al., 2000), and cognitive and behavioral avoidance (Epping-
Jordan et al., 1994), have also exhibited relationships with shorter survival.  
Observational studies on psychosocial factors and survival have been criticized, 
with one review of this literature concluding that there was little convincing evidence of a 
relationship (Petticrew, Bell, & Hunter, 2002). This review cited several studies reporting 
no significant association between psychosocial factors and cancer survival, with these 
studies outnumbering those with a significant relationship for most psychosocial factors 
included in this review. For studies that have not statistically controlled for known 
potential confounding variables such as age and disease stage (Sainsbury, Anderson, & 
Morgan, 2000), the validity of significant findings has been questioned. The possibility of 
publication bias has also been raised, as studies linking psychosocial factors with cancer 
survival generally had smaller sample sizes than those reporting no significant 
relationship (Petticrew et al., 2002). Because studies with a larger sample size have 
greater statistical power to detect a positive relationship, it is surprising that studies with 
a positive finding have smaller sample sizes. Still, it is unclear whether the oddity in 
sample sizes is attributable to publication bias. Based on currently available information 
from observational studies on psychosocial factors and cancer progression, an influence 
of psychosocial factors on progression can not be confirmed, but trends in this literature 
are noteworthy. Significant findings reported by observational research have exhibited a 
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trend toward prolonged survival that is associated with active coping (Faller, Bulzebruck, 
Drings, & Lang, 1999) and availability of psychosocial resources (Weihs et al., 2005). 
Conversely, shortened survival has been associated with avoidant coping and symptoms 
consistent with depressive states. A number of studies have also observed no significant 
relationship with survival using the same or similar psychosocial variables (Petticrew et 
al., 2002). Based on these inconsistencies, it seems reasonable to suggest that if a 
relationship exists between psychosocial variables and survival, it may vary as a function 
of a number of possible variables such as disease site and stage. 
In addition to observational literature on coping and psychosocial resources, the 
possibility that psychotherapeutic intervention could influence cancer survival has been 
investigated after randomized prospective trials showed evidence of increased survival 
time for patients with metastatic breast cancer (Spiegel, Bloom, Kraemer, & Gottheil, 
1989) and other cancers (Fawzy et al., 1993; Kuchler, Henne-Bruns, Wood-Dauphinee, 
Bestmann, & Rappat, 1999), with a survival effect also observed in a mixed cohort study 
(Richardson, Shelton, Krailo, & Levine, 1990). Although psychotherapeutic intervention 
targets quality of life improvements, the possibility of prolonged survival as a secondary 
benefit spawned further research. However, while subsequent interventions have 
generally achieved the goal of decreasing psychological distress, several psychological 
interventions in patients with breast cancer have not shown increased survival 
(Cunningham et al., 1998; Edelman, Lemon, Bell, & Kidman, 1999;Goodwin et al., 
2001).  
Research into the possibility that psychosocial intervention could prolong 
survival, in addition to enhancing quality of life, has been controversial. Reviewers have 
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noted the initial study reporting prolonged survival (Spiegel et al., 1989) was not 
originally designed with the intention of testing survival and consequently did not have a 
sufficient sample size for this analysis. As noted by Speigel, Kraemer, and Bloom (1998), 
larger samples are generally desirable for detecting between-group differences, not for 
supporting the null hypothesis. Questions have also arisen regarding the use of mean, as 
opposed to median, survival times in comparing treatment and control groups on the basis 
that survival curves are typically skewed, suggesting that the median would be a better 
indicator of central tendency (Coyne, Stefanek, & Palmer, 2007). Although patients were 
randomized to treatment and control groups in this study, subsequent review argued that 
the control group was anomalous because the survival times of these patients were lower 
than geographically-matched women with metastatic breast cancer from an available 
database (Fox, 1998). Though this is an interesting and useful hypothesis, but it is 
important to keep in mind that a control group assigned randomly from within the study 
sample is a more internally valid comparison group than a community database (Spiegel, 
Kraemer, & Bloom, 1998). Randomization is the preferred method for eliminating bias in 
group selection. Despite the best efforts of researchers, the samples that comprise 
interventions are treatment-seeking individuals that are willing to participate in research 
and may systematically vary in other ways that are different from the population of all 
patients in the community with cancer. 
Two meta-analyses of psychosocial intervention and survival have been 
published. Chow, Tsao, and Harth (2004) found no effect of intervention on 1-year or 4-
year survival for all cancers or for metastatic breast cancer, in particular. This report 
noted that the available data were insufficient for evaluating a small effect size for 
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survival (Chow et al., 2004). Another meta-analysis found that individual, but not group, 
interventions exhibited a significant effect on prolonged survival, though only three 
studies of individual therapy were included in this analysis (Smedslund & Ringdal, 
2004). Spiegel and Giese-Davis (2003), in their review of studies on group therapy and 
survival, found that 5 of 10 studies reported a prolonged survival effect, and no studies 
reported a survival deficit related to psychotherapeutic intervention. More recent 
randomized prospective trials have also found no effect of psychotherapeutic intervention 
on survival (Goodwin et al., 2001; Kissane et al., 2007; Kissane et al., 2004). The 
absence of a survival effect in a majority of studies questions the robustness of the 
survival effect. It has been noted that the proportion of studies finding an effect of 
psychosocial intervention on survival is greater than the proportion expected to be 
observed by chance alone (Spiegel, 2002). In addition, no trials have reported decreased 
survival for the treatment group, as compared to the control group, a further departure 
from the expected pattern if no relationship existed between psychosocial intervention 
and survival. Still, the possibility of publication bias in favor of positive results exists 
(Palmer & Coyne, 2004).  
Similarly, intervention research has produced inconsistent results. Based on the 
existing data, a robust, moderate or large effect of psychotherapeutic intervention on 
survival seems unlikely, but an effect of psychotherapeutic intervention on survival that 
is small or restricted to certain conditions may be present. One striking trend in research 
on a survival effect is that trials reporting a significant survival effect were generally 
conducted longer ago, with more recent trials noting no survival advantage (Goodwin et 
al., 2001;Kissane et al., 2007; Kissane et al., 2004; Spiegel et al., 2007). Spiegel (2002) 
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commented that medical treatments and outcomes have advanced significantly since the 
initial trials were conducted. Concurrently, support group availability and public 
awareness and support of women with breast cancer have increased. As a result, the 
variance in survival previously contributed by intervention may now be provided by 
available social support and medical care.  
In further reviewing the interventions that exhibited prolonged survival effects, 
among the common elements specified as “necessary but not sufficient” (Spiegel, 2002) 
for producing beneficial survival was quality of life improvement. In line with the 
emphasis on quality of life improvement, the learning of coping skills was identified as 
an essential component to interventions that may provide a survival benefit (Spiegel, 
2002). Quality of life improvement is interesting in part because this was the achieved 
target outcome for the initial trial that reported survival benefits for treatment participants 
(Spiegel & Bloom, 1981), and an intervention that did not improve quality of life would 
not be expected to improve survival (Coyne, Stefanek, & Palmer, 2007). The promotion 
of quality of life improvements seems appropriate as a primary target of 
psychotherapeutic intervention for patients with cancer regardless of the conclusion 
provided by research into associated survival benefits.  
The absence of a survival effect in more recent randomized trials with breast 
cancer patients presents compelling evidence that there is no current survival effect, 
though it may have been present prior to alterations in the culture surrounding breast 
cancer diagnosis and treatment. Improvement in quality of life outcomes underscore the 
utility of continued psychosocial intervention and presents an opportunity for needed 




Coping Mechanisms Targeted by Interventions 
One motivation for investigating coping is that coping skills training has often 
been a component of psychosocial interventions with demonstrated effectiveness (Antoni, 
Wimberly, et al., 2006). Successful psychosocial interventions in patients with breast 
cancer have generally incorporated active coping strategies, presumably to replace 
avoidance strategies. The act of engaging in a psychosocial intervention is essentially a 
form of active coping in the sense that the patient likely expects to confront the diagnosis 
of breast cancer and reactions to the diagnosis.   
Interventions for patients with breast cancer have aimed to enhance social 
support. In most group interventions, patients likely benefit from the social support 
provided by other group members (Spiegel & Diamond, 2001). Social support can consist 
of instrumental support that provides advice, assistance, or information. Social support 
can also be useful in ameliorating the effects of breast cancer through the provision of 
emotional support. The social support from group therapy provides the opportunity to 
interact with other people that are facing similar stressors and are typically more 
comfortable discussing breast cancer-related distress and fears of death and dying 
(Spiegel & Diamond, 2001).  
Supportive expressive group therapy (SET), one treatment used in breast cancer 
patients, facilitates emotionally expressive discussion on fears of dying and death, 
reordering life priorities, improving support from and communication with family and 
friends, integrating a changed self and body image, and improving communications with 
physicians (Spiegel & Classen, 2000). By facilitating emotional expression, SET 
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promotes active coping in that patients engage with the emotional effects of the stressor, 
breast cancer. Research has supported the usefulness of coping with cancer through 
actively processing and expressing emotions (Stanton et al., 2000). Emotional expression 
may benefit patients through a decrease in the use of avoidant coping strategies such as 
suppression (Giese-Davis et al., 2002) and repression as coping methods (Spiegel & 
Diamond,  2001).   
Finding meaning is relevant to coping with cancer in light of the existential 
concerns presented when diagnosed with a life-threatening illness. Park and Folkman 
(1997) extended the transactional model of stress and coping to include meaning-making 
coping, conceptualizing it as “a coping process that is initiated by recognition of a 
discrepancy between an individual’s appraised personal significance of an event and that 
individual’s global beliefs” (p. 121). They described the resolution of these discrepancies 
through 1) reappraisal of an event to assimilate it into the existing global meaning 
structure, or 2) modifying the global meaning structure in a way that is consistent with 
the event. Because this process requires active cognitive processing of the event, 
situational meaning, and global meaning, avoidant coping that reduces awareness of the 
stressor is a barrier to meaning-making coping. In contrast, emotional expression 
regarding existential concerns is central to SET, as well as other interventions for patients 
with breast cancer (Chan et al., 2006; Classen et al., 2001; Lee, Cohen, Edgar,  Laizner, 
& Gagnon, 2006;Spiegel et al., 1989). This focus on existential concerns may allow 
meaning-making coping to take place. 
 Social-cognitive theory (Bandura, 1986) emphasizes reciprocal interactions 
between the person, behavior, and the environment in explaining the acquisition and 
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maintenance of behavior patterns. Social-cognitive theory includes the concept of self-
efficacy, a person’s confidence in his or her ability to perform a specific behavior 
(Bandura, 1977). Because self-efficacy for a given behavior is a strong predictor of the 
person’s exhibiting that behavior (Bandura, 1977), it is a variable of interest. SET has 
increased patients’ self-efficacy to focus on and enjoy the present (Fobair et al., 2002). 
Self-efficacy for enjoying the present describes an individual that feels confident in 
producing positive, present-focused experiences, which is more characteristic of active 
coping. Because avoidant coping is incompatible with self-efficacy, an increase in self-
efficacy is consistent with active coping, but it should be noted that self-efficacy is not 
classified as a coping method.  
It is also noteworthy that didactic teaching of coping skills is not part of SET. 
Rather, active coping strategies such as seeking social support, emotional expression, and 
cognitive reappraisal seem to be integrated into the treatment process, and these activities 
are inconsistent with the use of avoidant coping strategies. Regarding outcomes, patients 
in SET interventions have exhibited evidence of treatment gains including reductions in 
trauma symptoms (Classen et al., 2001; Fobair et al., 2002; Spiegel et al., 1999), a target 
of particular interest in patients with breast cancer. Patients participating in SET have 
also reported decreased mood disturbance (Classen et al., 2001; Fobair et al., 2002; 
Goodwin et al., 1998; Goodwin et al., 2001; Spiegel & Bloom, 1981; Spiegel et al.,1999) 
and  anxiety (Fobair et al., 2002; Spiegel & Bloom, 1981; Spiegel et al., 1999), 
presenting evidence that the coping strategies embedded within this therapy may 
influence psychiatric morbidity. SET has also exhibited evidence of effectiveness in 
quality of life variables such as improved sleep (Fobair et al., 2002) and reduced pain 
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(Fobair et al., 2002; Goodwin et al., 2001; Spiegel & Bloom, 1981). Finally, participation 
in SET may promote improved nutrition (Goodwin et al., 1998).  
 In addition to SET, other interventions have been used in a number of studies of 
patients with breast cancer. Mindfulness-Based Stress Reduction (MBSR; Kabat-Zinn, 
1990) is an intervention that utilizes meditation, yoga, focus on body sensations, and 
group processes to cultivate mindfulness, a nonjudgmental awareness of moment to 
moment experiences. MBSR includes discussion of mindfulness and acceptance, and 
formally includes relaxation techniques such as yoga as part of the intervention. MBSR 
also utilizes a body scan technique that encourages focus on physical sensations, even 
those that are aversive and that patients may attempt to block from consciousness.  
 There is no consensus on the ways in which MBSR maps onto traditional 
conceptualizations of coping, but there is some available research literature on the topic. 
Activities such as meditation, yoga, and the body scan practiced in MBSR could be 
employed in response to stressors and would provide a concrete active coping effort to 
patients. Because avoidant coping involves attempts to remove distressing thoughts from 
consciousness, the promotion of awareness that permeates MBSR runs counter to many 
avoidant coping efforts. One study investigating the use of coping strategies in MBSR 
participants has supported the notion that they generally report increased active coping 
and decreased avoidant coping (Wilson, 2006). Examination of an intervention study has 
revealed that the increased use of acceptance associated with participation in this 
intervention mediated improved hemoglobin A1c levels in patients with diabetes (Gregg, 
Callaghan, Hayes, & Glenn-Lawson, 2007). Patients in MBSR interventions have 
exhibited evidence of treatment gains including reduced stress (Carlson, Speca, Patel, & 
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Goodey, 2003; Carlson, Speca, Patel, & Goodey, 2004), improved quality of life (Carlson 
et al., 2003) (Carlson et al., 2004), sleep (Carlson et al., 2003), and changes in the 
production of cytokines (Carlson et al., 2003), an essential component of the immune 
system. 
Cognitive-behavioral therapy (CBT) has also been implemented for women with 
breast caner. CBT is based on the idea that there are interactions between thoughts, 
behaviors and emotions. This treatment orientation is the one most closely aligned with 
the promotion of coping skills to be used in addressing stressors, and coping skills are 
sometimes taught in a didactic manner. Confidence in these coping skills has shown 
evidence of mediating the effect of intervention on quality of life outcomes, suggesting 
that coping is essential to the relationship between the diagnosis of breast cancer and 
clinically relevant outcomes (Antoni, Lechner, et al., 2006). 
 Several CBT interventions with breast cancer patients have formally incorporated 
problem solving coping strategies (Cimprich et al., 2005; Doorenbos et al., 2005). 
Problem solving is a domain of coping that encompasses several subsets of coping efforts 
directed at altering the stressor (Carver et al., 1989). Problem solving typically consists of 
assessment of the problem, generation of possible actions aimed at solving or altering the 
problem, decision making, and implementation of the chosen plan (D'Zurilla & Nezu, 
2001). Behavioral health goals such as smoking cessation, enhanced nutrition, and 
increased physical activity have been targeted in breast cancer patients. This strategy can 
be seen as a form of problem solving coping in the context of physical illness because 
this coping strategy addresses the stressor, breast cancer, which is likely appraised by the 
patient as threatening or harmful to her health, through health-promoting behavior.  
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 Methods of promoting relaxation are often provided in CBT interventions. These 
strategies are typically suggested as methods of coping with and reducing anxiety 
(Antoni, Wimberly, et al., 2006). Muscle relaxation and relaxing imagery techniques 
have been used with patients with breast cancer (Antoni, Wimberly, et al., 2006). Muscle 
relaxation typically consists of alternating tensing and relaxing of major muscle groups, 
while imagery typically consists of visualizing a relaxing situation (Greenberger & 
Padesky, 1996). These strategies are intended to arm patients with a way to ameliorate 
the anxious symptoms associated with breast cancer, preparing patients to cope with the 
stressor. The ability to enact active coping responses provides a viable alternative to 
avoidant coping strategies. Consequently, the frequency of avoidant coping strategies 
may be reduced. 
 Reappraisal of stressors, as described above, is another coping skill that has been 
included in CBT interventions in patients with breast cancer (Antoni, Wimberly, et al., 
2006; Northouse, Kershaw, Mood, & Schafenacker, 2005). Improved communication 
skills aimed at enhancing social support are also formally taught in CBT interventions 
(Andersen et al., 2006) 
Breast cancer patients in CBT interventions have exhibited evidence of treatment 
gains including reduced breast cancer-related intrusive thoughts (Antoni, Wimberly, et 
al., 2006). Available research also suggests that CBT is effective in reducing anxiety 
(Antoni, Wimberly, et al., 2006; Cimprich et al.,  2006), general distress (Simpson, 
Carlson, & Trew, 2001; Tatrow & Montgomery, 2006), providing additional support for 
the notion that active coping strategies are related to decreased psychiatric 
symptomatology. Studies of  CBT with breast cancer patients have noted improved pain 
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experience (Arathuzik, 1994; Tatrow & Montgomery, 2006), reduced social disruption 
(Antoni, Lechner, et al., 2006), decreased limitations associated with cancer-related 
symptoms (Doorenbos et al., 2005), and decreased serum cortisol (Cruess et al., 2000); 
improvements in mood (Antoni, Lechner, et al., 2005; Lewis, Casey, Brandt, Shands, & 
Zahlis, 2006; Simpson et al., 2001), perceived social support (Andersen et al., 2004; 
Cimprich et al., 2005),  behavioral health (Andersen et al., 2004; Cimprich et al., 2005), 
treatment adherence (Cimprich et al., 2005),  and quality of life (Simpson et al., 2001), 
increased perceptions of benefits related to breast cancer (Antoni, Lechner, et al., 2006; 
Cruess et al., 2000; McGregor et al., 2004), and improvements in indicators of immunity 
(Andersen et al., 2004; McGregor et al., 2004). 
 
Daily Assessments 
 One feature of the transactional model of stress is that coping outcomes are likely to 
affect appraisals or future coping efforts. Successful coping efforts might lead to 
decreased stress appraisals, while unsuccessful coping efforts might lead to increased 
stress appraisals and altered coping strategies. As this process is repeated, memories of 
coping efforts will be expected to be altered. The transactional model predicts that 
success or failure of coping efforts would alter the stressor, stressor-relevant appraisals, 
and subsequent coping efforts. Thus, assessments of coping are likely to be highly 
dependent on the time of assessment (Tennen & Affleck, 1996). A stressor could initially 
be countered using denial, but after the stressor persists for several days, problem-solving 
strategies could be used. If problem solving proves unsuccessful, the individual may cope 
by seeking emotional social support. The coping method reported by this individual could 
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be denial, problem-solving, or seeking social support depending on the time of 
assessment. Further, a trait-oriented assessment asking for a retrospective report of the 
person’s typical coping strategy may yield a commonly employed coping effort. 
However, this coping effort may not be used in response to the stressor of interest in a 
given situation. The discrepancy between retrospective and daily assessments of health-
relevant information is supported by recall bias in chronic pain (Erskine, Morley, & 
Pearce, 1990; Larsen, 1992) and panic attacks (Margraf, Taylor, Ehlers, Roth, & Agras, 
1987; Rapee, Craske, & Barlow, 1990). In the same population, comparisons between 
retrospective and daily assessments found that infrequently employed coping strategies 
were significantly less likely to be recalled in retrospective reports as opposed to daily 
assessments (Porter & Stone, 1996). 
 While many valuable findings have emerged from the coping literature, research 
methods have in some ways been inconsistent with the transactional model of stress 
(Lazarus, 2000). The rapidly fluctuating stress, coping, and adaptation process proposed 
by this model suggests that retrospective report may be clouded by the success or failures 
of coping efforts employed over the period of time for which respondents are reporting. 
In response to this problem, coping assessments have been developed that focus on 
measuring the coping process over a period of consecutive days. For example, diaries and 
other self-report measures can be used to assess dynamic processes, such as day-to-day 
coping. Use of such measures minimizes retrospective reporting bias due to assessments 
that occur closer to the time of occurrence (Tennen & Affleck 1996). Furthermore, 
individual data sets can be aggregated and group trends studied, preserving the strengths 




Stress-related cortisol secretion has often been measured by noting the total 
cortisol secretion in a given period of time or the cortisol level at one point during the day 
(Kirschbaum & Hellhammer, 1994). Another marker of HPA axis activity is the deviation 
of circadian cortisol rhythms. In approximately 90% of healthy people, cortisol levels 
begin to rise immediately prior to awakening, peak 30-45 minutes after awakening, and 
decrease slowly throughout the rest of the day (Posener, Schildkraut, Samson, & 
Schatzberg, 1996). Diurnal cortisol slopes have been reported to exhibit significant 
variation between individuals, with a small proportion of healthy individuals exhibiting 
flat slopes (Stone et al., 2001). 
Perhaps due to the sensitivity of the HPA axis to stress appraisals, studies have 
observed an association of psychosocial variables with disrupted circadian physiological 
functioning (Antoni, Lutgendorf, et al., 2006). In two different samples of patients with 
metastatic breast cancer, lower perceived social support was related to disrupted circadian 
cortisol slopes (Abercrombie et al., 2004; Turner-Cobb, Sephton, Koopman, Blake-
Mortimer, & Spiegel, 2000). Depression has been linked with persistently elevated 
cortisol levels throughout the day (Deuschle et al., 1997). In another study, participants 
who were unemployed exhibited significantly decreased evening cortisol levels relative 
to their employed counterparts (Ockenfels et al., 1995). While findings are mixed, a 
number of studies have found that people with PTSD exhibit diminished total daily 
cortisol secretion and disrupted circadian cortisol profiles marked by a flattened diurnal 
cortisol slope (Miller, Chen, & Zhou, 2007), without the morning elevations and evening 
nadir characteristic of many healthy individuals (Posener et al., 1996). 
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Intrusions and Physiology 
As a type of distress, it is not surprising to note that intrusions are associated with 
alterations in physiology. The presence of breast cancer-specific intrusions was 
associated with elevated cortisol during the work period in healthy women (Dettenborn, 
James, Valdimarsdottir, Montgomery, & Bovbjerg, 2006). In Three Mile Island-area 
residents, disaster-specific intrusions were associated with increased cortisol, 
epinephrine, norepinephrine, and cortisol obtained by collecting urine between 6 p.m. and 
9 a.m. Intrusions were also related to increased heart rate and systolic blood pressure 
(Davidson & Baum, 1986). Intrusions have also been linked with immunosuppression in 
students anticipating an examination (Workman & La Via, 1987). In addition, in men 
undergoing testing for HIV, intrusions were correlated with increased plasma cortisol on 
the day of sample collection at 1 week, 3 weeks, and 5 weeks after being informed of test 
results. To reduce confounding from diurnal variation in cortisol values, blood samples 
were provided by fasting participants between 7:30 a.m. and 10:30 a.m. (Antoni et al., 
1990). Finally, men that were within 1.5 years of returning from Operation Desert Storm 
combat in Iraq exhibited evidence of a relationship between increased intrusions and 
hypersensitivity to inhibition of cortisol secretion, one indicator of HPA axis dysfunction. 
(Kellner, Baker, & Yehuda, 1997). Sensitivity to inhibition of cortisol secretion was 
tested with the administration of a synthetic steroid called dexamethasone the night prior 
to saliva collection. Because dexamethasone inhibits ACTH production, it typically 
suppresses the level of cortisol secreted the following morning. The dexamethasone test 
is used to assess the response of the HPA axis to inhibitory mechanisms (Kirschbaum & 
Hellhammer, 1994). Taken together, these reports point to intrusions as a variable of 
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particular interest in research on the effects of psychological distress on physiology, 
specifically cortisol. 
 
Circadian Cortisol Rhythms and Trauma 
 While the majority of research has supported the notion of increased cortisol 
secretion in response to stress, the majority of studies of individuals that have been 
exposed to traumatic events and developed PTSD have observed decreased cortisol 
secretion (Miller et al., 2007). However, conflicting results have been noted across 
studies. Yehuda (2002) reviewed studies of cortisol and trauma and concluded that 
individuals exposed to trauma exhibited normal morning elevations in cortisol, but a 
lower nocturnal cortisol nadir. A more recent meta-analysis found that individuals with 
PTSD were characterized by consistently decreased cortisol output throughout the day, 
with a flat diurnal slope. This review also found that time since the traumatic event was 
negatively correlated with overall cortisol output and attributed conflicting findings to 
variability in time since the stressor (Miller et al., 2007) Among the studies included in 
this meta-analysis, the length of time since the trauma ranged from 1-720 months.  
 The distinct diurnal cortisol profiles of people with PTSD could be related to the 
unique features of this disorder. The Diagnostic and Statistical Manual of Mental 
Disorders, 4th Edition (DSM-IV; APA, 1994), criteria include a response of “intense, fear, 
helplessness, or horror” to the traumatic event. The DSM-IV criteria also specify that the 
individual re-experiences the event, suggesting that the intense responses that occurred 
during the original event recur during the course of the disorder. The typical diurnal 
cortisol profile has been conceptualized as healthy cortisol output for an individual that is 
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not experiencing stress (Miller et al., 2007) because the decrease in cortisol throughout 
the day allows for healing and growth following a short-term adaptation to awakening 
through a cortisol increase (Epel & McEwen, 1998). In contrast, the flattened diurnal 
cortisol slope characteristic of individuals who have experienced a traumatic event and of 
patients with breast cancer could be viewed as an adaptive response to a chronic stressor 
in that the individual must have energy available at all times to counter the stressor and 
can not afford a decrease in cortisol throughout the day (Miller et al., 2007). 
Nevertheless, a constant level of cortisol throughout the day has several potential costs. 
First, invariability of cortisol availability could render the person less able to mount an 
increased response to an acute stressor (Epel & McEwen, 1998). Second, the allostatic 
load that can occur with chronic overactivation of the HPA axis could leave the person 
vulnerable to illness onset or progression (McEwen & Stellar, 1993). Perhaps most 
importantly, the disruption of circadian rhythmicity itself may be associated with illness 
onset or progression (Antoni, Lutgendorf, et al., 2006). 
 
Circadian Rhythms and Cancer 
Although not studies of cortisol rhythms, several studies of women with abnormal 
circadian activity rhythms have supported a link of these rhythms with elevated breast 
cancer vulnerability (Davis, Mirick, & Stevens, 2001; Pukkala, Auvinen, & Wahlberg, 
1995; Schernhammer et al., 2001). Disruption of circadian rhythms has been identified as 
one possible contributor to the increased breast cancer incidence observed in women 
whose occupations expose them to light at night time, resulting in an abnormal pattern of 
activity and environmental stimuli. These large, epidemiological studies typically 
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matched women with breast cancer diagnoses to control cases to compare the groups in 
terms of night shift work. In one study, 7,035 Danish women employed in various 
occupations that required work at night for at least one year exhibited elevated breast 
cancer incidence as a group when compared to matched, employed control women 
(Hansen, 2001). Additionally, within the sample of night shift workers in this study, 
increased night shift work was related to increased breast cancer incidence. Similar 
findings were reported in a study of 78,562 nurses in the United States that worked at 
least three night shifts per month for at least one year. This study found that nurses 
working at least 30 years of night shifts had increased breast cancer incidence relative to 
nurses that had never worked rotating night shifts (Schernhammer et al., 2001). Night 
shift work was also related to breast cancer incidence in a study matching women in the 
United States diagnosed with breast cancer to age-matched controls recruited through 
random-digit dialing (Davis et al., 2001). 
Prior to these studies on breast cancer incidence in women performing shift work, 
a study of Finnish flight attendants examined the relationship between this occupation 
and breast cancer incidence. These flight attendants exhibited an elevated rate of breast 
cancer incidence relative to the rate observed in the general population (Pukkala et al., 
1995). Although circadian disruption was not proposed as the mechanism for increased 
incidence in this study, flight attendants often perform night shift work and are exposed 
to inconsistent light/dark rhythms due to travel, suggesting circadian disruption as a 
possible mechanism. As a whole, these studies support the relevance of sleep/wake 
rhythms in cancer incidence. The precise mechanism of the connection between 
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sleep/wake rhythms and breast cancer incidence is not established. Also of interest is the 
question of whether sleep/wake rhythms and cancer progression influence one another. 
The circadian physiological system is influenced by melatonin, a hormone 
secreted by the pineal gland, which registers the amount of light taken in by the eye. 
Using this input, the pineal gland alters the sleep-wake cycle by secreting more melatonin 
when it registers less light, thus cueing sleep. Melatonin levels typically peak at night and 
suppress estrogen production, but exposure to light inhibits the melatonin peak. As a 
result, night shift work may lead to increased estrogen in the body, a factor related to 
increased risk of breast cancer (Davis et al., 2001). Thus, melatonin is one possible 
mechanism for the observed effect of night shift work on breast cancer incidence 
(Bartsch & Bartsch, 2006; Stevens, 2006). While this mechanism is promising, other 
possible effects of circadian disruption could also bring about alterations in cancer 
incidence. 
An estimated 30-70% of patients with breast cancer exhibit disruption of 
circadian cortisol rhythms marked by limited diurnal variation, elevated cortisol secretion 
throughout the day, or erratic profiles (Sephton & Spiegel, 2003). Flattened diurnal 
cortisol rhythms have been demonstrated in women with breast cancer (Abercrombie et 
al., 2004; Carlson et al., 2004) as well as a sample consisting of patients with cancer at 
varied sites (Touitou, Bogdan, Levi, Benavides, & Auzeby, 1996). Cancer patients also 
have altered metabolic, immunologic and rest-activity rhythms with greater circadian 
disturbance in more advanced cases (Mormont & Levi, 1997).  
The ability of circadian cortisol rhythms to predict disease progression was 
investigated in women with metastatic breast cancer that were recruited to participate in a 
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trial of Supportive/Expressive group therapy (SET). These women provided saliva 
samples at 8am, noon, 5pm, and 9pm on three consecutive days prior to randomization to 
treatment or control groups. This allowed for calculation of a diurnal cortisol slope by 
regressing collection times on cortisol values. A flatter diurnal cortisol slope, in contrast 
to the decrease in cortisol levels throughout the day that is characteristic of circadian 
rhythmicity, was a significant predictor of mortality in this sample (Sephton, Sapolsky, 
Kraemer, & Spiegel, 2000). This effect was independent of immune factors including the 
numbers and activity of natural killer (NK) cells, an immune cell type that is particularly 
important in tumor resistance. Other variables correlated with the diurnal cortisol slope 
were statistically controlled in subsequent analyses. These variables included metastasis 
to the chest wall or lymph nodes, as opposed to bones or internal organs, taking the 
medication megestrol, nocturnal awakenings, and marital disruption. The predictive 
ability of the diurnal cortisol slope was independent of each of the potential confounds 
tested. The effect of the diurnal cortisol slope on survival was also independent of the 
effects of common prognostic factors including age at diagnosis, estrogen receptor status, 
and disease-free interval (Sephton et al., 2000). Survival was assessed an average of 5.9 
years (range = 3.1-7.7) after cortisol data were collected. The robust relationship between 
the diurnal cortisol slope and survival identified circadian cortisol rhythms as an 
important variable for future research.  
Interestingly, the circadian cortisol rhythm was not retained in a model predicting 
prolonged survival using clinical predictors and the rest-activity rhythm. Additionally, the 
rest-activity measure employed in this study was not significantly associated with the 
circadian cortisol rhythm. This finding stands in contrast to the studies reviewed above 
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reporting an association between sleep and circadian cortisol rhythms. Part of the 
explanation for this finding may lie in the methodology. Serum samples used to measure 
the circadian cortisol rhythm were collected at 8 a.m. and 4 p.m. on two consecutive 
days. The circadian rhythm was estimated by subtracting the 4 p.m. value from the 8 a.m. 
value to yield a difference score for each subject (Mormont et al., 2000). The study 
reporting the diurnal cortisol slope as a predictor of survival in patients with metastatic 
breast cancer sampled saliva on three consecutive days at four time points: 8 a.m., noon, 
5 p.m. and 9 p.m. (Sephton et al., 2000). The circadian rhythm was operationally defined 
by a diurnal slope derived from a regression of cortisol values on collection times. The 
latter design benefits from an additional day of collection, and the added sampling times 
likely increased the reliability of the assessment of the diurnal rhythm (Kraemer et al., 
2006). The collection of four samples throughout the day also offers potential benefit 
because of added variability assessed in cortisol secretion. In addition, because the 4 p.m. 
sample in the Mormont et al. study was the final sample taken, the evening nadir 
characteristic of typical cortisol profiles was replaced in this analysis by an afternoon 
value (Mormont et al., 2000). This reduced variability could have contributed to limited 
predictive ability of the circadian cortisol rhythm and the absence of an association with 
the rest-activity rhythm (Mormont et al., 2000). Saliva samples assess the level of free 
cortisol, the amount that is unbound and active. Because serum samples assess the total 
cortisol level, variance in circadian cortisol rhythms is introduced by the sampling 
method employed. Finally, the regression slope employed in the Sephton et al. (2000) 
study fits well with the concept of changes in cortisol availability with respect to time 
throughout the day, while the difference between the two values employed in the 
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Mormont et al. study indicates the magnitude of the difference between these two 
measurements. Still, it is unclear whether differing methodologies account for the lack of 
an association between rest-activity and circadian cortisol rhythms in this study. 
Animal studies have also supported a relationship between circadian rhythms and 
cancer progression. In mice, mutations to genes essential to circadian rhythmicity are 
related to faster tumor progression (Fu & Lee, 2003; Fu, Pelicano, Liu, Huang, & Lee, 
2002). Similarly, destruction of the murine suprachiasmatic nuclei that control circadian 
rhythms of motor activity and adrenocortical secretion has produced faster tumor 
progression (Filipski et al., 2002). 
Research on the diurnal cortisol decrease has been complemented by research on 
the cortisol awakening response (CAR). These studies focus on the rise in cortisol that 
typically follows awakening. An increased CAR has been linked with stress (Schlotz, W., 
Hellhammer, J., Schulz, P., & Stone, A., 2004) and symptoms of depression (Pruessner, 
Hellhammer, Pruessner, & Lupien, 2003). Conversely, a diminished CAR has been 
linked with PTSD (Rohleder, Joksimovic, Wolf, & Kirschbaum, 2004), poor sleep in 
patients with insomnia (Backhaus, Junghanns, & Hohagenet al., 2004), people with 
chronic fatigue (Roberts, Wessely, Chalder, Papadopoulos, & Cleare, 2004), clinical 
depression (Huber, Issa, Schik, and Wolf, 2006), and job burnout (Pruessner et al., 1999).  
Cortisol typically reaches its nadir early in the evening, with a rise shortly prior to 
awakening (Wilhelm, Born, Kudielka, Schlotz, Wust, 2007). Under laboratory 
conditions, an increase in cortisol during the period immediately preceding awakening 
was negatively correlated with the CAR (Wilhelm et al., 2007). These results may be 
reconciled with research indicating that a later awakening time is associated with a 
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decreased CAR in nonclinical samples (Stetler & Miller, 2005). With this in mind, an 
increased CAR could be indicative of disrupted circadian rhythmicity marked by an 
insufficient pre-awakening cortisol rise. However, the majority of CAR studies have 
concluded that the CAR is driven by awakening, rather than by circadian cortisol 
rhythms, suggesting no effect of sleep variables on the CAR aside from the time of 
awakening (Hucklebridge, Clow, Rahman, & Evans, 2000; Stetler & Miller, 2005). 
In contrast to studies suggesting that disruption of circadian rhythms may pose a 
risk of cancer and stress-related conditions, new data present the potentially positive 
effects of circadian regulation, suggesting that normalizing circadian periodicity may 
promote tumor defense and enhance treatment effects (Fu & Lee, 2003). A cognitive-
behavioral stress management intervention has resulted in reductions in serum cortisol in 
breast cancer patients (Cruess et al., 2000), and a behavioral intervention also observed 
reduced serum cortisol in patients randomized to the treatment group (Schedlowski, Jung, 
Schimanski, Tewes, & Schmoll, 1994). Patients with breast cancer who participated in a 
mindfulness-based stress reduction (MBSR) intervention also reduced saliva cortisol 
levels at post-treatment, but only for those patients with elevated cortisol at the outset of 
the study (Carlson et al., 2004), an effect also observed in plasma cortisol in an 
experiential-existential group therapy intervention (van der Pompe, Duivendoorden, 
Antoni, Visser, Heijnen, 1997). In the MBSR study, a reduction of cortisol in patients 
exhibiting patterns marked by abnormally high afternoon values was also observed 
(Carlson et al., 2004). A meditation intervention in healthy male adults resulted in 
lowered morning basal cortisol levels and increased reactivity of cortisol to laboratory 
stressors (MacLean et al., 1997). Increased responsivity to an acute stressor is likely a 
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healthy endocrine response enabling short-term adaptation to environmental demands 
(Epel & McEwen, 1998). Given more recent results underscoring the importance of the 
circadian rhythm, future interventions measuring cortisol could investigate whether 
reductions in overall cortisol are accompanied by regulated circadian cortisol rhythms. 
Given these findings, the possible role of circadian disruption as a mechanism for 
explaining the negative effects of psychosocial variables on disease is an important area 
of research. The role of coping in mitigating deleterious effects of stress on circadian 
disruption and quality of life is also in need of clarification. 
 
Circadian Disruption in Response to Acute Stressors 
 Although conceptualizations of the destructive effects of stress on physiological 
responses have often focused on the wear and tear that may result from exposure to 
chronic stressors, disruption of circadian rhythms can also result from acute stressors. 
High intraindividual variability in the morning cortisol increase and diurnal cortisol slope 
has been noted between consecutive days of saliva sampling (Kraemer et al., 2006). The 
morning cortisol increase, in particular, has been found to be sensitive to psychological 
states such as stress (Hellhammer et al., 2007). This suggests that diurnal cortisol profiles 
are responsive to acute events or psychological states, as opposed to being stable 
characteristics that are only altered slowly over time.  
 
Implications of Circadian Disruption 
Further research is needed to clarify the implications of disrupted circadian 
cortisol and rest-activity rhythms. These disruptions may be implicated in a poor 
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response of this system to acute environmental stressors. This view is supported by 
studies indicating altered circadian cortisol profiles in patients reporting depression 
(Giese-Davis, et al., 2006; Lupien et al., 1999), a condition that typically incorporates 
perceptions of helplessness and hopelessness, as well as inactivity. Similarly, laboratory 
studies have noted a blunted cortisol response to social stressors (Burke, Davis, Otte, & 
Mohr, 2005) and a blunted response to administration of a corticosteroid medication 
called dexamethasone in those reporting depression (Burke et al., 2005; Giese-Davis et 
al., 2006). 
In recent work on circadian cortisol rhythms in women with breast cancer, a 
flattened diurnal cortisol slope appeared to be related primarily to elevated evening 
cortisol levels, with no relationship observed between the diurnal slope and awakening 
levels. However, a flatter diurnal slope was associated with a more dramatic cortisol 
increase in the 30 minutes after awakening. It should be noted that the awakening cortisol 
value, and not the 30 minute post-awakening value, is used in calculating the diurnal 
cortisol slope. In addition, the diurnal slope was not significantly associated with social 
stress produced by the Trier Social Stress Test, suggesting that disrupted rhythms are not 
due to acute stress. Rather, a flattened diurnal cortisol slope was associated with 
diminished suppression of morning cortisol secretion in response to dexamethasone 
administration. Dexamethasone acts on inhibitory mechanisms that reduce the secretion 
of ACTH by the pituitary gland and, subsequently, the secretion of cortisol by the adrenal 
gland. Because dexamethasone administration is expected to decrease cortisol secretion, 
the blunted response in patients reporting depression suggests disruption of the HPA axis. 
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Taken together, these findings suggested that the exaggerated cortisol response to 
awakening and sustained cortisol secretion throughout the day was due to impaired 
negative feedback inhibition (Spiegel, Giese-Davis, Taylor, & Kraemer, 2006). A study 
dividing patients with metastatic breast cancer into a group with a depressive disorder or 
taking antidepressant medication and a group without depression also found that 
depression was unrelated to cortisol reactivity to the Trier Social Stress Test. Patients 
with depression did exhibit an exaggerated awakening cortisol response, though no other 
relationships with circadian cortisol rhythms were observed (Giese-Davis et al., 2006). 
Considering previous work linking a flattened diurnal cortisol slope with an exaggerated 
awakening response, it is interesting to note that distress, depression in this case, may 
influence this circadian disruption. Finally, in a subset of women with metastatic breast 
cancer, emotional expression during the first session of group therapy (SET) was related 
to a steeper diurnal cortisol slope. It should be noted that saliva samples for cortisol assay 
were provided prior to the initiation of treatment, suggesting that it is the propensity to 
express emotion, rather then the expression that occurred in the videotaped session, that 
was related to a more rhythmic diurnal cortisol profile (Giese-Davis, DiMiceli, Sephton, 
& Spiegel, 2006). This finding builds on the observation that depression may be related 
to disruption of circadian cortisol rhythms by suggesting that active coping, specifically 
emotional expression, may be associated with a more normalized circadian cortisol 
rhythm. 
The sustained hypersecretion of cortisol characteristic of people with depression 
has been observed in several studies of patients with cancer (Andersen, 2002), including 
gynecological (Evans, McCartney, Nemeroff, 1986) and pancreatic cancer (Joffe, 
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Rubinow, Denicoff, Maher, & Sindelar, 1986). These blunted responses to acute stressors 
suggest impairment of the HPA axis to be responsive to environmental demands. If an 
individual lacks the physiological response needed to cope with an acute stressor, 
adaptation could be compromised. Conversely, if the HPA axis does not inhibit cortisol 
secretion in response to physiological cues, overexposure to cortisol and catabolic 
processes may suppress immunity and break down muscle tissue.  
Stress-related disruption of circadian rhythms may also reduce the effectiveness 
of chronomodulated chemotherapy. Chronomodulated chemotherapy attempts to target 
tumors with chemotherapeutic drugs at a point in the day at which normal cells are not 
expected to be actively mitotic to minimize the side effects on these cells. If circadian 
rhythms are disrupted, the expected benefits of this method of administration would be 
eliminated (Sephton & Spiegel, 2003). 
A recent review and meta-analysis of cortisol research has described the condition 
under which cortisol profiles become flattened. This review concluded that a stressor that 
is threatening to physical integrity, traumatic, and uncontrollable is most likely to elicit a 
flattened diurnal cortisol profile (Miller et al., 2007). A diagnosis of breast cancer 
typically has these features. A diagnosis of metastatic breast cancer may fit particularly 
well with these features because advanced disease likely promotes a sense of imminent 
threat and uncontrollability. These conceptualizations lend coherence to the robust 
predictive effect of the diurnal cortisol slope on survival in patients with metastatic breast 
cancer (Sephton et al., 2000). It is important to note that Miller et al.’s assertions 
regarding disruption of circadian cortisol rhythms suggest that distress and appraisals 
regarding the stressor are related to circadian disruption, as opposed to circadian 
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disruption driven exclusively by physiological effects of chronic illness. Primary breast 
cancer also threatens physical integrity, though likely to a lesser extent. Cancer is a life-
threatening illness and produces elevations in intrusions (Bleiker, Pouwer, van der Ploeg, 
Leer, & Ader, 2000). Although medical treatments offer a chance at remission and 
psychosocial interventions and coping can influence the effects of cancer on quality of 
life, cancer can only be controlled to a limited extent. Consequently, alterations in 
circadian cortisol rhythms are of particular interest in women with breast cancer. 
 
Sleep Disruption in Breast Cancer 
 Patients with breast cancer have consistently reported sleep disturbance (Payne, 
Piper, Rabinowitz, & Zimmerman, 2006). This sleep disturbance has included difficulty 
with sleep onset and maintenance, as well poor sleep quality (Roscoe et al., 2007). At 
least one form of sleep disturbance was reported by 63% of women with metastatic breast 
cancer (Koopman et al., 2002). Of these sleep concerns, nocturnal awakenings were the 
most frequent problem, with 44% of the sample noting this disturbance. Another study of 
patients with breast cancer found that 61% reported significant decrements in sleep 
quality (Fortner, Stepanski, Wang, Kasprowicz, & Durrence, 2002). Overall, patients 
with breast cancer report sleep disturbance that is approximately twice that of the general 
population (Savard, Laroche, Simard, Ivers, & Morin, 2003).  
Distress related to the diagnosis of breast cancer has been identified as a likely 
contributor to the development of sleep disturbance (Roscoe et al., 2007). Specifically, 
depression predicted subsequent worsening of sleep disturbance in patients with breast 
cancer. Because sleep disturbance is a symptom of depression, this item was excluded 
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from analysis, with no alteration to the observed results (Palesh et al., 2007). Even after 
completing treatment for breast cancer, these women continue to report elevated sleep 
disturbance (Couzi, Helzlsouer, & Fetting, 1995). Evidence suggests that sleep 
disturbance is predictive of decreased subsequent quality of life in patients with breast 
cancer (Fortner et al., 2002). Based on these observations, a recent review has called for 
interventions specifically designed to reduce sleep disturbance in patients with cancer 
(Berger et al., 2005). 
Not surprisingly, sleep disruption and disruption of circadian cortisol rhythms 
appear to affect one another (Koopman et al., 2002; Van Cauter, Leproult, & Kupfer, 
1996), though not in all studies (Mormont et al., 2000). Circadian rhythmicity is essential 
to sleep functioning. This rhythmicity is largely generated by the suprachiasmatic nuclei 
(SCN) in the hypothalamus and affects both cortisol rhythms and sleep. The SCN 
circadian disruption is a recognized cause of sleep difficulty. The American Academy of 
Sleep Medicine describes eight groups of sleeping disorders, with one group being 
circadian rhythm sleep disorders. These include sleep disturbance resulting from 
alterations to the circadian timing system (American Academy of Sleep Medicine, 2005). 
Perhaps due to the availability of energy produced by elevated cortisol, elevated cortisol 
during the night is related to sleep disturbance (Van Cauter et al., 1996). Decreased sleep 
has been associated with higher cortisol levels in the evening (Koopman et al., 2002), a 
time when cortisol is typically approaching its nadir. Elevated evening cortisol values 
have been observed in women with breast cancer, and elevated evening cortisol is 
consistent with the flattened cortisol profile characteristic of women with breast cancer 
(Spiegel, Giese-Davis, Taylor, & Kraemer, 2006). Cortisol increases are also associated 
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with nighttime awakenings and increased stage 1 sleep, which is lighter and less 
restorative sleep, throughout the night (Born et al., 1986; Follenius, Brandenberger, 
Bandesapt, Libert, & Ehrhart, 1992).  
Just as elevated cortisol, especially in the evening when cortisol is typically at its 
nadir value, is associated with sleep difficulty the following night, disruptions in sleep are 
associated with altered cortisol during the subsequent day. In patients with breast cancer, 
increased nocturnal awakenings have been associated with a flatter diurnal cortisol slope 
(Sephton, Sapolsky, Kraemer, & Spiegel, 2000). In a study of healthy adult men, the day 
following sleep deprivation was marked by increased total cortisol and delayed decrease 
of cortisol after the morning peak, suggesting that sleep disturbance could reduce the 
resiliency of the stress response system (Leproult, Copinschi, Buxton, & Van Cauter, 
1997). Awakenings also appear to be related to increased nocturnal cortisol levels (Spath-
Schwalbe, Gofferje, Kern, Born, & Fehm, 1991).  
 
Actigraphy 
In addition to endocrine circadian rhythms, the circadian activity rhythm, or 
sleep/wake rhythm, has been a variable of interest in patients with cancer. Actigraphy, or 
the recording of body movement, measures circadian rest-activity rhythms, or waking 
and sleep activity (Ancoli-Isreal et al., 2003). Polysomnography is typically considered 
the preferred method of distinguishing sleep from wakefulness. While sleep/wake 
indentification is similar, actigraphy does present several advantages over 
polysomnography. Using actigraphy to assess circadian rest-activity rhythms provides an 
unobtrusive measure of circadian rhythms and sleep-wake cycles (Ancoli-Isreal et al., 
63
  
2003). Once they are initialized, watchlike devices worn on the nondominant wrist record 
activity levels throughout the day and night without any need for maintenance. The 
unobtrusive nature of actigraphic assessments allows for naturalistic observation of sleep. 
Actigraphy also allows for long-term observation of circadian rhythms throughout 24 
hours and across multiple days. 
The rest-activity circadian cycle has been used as a reference for chemotherapy 
administration at specific times to improve tolerability and efficacy (Mormont & Levi, 
2003). This measure has demonstrated prognostic survival value in a study of patients 
with metastatic colorectal cancer in which cortisol rhythms did not exhibit prognostic 
value (Mormont et al., 2000), supporting the use of multiple measures of circadian 
function. Actigraphic recordings correlate well with results obtained by traditional 
polysomnography, with correlations for total sleep overnight typically at or above .85 
(Acebo & LeBourgeois, 2006). Actigraphy also correlates well with measurements of 
melatonin and core body temperature rhythms (Ancoli-Isreal et al., 2003; Selmaoui & 
Touitou, 2003). The usefulness of actigraphy in assessing activity rhythms is supported 
by the difficulty inherent in self-reported activity levels. Subtle changes in activity levels 
may be challenging to remember and accurately report. Also, self-reported sleep 
disturbances are sometimes not found when assessed with actigraphy  (Dagan, Zinger, & 
Lavie, 1997). 
Actigraphy has proven particularly useful as a tool for investigating quality of life 
and clinical features of breast cancer. Given the disruption of circadian physiology 
observed in cortisol rhythms in patients with breast cancer, it is not surprising that these 
women have also reported marked sleep disturbance in a sample of patients studied prior 
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to the initiation of chemotherapy (Ancoli-Israel et al., 2006). In women with breast 
cancer, actigraphy yielded unique data when compared with sleep diaries in one study. A 
sample of women with breast cancer who were participating in a sleep intervention 
reported fewer awakenings and less total rest in sleep diaries when compared with 
actigraphic recordings (Berger et al., 2002). In addition, nighttime awakenings noted by 
actigraphic recordings were observed to be related to increased fatigue following 
chemotherapy (Berger, et al., 2002).  
In a study of circadian rhythms and cancer progression, Mormont et al. (2000) 
carried out a study using actigraphy as a measure of circadian rhythms in a sample of 
patients with metastatic colorectal cancer referred for chronomodulated chemotherapy. 
Actigraphic recordings and serum samples used to calculate circadian rhythms were 
collected prior to the initiation of chemotherapy. Actigraphy data yielded an 
autocorrelation as a measure of circadian rhythmicity and a variable that quantified the 
amount of motion while in bed as a measure of rest-activity rhythm. The rest-activity 
measure was related to tumor progression and survival in this study (Mormont, et al., 
2000), lending support to the idea that sleep disturbance is of prognostic significance in 
patients with cancer.  
The studies reviewed above indicate that actigraphy provides an unobtrusive, 
naturalistic estimate of sleep that is comparable to polysomnography, the gold standard 
for sleep assessment. Research indicates that actigraphy provides an objective measure 
yielding data not available from sleep diaries. In patients with colorectal cancer, the 24-
hour rest-activity rhythm was predictive of tumor progression and survival, supporting 
the clinical importance of actigraphy in patients with cancer. However, the explanation 
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for disrupted circadian actigraphy rhythms is unclear. Further research is needed to 
determine whether psychosocial factors may influence disrupted circadian actigraphy 
rhythms. Investigation of psychosocial factors that may be related to circadian activity 
rhythms, a prognostic variable of interest in this population, may specify psychosocial 
variables or symptoms that merit close monitoring during the course of treatment. 
Monitoring of these symptoms may assist in identification of patients most likely to 
benefit from intervention. This research may also inform the structure and content of 
future interventions by identifying psychological symptomatology that may be related to 
disruption in circadian actigraphy rhythms. The relationship between psychological 
symptoms and actigraphy rhythms are particularly interesting because actigraphy 
rhythms are essentially a behavioral variable that may be amenable to influence by the 
patient. Although actigraphy has demonstrated relationships with melatonin and body 
temperature rhythms, the relationship between actigraphy and cortisol rhythms is not 
established and is of interest in this study. 
 
Hypotheses 
 Figure 3 illustrates the proposed relationships between cancer-related intrusions, 
coping, and circadian disruption in this study. It was hypothesized that cancer-related 
intrusive thoughts would disrupt rhythms of both salivary cortisol and rest-activity 
rhythm as measured with actigraphy. The extent to which cancer-related intrusions 
disrupt circadian rhythms was hypothesized to vary as a function of the level of avoidant 
coping used. Specifically, it was hypothesized that increased avoidant coping would be 
associated with a stronger positive relationship between cancer-related intrusions and 
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circadian disruption. Finally, it was hypothesized that cortisol and rest/activity rhythms 
would be associated. 
Figure 3. Hypothesized relationships between cancer-related intrusions, avoidant coping, and 
circadian disruption 
Hypothesis 1a: Cancer-related intrusions 
will be significantly and positively 
associated with circadian disruption, as 
measured by salivary cortisol and 
actigraphy. 
 
Hypothesis 1b: Avoidant coping will 
moderate the relationship between cancer-
related intrusions and circadian disruption. 
 
Hypothesis 2: Diurnal salivary cortisol 
slope and rest-activity rhythm obtained by 



















Figure 3. Possible relationships between cancer-










Hypothesis 1a: Cancer-related intrusions will be significantly and positively 
associated with circadian disruption, as measured by salivary cortisol and actigraphy. 
Cancer-related intrusions are of particular interest in women that have recently 
been informed of their diagnosis of breast cancer because of the potentially traumatic 
effect of the diagnosis (Andrykowski, Cordova, Studts, & Miller, 1998) and the 
subsyndromal PTSD symptoms often observed following diagnosis (Butler, Koopman, 
Classen, & Spiegel, 1999). A finding in breast cancer patients that cancer-related 
intrusions are associated with circadian disruption would support research suggesting 
circadian disruption as a mechanism for the effect of psychological distress on health by 
investigating whether a relationship exists between distress and the proposed mechanism, 
circadian disruption. Limited studies of the effects of intrusions on cortisol exist. In 
people living close to the damaged Three Mile Island nuclear power station, intrusions 
were associated with increased 15-hour overnight urinary cortisol (Davidson & Baum, 
1986). In addition, intrusions have been related to increased plasma cortisol levels in 
homosexual males receiving HIV testing (Antoni et al., 1990). These studies examined 
alterations in cortisol production, but they did not include a description of circadian 
cortisol rhythms. This suggests that cortisol is responsive to intrusions following a 
specific event. Clearly, though, further research is needed to clarify this relationship. 
 
Hypothesis 1b: Avoidant coping will moderate the relationship between cancer-
related intrusive thoughts and circadian disruption. 
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Exploring the moderation of these relationships by coping will inform debate 
about possible psychological intervention. Participants in cognitive-behavioral 
interventions have demonstrated reduced cortisol in comparison to a wait-list control 
group (Cruess et al., 2000; Gruber et al. 1993), suggesting that active engagement of the 
stressor may influence the effect of the stressor on clinical outcomes. Undergoing 
psychosocial treatment typically includes engagement of the stressor through direct 
discussion of the experience of having breast cancer and learning coping skills aimed at 
ameliorating the effects of illness. Active coping efforts are in contrast to avoidant coping 
strategies that might otherwise be ineffectively used to manage intrusions.  
Horowitz’s (1976) view on stress response patterns was that initial intrusive 
thoughts are followed by avoidance that impairs adaptation to a traumatic experience. In 
addition to delayed processing of a negative event, avoidance could impair adaptation by 
preventing the implementation of other coping strategies (Jim, Richardson, Golden-
Kreutz, & Andersen, 2006). Given the life-threatening nature of a diagnosis of breast 
cancer, it is expected that cancer-related intrusions will be prominent immediately after 
being informed of the diagnosis. However, avoidant coping is hypothesized to influence 
the effects of cancer-related intrusive thoughts on circadian disruption. When avoidant 
coping is low, intrusions may be part of adaptation to the stressor. It has been proposed 
that this adaptation is marked by the expression of catabolic hormones such as cortisol 
that are balanced by the expression of anabolic hormones that promote recovery from 
acute stressors and growth (Epel & McEwen, 1998). In this way, patients that are low in 
avoidant coping may not experience disruption of circadian rhythms related to intrusions. 
Rather, they may engage in emotional processing, which can promote meaning-making 
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and reduced distress (Kennedy-Moore & Watson, 2001). Conversely, intrusions related to 
a diagnosis of breast cancer may be related to circadian disruption in patients that inhibit 
processing by engaging in avoidant coping. 
Research into avoidant coping as a moderator of the effects of breast cancer-
specific intrusions on circadian disruption is lacking. As a result, the influence of 
avoidant coping on this relationship is unknown. Based on available research, it seems 
likely that avoidant coping will aggravate the effects of intrusions on circadian 
disruption, but the opposite relationship is possible. The patients in this study had learned 
of their diagnosis of breast cancer within the past few weeks. It is possible that avoidant 
coping could shield the patient from circadian disruption for a short period of time. If this 
is the case, elevated avoidant coping would be expected to be related to decreased 
circadian disruption, and decreased avoidant coping would exhibit an association with 
increased circadian disruption. In addition, it should be noted that direct effects of 
avoidant coping on psychological and physiological adaptation have also been 
researched. This is an interesting relationship because avoidant coping may have 
deleterious effects on circadian disruption regardless of the distress caused by a stressor 
such as breast cancer. It is possible that avoidant coping brings about a state in which 
individuals do not cognitively process a stressor and consequently are continually 
confronted by it (Park & Folkman, 1997). Due to the exploratory nature of this study, all 
possibilities will be considered. 
 
 Hypothesis 2: Diurnal salivary cortisol slope and rest-activity rhythm obtained by 
actigraphy will be significantly and positively associated. 
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 Cortisol rhythms assessed using salivary samples and rest-activity rhythms 
assessed using actigraphy are both used as measurements of circadian disruption. The 
nature of these variables suggests they are related. The relationship between cortisol and 
rest-activity rhythms will be explored to investigate their effects on one another and the 








 Because the transactional model is process oriented, it focuses on an individual’s 
response to a specific stressor (Folkman, Lazarus, Dunkel-Schetter, DeLongis, & Gruen, 
1986). In this study, the stressor (breast cancer diagnosis), setting (outpatient clinic), and 
timing (between diagnosis and initiation of treatment) were relatively consistent. The 
experience of having breast cancer is likely to vary considerably over time (Lazarus & 
Folkman, 1984, p. 146). Women often acquire information regarding cancer and its 
treatment that changes their understanding of the stressor. The rigors of treatment could 
worsen intrusions, or treatment could provide some relief in that efforts are being 
undertaken to address the illness and perhaps send the cancer into remission. Once 
treatment is initiated, the prognosis could improve or worsen depending on the cancer’s 
response to treatment.  
 To attempt to control for variance in the stressor and timing, women with breast 
cancer that had been recently diagnosed were recruited between the time of diagnosis and 
the initiation of treatment. Because women with the same chronic illness (breast cancer) 
at the same body site (breast) make up this study, all of the participants share this stressor 
in common. By keeping the timing of diagnosis and treatment relatively consistent, 
variance in breast cancer as a stressor is reduced. In their presentation of the transactional 




conceptualization of dominant coping responses that are employed across time 
andsituations. Rather, the investigation of coping efforts undertaken in response to a 




Although study amendments modified the protocol during the accrual period, all 
participants in this study were women diagnosed with breast cancer who enrolled and 
completed data collection between the time of diagnosis and the initiation of treatment. 
Patients who were initially eligible for this study included newly diagnosed women 
referred for surgical treatment of breast cancer who spoke and read English proficiently 
enough to adequately complete questionnaires. The first participant was enrolled on 
6/3/05. Nine patients were enrolled prior to the approval of an amendment on 1/31/06 
that sought to eliminate variance in disease characteristics by restricting enrollment to 
patients with primary breast cancer. One additional patient was enrolled under this 
protocol before inclusion criteria were widened, due to accrual rate concerns, to all 
patients with stage I-IV (primary, metastatic, or recurrent) breast cancer on 3/17/06. 
Fourteen patients were enrolled under this protocol. To allow for secondary hypothesis 
testing, an amendment adding the collection of nipple aspirate fluid from the surgical 
procedure, when available, was approved on 10/27/06, and 20 patients were enrolled 
under this protocol. The final protocol stated that women diagnosed with stage I-IV (primary, 
recurrent, or metastatic) breast cancer who had not begun curative treatment such as lumpectomy, 
mastectomy, chemotherapy, or radiation and spoke and read English proficiently enough to 
adequately complete questionnaires would be eligible for the study.  
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Patients who were referred for surgical consultation were informed of the results 
of their biopsy, an examination of breast tissue by a pathologist to determine whether a 
malignancy is present. There are four types of breast tumor biopsy. A core biopsy uses a 
hollow needle to remove tissue from an area of the breast suspected of being cancerous. 
A fine needle aspiration uses a thinner needle to remove cell samples from an area of the 
breast suspicious for cancer. An excisional biopsy surgically removes suspicious tissue 
from the breast as well as some healthy tissue in the surrounding area. An incisional 
biopsy surgically removes a portion of the suspicious tissue from the breast. A vacuum-
assisted biopsy uses a needle to take multiple samples from the suspicious area of the 
breast with one needle insertion. 
Patients referred for this study had been diagnosed in several different ways. Some 
patients referred for this study had received feedback regarding biopsy results during the 
visit that immediately preceded their invitation to enroll in this study. However, some 
patients received biopsy information from another physician prior to being referred for 
surgical consult. In addition, some patients were informed of pathology results indicating 
a diagnosis of breast cancer over the phone prior to their surgical consult visit. Finally, it 
should be noted that some patients were told that they likely had breast cancer based on 
preliminary testing, prior to undergoing the pathology testing necessary for a definitive 
diagnosis. As a result, most patients reported they had learned of their breast cancer 
diagnosis prior to the date of their clinic visit and enrollment in this study. These patients 
completed testing needed to confirm a diagnosis of breast cancer before being referred to 
this study, which accounts for the time lag between self-reported diagnosis date and 
referral to this study. At the conclusion of their clinic visit, eligible patients were 
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introduced to the study by the surgeon, and then met with a research assistant to receive 
information about the study and an invitation to enroll.  
Because chart reviews did not reveal the precise time of diagnosis, the time lag 
between diagnosis and enrollment in this study was calculated as the number of days 
between each participant’s reported date of diagnosis and the day the first daily 
questionnaire was completed. Because participants were asked to complete the first daily 
questionnaire one day after enrollment into the study, one day was subtracted from the 
difference between diagnosis date and the first day of data collection. Four participants 
did not provide a diagnosis date, so the earliest reference to a diagnosis of breast cancer 
available in the medical chart was used for these participants. The time between diagnosis 
and enrollment ranged from 0 to 122 days, with a mean of 17.8 days (SD = 21.2) and 
median of 14 days. 
All of these patients completed data collection prior to undergoing surgical treatment 
for breast cancer. Surgeries typically occurred approximately four weeks after patients 
were informed of the diagnosis of breast cancer. Figure 4 demonstrates the timeline for 
patient treatment and recruitment into the study. Patients diagnosed with ductal 
carcinoma in situ (DCIS), cancerous cells that line the milk ducts but have not grown into 
the surrounding breast tissue, were not targeted for this study because study materials 
discussed the diagnosis of breast cancer, and these patients had been informed that they 
had precancerous, as opposed to cancerous, cells. Patients with DCIS were not 
specifically excluded from the study in initial inclusion/exclusion criteria, and one patient 
with DCIS was enrolled based on referral for breast cancer, but later pathology results 
indicated this patient had DCIS, as opposed to invasive breast cancer. Because patients 
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with DCIS confronted the option of surgery and previous research has indicated a 
significant psychological impact of DCIS on patients (DeMorgan, S., Redman, S., White, 
K., Cakir, B., & Boyages, 2002), the three patients with DCIS who were enrolled were 
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Figure 4. Study assessments with respect to the expected timeline of medical treatments. 
At the “Pre-surgical Clinic Visit”, patients met their surgeon regarding breast cancer 
diagnosis, then enrolled in the study and were given materials for home-based data 
collection. All data collection was completed prior to surgery. After completion of four 
days of “Home-based Collection”, patients returned study materials to the investigator. 
Home visits were arranged as needed. 
 
Patients were recruited at the Brown Cancer Center, Norton Healthcare Pavilion 
and Children’s Foundation Building by referral from surgeons Dr. Anees Chagpar and 
Dr. Kelly McMasters. Medical charts were reviewed at the outset of the clinic day to 
screen for potentially eligible patients. Because a confirmed diagnosis of primary breast 
cancer was required for inclusion, the surgeons determined patient eligibility during the 
clinic visit. Eligible patients that were not referred to the study due to demands on clinical 
time, patient unavailability due to scheduled events that did not allow for interview with 
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research staff, or research staff unavailability due to being occupied with other patients 
were identified by speaking with medical staff at the end of the clinic day. These patients 
were contacted by phone and invited to participate in the study. Three of the twelve 
patients approached in this manner were enrolled and provided enough data to be 
included in analyses. After the surgeon had introduced the study, a research assistant met 
with the patient at the clinic, provided information about the study, and answered any of 
the patient’s questions. All participants recruited for participation in the study were asked 
to sign informed consent and HIPAA Research Authorization protocols approved by the 
University of Louisville Institutional Review Board on the use of human subjects in 
research.  
Participants were given two questionnaire packets, a saliva collection kit, and an 
actigraphy device. A research assistant explained the rationale and procedure for filling 
out daily questionnaires assessing the previous day’s intrusions, coping, and data 
collection each morning. The research assistant also explained saliva collection using 
collection materials, and participants were invited to practice using these materials.  
Patients who met eligibility criteria for this study were initially recruited by phone 
after a call from the clinic to a research assistant following the patient’s appointment with 
the surgeon. Due to poor accrual early in the study, graduate research assistants were 
given space behind the nursing desk to monitor patient flow and ensure that patients were 
referred to the study. Research assistants actively worked together with clinic staff to 
build relationships, discuss issues or problems, and encourage referrals. 
Seventy-four potentially eligible patients were referred for this study between 
May 2005 and June 2007. Five patients referred after leaving the clinic because of 
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patients’ time demands were unable to be contacted by phone. Of the 18 patients who 
declined to participate, 15 declined due to time constraints and/or response burden, two 
did not specify a reason, and one stated she was uncomfortable consenting to chart 
reviews. Seven patients enrolled in the study but were unable to provide enough data to 
be included in any primary analyses. Of these seven patients, one patient provided no 
data due to acute illness and another patient provided no data due to the time demands of 
attending to visiting family. Two patients provided complete data except for rest/activity 
rhythms due to technical problems with the actigraphy device and were not included in 
analyses with actigraphy variables, but data provided by these two patients were part of 
analyses with no actigraphy variables, including analyses for hypotheses 1a and 1b with 
cortisol as an outcome variable. Similarly, one patient provided complete data except for 
saliva samples, so she was eligible for analyses testing effects on actigraphy outcomes for 
hypotheses 1a, 1b, and 2, but not in analyses testing effects on cortisol outcomes. One 
patient was excluded from all analyses with cortisol variables because she reported taking 
systemic steroids, which alter salivary cortisol. The remaining patients who provided 
incomplete data did not provide questionnaire data sufficient for analysis, with one of 
these patients also missing the majority of the saliva samples requested in the study 
protocol. Forty-five patients provided enough data to be included in analyses. 
 
Daily Assessments of Intrusions and Avoidant Coping 
Daily self-reports of breast cancer-specific intrusions and avoidant coping were 
collected to assess coping efforts employed in a given day, as opposed to trait-oriented 
measures that ask participants to recall which coping strategies they usually employ. A 
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drawback of trait-oriented measures of coping is that, even if a participant has a dominant 
coping response, it may not be used in response to a given stressor at a given time. In 
contrast, questionnaires used in this study asked about the participant’s coping efforts that 
occurred over the course of one day in response to the experience of having breast cancer. 
The data obtained by daily assessments aim to minimize the influence of the daily 
variability in intrusions and coping on the assessments obtained. 
Daily assessments also present an opportunity to reduce retrospective reporting 
bias by placing the time of the assessment close to the time of the event of interest. Recall 
of breast cancer-specific intrusions and avoidant coping that occurred yesterday is likely 
to be better than recall of coping efforts that occurred a longer period of time prior to the 
assessment. Previous studies suggest that retrospective report bias alters recollection, and 
that daily assessments provide different data than retrospective reports relying on 
memory to assess events occurring farther from the time of assessment (Erskine, Morley, 
& Pearce, 1990; Larsen, 1992; Margraf, Taylor, Ehlers, Roth, & Agras, 1987; Rapee, 
Craske, & Barlow, 1990). Also, the transactional model of stress and coping used to 
inform the design of this study is dynamic, with coping efforts and outcomes continually 
altering one another and the stressor. These alterations magnify the retrospective 
reporting bias for the topic of research. An assessment at the outset of the collection 
period would sample only a small portion of the data available over that time span. 
Conversely, an assessment at the end of the collection period would likely prompt 
participants to describe their coping based on heuristics, personal beliefs about the stress, 
coping and adaptation process, or salient events (Tennen & Affleck, 2000). As a result, 
daily assessments provide a means of collecting data over the entire study period while 
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minimizing problems associated with retrospective reporting of these phenomena. 
Overall, the use of daily assessments in this study adheres more faithfully to the 
transactional model of stress and coping by assessing coping as an effort undertaken 
within a specific context, as opposed to assessing a coping strategy as it applies broadly 
to all contexts. Daily assessments reduced retrospective reporting bias by asking 
participants to report on a brief period of time, one day, that occurred recently. 
Participants were asked to complete daily assessments each morning, as opposed 
to completing them immediately before going to sleep, to minimize the effect of the 
assessments on sleep. Intrusions, in particular, are of concern because pre-sleep intrusions 
are likely to be related to sleep disturbance (Gross & Borkovec, 1982; Wicklow & Espie, 
2000). While investigation of this relationship is one focus of the study, an influence of 
study methodology would limit the generalizability of any knowledge obtained by this 
study. If participants were prompted by questionnaires on breast cancer-specific 
intrusions and avoidant coping to think about breast cancer immediately prior to going to 
bed for the night, findings regarding a relationship between intrusions and circadian 
disruption may not apply to most patients with breast cancer, who are not typically 
prompted to think about breast cancer-specific intrusions prior to going to bed. Pre-sleep 
assessments could also disrupt participants’ bedtime routines by including an extra 
activity. To the extent that this disruption would alter participants’ sleep, the disruption of 






Physiological Data Collection 
 Circadian Disruption 
Salivary Cortisol - Cortisol has a strong circadian rhythm that is measurable in saliva, and 
it is an important messenger in the circadian control of peripheral tissues by the central 
clock (Mormont & Levi 1997).  Salivary cortisol provides a reliable estimate of free 
hormone levels in blood (Kirschbaum & Hellhammer, 1994). Salivary cortisol was 
measured in a series of twelve saliva samples collected by participants at home over 72 
hours. At the time of enrollment a study coordinator met with the patient to explain saliva 
collection procedures, demonstrate the use of study materials, and allow the patient to 
practice using these materials. Written instructions for saliva sample collection is 
provided in Appendix A. Participants were given multiple phone numbers of study 
coordinators and encouraged to call with any questions about the study or data collection.   
Participants received twelve pre-labeled “salivette” tubes (Walter Sarstedt Inc., 
Newton, North Carolina). Collection was requested for three consecutive days at waking, 
30 minutes after waking (+30 min), at 4 p.m., and just before going to bed. The sampling 
times were selected because they allow calculation of the diurnal cortisol slope, a variable 
that is prognostic for survival in metastatic breast cancer patients (Sephton et al., 2000). 
Medication Event Monitoring System (MEMS) bottles and caps (Aardex, Ltd.) were used 
to store cotton saliva collection swabs. MEMS caps contain microelectronics that record 
the exact time and the date the bottle is opened, and a software program stores collection 
time data. An interface was used to download Medication Event Monitoring System 
(MEMS; Aardex, 2001) data on times of saliva sample completion onto computer after 
these devices had been used to assess the times at which participants had removed cotton 
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swabs to provide saliva samples. 
 Participants were asked not to eat, drink, brush teeth, use mouthwash, chew gum, 
or smoke for the 30 minutes prior to saliva sample collection. The purpose of the MEMS 
devices in recording sample collection times was explained to participants, and they were 
asked to open the MEMS devices only when providing a saliva sample and to close the 
lid tightly when done using the device. Participants were instructed to also record sample 
collection times on stickers placed on the salivettes with a marker provided in the 
collection kits. Participants were asked to refrigerate samples as soon as possible after 
collection but informed that it was permissible to leave samples unrefrigerated if 
necessary, such as a 4pm sample provided while at work. They were advised that samples 
could not be left unrefrigerated for more than a day.  
Cortisol assays were conducted by Elizabeth Lush and Robyn McLean at the 
Biobehavioral Research Laboratory at the University of Louisville. A research assistant 
centrifuged, aliquoted, and froze saliva samples at -80 °C. Assays were conducted using 
an enzyme immunoassay (EIA) developed for use in saliva (Salimetrics, Inc., State 
College, PA). The sensitivity of the assay was 0.007 ug/dL. The inter-assay coefficient of 
variation was 7.4% using the low control and 3.4% using the high control. The intra-
assay coefficient of variation was 5.7% using the low control and 2.8% using the high 
control. Because cortisol values are typically positively skewed, cortisol values were log-
transformed prior to analysis for all primary cortisol outcomes. Calculated variables were 
the diurnal mean (mean of all 12 log-transformed values), diurnal slope (unstandardized 
beta weight of natural log-transformed cortisol regressed on collection time excluding 
+30min sample), mean waking level, and cortisol awakening response (CAR) slope, 
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calculated by regressing the unstandardized beta of the wake and +30min log-tranformed 
cortisol values on the collection times, and mean bedtime cortisol. The wake cortisol 
value was chosen as the first value for the calculation of the diurnal cortisol slope to 
reduce collinearity with the CAR slope and because using the waking value to anchor the 
calculation of the diurnal slope has been shown to promote more reliable calculation 
across days (Kraemer et al., 2006). The CAR slope was chosen as the primary measure of 
the HPA response to awakening because the CAR % increase and area under the 
awakening curve are more influenced by the level of the awakening cortisol value and 
consequently were not considered as valid an index of the response to awakening as the 
CAR slope. 
For secondary analysis, CAR % increase was calculated using the mean percent 
increase from the wake to the +30min raw cortisol values, and the area under the 
awakening cortisol curve was calculated using log-transformed cortisol values for the 
wake and +30min samples. The area under the awakening cortisol curve was calculated 
using log-transformed cortisol values because the raw values did not have a normal 
distribution. A questionnaire was used to query sample collection times as well as factors 
that may affect cortisol secretion, such as medications, stressors, sleep, exercise, and 
menstrual cycle phase. 
 
Actigraphy 
Actigraphy, or the recording of body movement, measures circadian rest-activity 
rhythms, or waking and sleep activity. Body movements were recorded by a device called 
the Mini-Motionlogger (Ambulatory Monitoring Systems, Inc., Ardsley, NY 10502), and 
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stored for later analysis. An interface was used to transfer data from actigraphy devices 
onto computer (Ambulatory Monitoring, 2004) after participants had worn the device on 
their wrists for three consecutive days. These devices were worn on participants’ wrists 
where a piezoelectric beam generated voltage each time the device moved. Data were 
quantified using the proportional integration mode of the Mini-Motionlogger. This mode 
performed better than other modes when comparing scores to polysomnography (Jean-
Louis, 2001). Motions were recorded in 60-second segments, with voltage signals from 
each minute creating a curve, allowing for calculation of area under the curve (AUC). A 
moving average AUC is calculated for seven-minute segments that include the previous 
four and subsequent two minutes. Segments are scored as “wake” or “sleep” using 
calculations based on the University of California – San Diego (UCSD) Sleep Scoring 
Algorithm (Cole, Kripke, Gruen, Mullaney, & Gillin, 1992).  
The circadian rhythm in activity was estimated using the autocorrelation 
coefficient calculated based on 24-hour time lags. This autocorrelation assesses the 
association of data in a given 1-minute time period with data in that same 1-minute time 
period on other days. Dowse and Ringo (1989) described the autocorrelation calculation 
as follows: “If Xi is the measurement at time i, the correlation coefficient rk, between Xi 
and Xi+k is computed for lags k, with k = 1 to 4320 minutes (72 hours)”. Briefly, the 
autocorrelation is a measure of circadian consistency, the similarity of rest/activity 
patterns across days (Roscoe et al., 2002). Using this calculation, a higher autocorrelation 
is indicative of a more pronounced circadian rhythm. Participants with a strong circadian 
rhythm would be expected to exhibit similar activity levels at similar times of day, 
yielding a high autocorrelation. Circadian rhythmicity was also assessed using two 
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dichotomy indices. The dichotomy index for time in bed yields the percentage of time 
spent in bed in which the activity level falls below the median activity level for time out 
of bed. Conversely, the dichotomy index for time out of bed yields the percentage of time 
spent out of bed in which the activity level falls below the median activity level for time 
in bed. In both cases, a higher dichotomy index indicates more frequent inactivity, but 
inactivity while in bed is consistent with strong circadian rhythmicity, while inactivity 
while out of bed is consistent with circadian disruption. Sleep variables yielded by 
actigraphy data included sleep latency, total sleep time, sleep efficiency (% of time in bed 
that the participant is asleep), and awakenings. Someone with a strong circadian rhythm 
would be expected to exhibit high dichotomy index percentages for time in bed and low 
dichotomy index percentages for time out of bed. Table 1 presents circadian rhythm 
variables, calculation methods, and implications. 
Table 1. Circadian rhythm variables, their methods of calculation, and descriptions of 
their meanings. All cortisol values measured in (µg/dL). 
 
Actigraphy 
Variable Calculation What it Means 
Autocorrelation Correlation of 1-minute 
epoch on one day with same 
epoch on different days 
Lower value indicates 
disrupted circadian activity 
rhythm 
Dichotomy/Inside (D/I) % of time in bed in which 
activity falls below median 
activity for time out of bed 
Lower value indicates more 
activity while in bed 
(circadian disruption) 
Dichotomy/Outside (D/O) % of time out of bed in 
which activity falls below 
median activity for time in 
bed
Lower value indicates less 
activity while out of bed 
(circadian disruption) 
Cortisol 
Waking Cortisol Mean natural log-
transformed cortisol value 
across all saliva collection 
days  
Cortisol level immediately 
after first waking 
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Variable Calculation What it Means 
Morning Slope Waking and +30min 
natural log-transformed 
cortisol regressed on 
collection times 
Primary measure of CAR, 
higher values indicate 
greater HPA activation in 
response to awakening 
CAR % increase Mean % increase from 
waking to +30min using 
raw cortisol  
Secondary measure of CAR, 
higher values indicate 
greater HPA activation in 
response to awakening 
Area Under the Awakening 
Cortisol  Curve 
Total area under slope 
from mean waking to mean 
+30min using raw cortisol 
values, then total was 
natural log-transformed 
Secondary measure of CAR, 
higher values indicate 
greater HPA activation in 
response to awakening 
Diurnal Cortisol Slope Waking, 4pm, and bedtime 
natural log-transformed 
cortisol regressed on 
collection times 
Higher values indicate 
abnormal rhythms that can 
include low morning level, 
peaks occurring in the 
afternoon or evening, or 
flattened rhythms 
Overall Diurnal Mean 
Cortisol 
Mean of all natural log-
transformed cortisol 
samples 
Total cortisol secretion 
Bedtime Cortisol Mean of all natural log-
transformed bedtime 
cortisol samples 
Cortisol levels at bedtime 
 
 Blood Pressure and Heart Rate 
 Patients presenting at the surgical clinic typically underwent assessments of blood 
pressure and heart rate that were available in the patient’s medical record. Chart review 
sought to obtain these data. When more than one assessment was available in the 
patient’s medical record, the assessment closest to the time of study enrollment was 






Data Storage and Management 
Data were retrieved by coordinating with patient hospital visits, arranging to meet 
at the patient’s treatment center, or a research assistant driving to the patient’s house. 
Questionnaires were reviewed to ensure completeness, and patients were asked to 
complete items that they missed, though they retained the option to decline to answer 
these items.  
 
Assessments 
Potential control variables 
Participants completed a brief background questionnaire assessing demographics 
such as age at diagnosis, ethnicity, marital status, religious affiliation, family size, 
education, employment, household income, medical history, and current medications. All 
ages were calculated based on the most recent diagnosis, as opposed to the time of the 
first cancer diagnosis in cases of recurrent cancer.  
The participants’ medication regimens were assessed on the day of study 
enrollment as part of the initial interview. Each participant was prompted to report the 
medication, dosage, number of times per day or week it was taken, and the reason it was 
taken. Medications were then entered the database according to their medication class. In 
the database, the first column listed the total number of medications from a given class 
the participant reported taking. The next column presented the generic name of the 
specific medication taken. If multiple medications from one class were part of the 
participant’s medical regimen, a third column listed all of them.  
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Systemic steroids were separated from other steroids (e.g. nasal steroids) in the 
database because systemic steroids are known to affect cortisol assessments. Oral, patch, 
and vaginal ring contraceptive medication were recorded as systemic contraceptives, 
separately from other forms of contraception because systemic contraceptives likely alter 
cortisol levels. One participant was excluded from analyses involving cortisol summary 
variables due to reporting use of oral fluticasone  A sleep variable was created that 
included all medications patients reported taking for the purpose of sleep because 
circadian rhythms and sleep were a focus of this study. Medications were included in this 
category even if they belonged to another medication class. Finally, antidepressants were 
among the classes of drugs recorded in the database, as they likely influence cortisol 
levels. 
Data on disease status (diagnostic testing, age at diagnosis, time since diagnosis, 
stage, grade, time since diagnosis, age at diagnosis) was collected by chart review. 
Reviews were conducted by study personnel Eric Dedert, Elizabeth Lush, and Meagan 
Martin in the medical records office at the Children’s Foundation Building in Louisville, 
Kentucky. Reviews were conducted for all patients. A medical review form containing 
the variables listed above was used to standardize the variables sought in review.  
 
Breast cancer-specific intrusions 
Impact of Event Scale (IES) – The IES (Horowitz & Wilner, 1979) is a 15-item measure 
that was developed based on studies of responses to stressful events. In particular, 
intrusions and avoidance associated with the event are assessed. In this study, the event 
was specified as the diagnosis of breast cancer. Participants rate whether comments on 
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the scale are true for them “Not at all”, “rarely”, “sometimes”, or “often”. Scores are 
obtained by assigning the weights 0, 1, 3, and 5 to the frequency categories indicated. 
Participants rate how frequently these symptoms were true for them on a four-point scale. 
The IES has been utilized in several samples, including patients with breast cancer 
(Cordova et al., 1995). A review of psychometric properties of the IES reported high 
internal consistency indicated by a mean alpha reliability coefficient of 0.86 for the 
intrusions subscale (Sundin & Horowitz, 2002). A study with patients scheduled for 
breast biopsy reported reliability of .89 for the intrusions subscale and .85 for the 
avoidance subscale (Lebel et al., 2003). In the current study, Cronbach’s alpha was .930 
for items collapsed across days, with alpha coefficients for individual days ranging 
between .856 on day one and .930 on day four, 
The initial report on the IES noted a correlation of .41 between the two subscales, 
intrusion and avoidance, suggesting that these subscales are related but not redundant 
(Horowitz & Wilner, 1979). Studies have generally found moderate correlations between 
these two subscales (Sundin & Horowitz, 2002). Examination of convergent validity by 
comparing the IES with the Mississippi Scale for Civilian PTSD, an existing measure of 
reactions to a traumatic event, revealed that the two measures were moderately correlated 
(r = .51; Devilly, Spence, & Rapee, 1998).  
The IES is particularly well suited to this study because breast cancer can be 
specified as the stressor, allowing for a more focused analysis of the intrusions related to 
being diagnosed with breast cancer. The original instructions prompt respondents to 
provide data on how frequently statements were true for them during the past seven days. 
To orient responses specifically to intrusions related to breast cancer in the past day, a 
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portion of the instructions for the daily questionnaire were modified to read “Please fill in 
each item, indicating how frequently the comments were true for you YESTERDAY 
regarding your diagnosis and treatment of BREAST CANCER”. The 7-item intrusions 
subscale of the IES was completed upon awakening on four consecutive mornings and 
asked about the previous day’s intrusions. All daily questionnaires were completed after 
participants had provided an awakening saliva sample. The awakening saliva sample was 
given priority because any delay in this sample would be likely to obscure the true 
awakening cortisol value due to the sharp increase in cortisol that typically occurs within 
minutes after awakening (see Appendix A for data collection instruction in “Daily 
Questionnaire”). The mean intrusions score from the four consecutive mornings was used 
in analyses.  
The IES was initially conceptualized as a measure of intrusions and avoidance, 
but subsequent studies of the factor structure of this measure have argued for alternative 
conceptualizations. In addition to examining the intrusions and avoidance subscores, 
examination of the summary score of the entire IES has been proposed based on a study 
with Vietnam veterans (Hendrix, Jurich, & Schumm, 1994). A three-factor model, 
including a sleep disturbance scale as well as the traditional intrusions and avoidance 
subscales, has also been proposed (Larsson, 2000). Finally, a proposed four-factor model 
has added a numbing factor to those included in the three-factor model. This study found 
that four factors produced the best fit in a sample of police officers and fire fighters 
assessed eight years after they had been involved in rescue work at the site of an airplane 
crash (Witteveen et al., 2006). The sleep disturbance factor of the four-factor model was 
comprised of item 4 (“I had trouble falling asleep or staying asleep, because of pictures or 
90
  
thoughts about it that came into my mind”) and item 6 (“I had dreams about it”). The 
content of these two items supports an interpretation of them as indicators of sleep 
disturbance in addition to, or as opposed to, intrusions characterized by disturbing 
dreams. To determine whether the inclusion of these two items influences the relationship 
between intrusions and circadian disruption, secondary analyses were conducted with 
these two items removed. 
Although the IES includes items assessing avoidance, these items were not 
included in the daily questionnaire. The IES avoidance items were also not used in 
analyses of avoidant coping because the IES conceptualizes and measures avoidance as a 
symptom of distress. (Horowitz, 1976). Consequently, the avoidance items from the IES 
are not appropriately conceptualized as avoidant coping, and a measure of avoidant 
coping efforts was used instead of the avoidance subscale of the IES. An attempt was 
made to keep the daily assessment procedures as brief as possible because participants 
were recruited at a site at which the research group had not previously recruited and were 
adjusting to a recent breast cancer diagnosis, and it was unclear what response burden 
might be most appropriate. In addition, there was concern that lengthy assessment 
procedures completed at a specific time of day might interfere with circadian rhythms. In 
addition, intrusions were a focus of this study because they are a measure of distress that 
was expected to be especially closely connected to the diagnosis of breast cancer. 
 
Avoidant coping 
Brief COPE – The Brief COPE is a 28-item self-report measure (Carver, 1997) that is an 
abbreviated version of the original 60-item COPE (Carver et al., 1989). Validation 
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studies of the COPE supported the 14 factor structure of the measure (Carver et al., 
1989). The Brief COPE was developed because the author found that the original version 
had considerable redundancy and was found to be too lengthy by respondents (Carver, 
1997). Subscales from the COPE were reduced to 2-item subscales for the Brief COPE in 
a study of residents recovering from a hurricane in their community. Items were chosen 
for inclusion in the Brief COPE based on high loadings with its factor in the original 
study and clarity based on feedback from prior studies (Carver, 1997). In the current 
study, the ‘denial’, ‘self-distraction’, and ‘behavioral disengagement’ subscales were 
used to derive the avoidant coping subscale score. In the original validation study, the 
alpha reliability coefficients for these scales were .54, .71, and .65, respectively (Carver, 
1997). In validation studies for the original COPE, the 4-item subscales that ultimately 
became the 2-item denial, self-distraction, and behavioral disengagement subscales 
correlated negatively with optimism and perceived control, and positively with anxiety 
(Carver et al., 1989). Factor analysis has supported the use of the denial, self-distraction, 
and behavioral disengagement scales to comprise an avoidant coping scale (Rudnicki, 
Graham, Habboushe, & Ross, 2001). Avoidant coping was assessed in this study using 
the two items from self-distraction, denial, and behavioral disengagement on the Brief 
COPE, for a sum of six items. 
The original development of the COPE had instructions that read “this 
questionnaire asks you to indicate what you generally do and feel when you experience 
stressful events”. There was also a situational version that asked respondents to think 
about the most stressful event that had happened to them over the past two months and 
report on the coping they used in response to that event (Carver et al., 1989). For the 
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current study, the instructions were modified to read “This questionnaire asks you to 
indicate what you did and felt yesterday, when you experienced stressful events related to 
having breast cancer”. The author has supported the adaptation of this measure to 
research applications through the alteration of the measure’s instructions and verb tense 
of the items (Carver, 1997), and this has previously been done in studies of breast cancer 
patients’ coping with breast cancer (Bellizzi & Blank, 2006). The Brief COPE has been 
used in studies of patients with breast cancer (David, Montgomery, & Bovbjerg, 2006; 
Fogel, 2004).  
In the current study, the 6-item avoidant coping scale was completed on four 
consecutive mornings and asked about the previous day’s avoidant coping. As with the 
IES, daily assessments of avoidant coping aimed to minimize measurement error due to 
retrospective reporting bias while increasing adherence to the transactional model of 
stress. Questionnaires were completed after participants had provided the awakening 
saliva sample. The avoidant coping score used for analyses was the mean avoidant coping 
score from the four collection times. The IES avoidance subscale was not included in 
daily assessments and not used in any analyses. Cronbach’s alpha for the 6-item scale 
was .939 when items from all four days were assessed, with alpha reliability coefficients 
for individual days ranging from .710 for day four to .851 for day three. 
 
Profile of mood states (POMS) 
The POMS (McNair et al., 1971) is a 65-item scale assessing six dimensions of 
affect. It was designed to assess rapid fluctuations in mood and conceptualized moods as 
rapidly changing. The POMS has been used in a number of studies of patients with 
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cancer (Cassileth et al., 1985). The POMS was administered in a packet with other 
measures to be used for future analyses, to be completed at a time during the four day 
data collection period that was convenient for the participant. In contrast to the daily 
assessments, the POMS was completed only once during the course of data collection. In 
the current study, the depression-dejection subscale was used to identify participants that 
may be suffering from clinically significant depression in secondary data analysis 
(Patterson et al., 2006).  
 
Data Reduction and Analysis 
 Control Variables 
 All questionnaire data were manually entered, cleaned, and examined for 
abnormal responses. Bivariate correlations were used to examine relationships of control 
measures with cortisol and actigraphy variables and evaluate these variables as potential 
candidates for inclusion in hierarchical regression equations. Age at diagnosis and 
summary stage were used as control variables in all analyses. Additional potential control 
variables included racial background education, income, weight, systolic blood pressure, 
diastolic blood pressure, tumor size, nodal involvement, estrogen receptor status at the 
time of diagnosis, progesterone receptor status at diagnosis, human epidermal growth 
factor receptor (her2/neu) status at diagnosis, tumor grade at diagnosis, time since 
diagnosis, each class of medications taken by at least 5% of the sample, and all 





Approach to Primary Analyses 
 Data were analyzed using an exploratory approach, as opposed to a confirmatory 
approach. The aim of an exploratory approach is to maximize the depth of investigation, 
develop a better understanding of a dataset, and to generate hypotheses for future 
research. Consequently, no formal adjustments for multiple comparisons, such as a 
Bonferroni correction, were used in this study. The drawback to exploratory research is 
that statistically significant findings must be viewed with skepticism because a large 
volume of analyses is likely to yield some significant relationships that are spurious 
(Babyak, 2004). As a result, it is crucial to exploratory research to be cautious in 
interpreting the results obtained. 
 Exploratory analyses are useful for investigating relationships that are not yet well 
understood. Although significant research on breast cancer-specific intrusions and 
avoidant coping has taken place, the relationships between these variables and circadian 
physiological and rest/activity rhythms have not ever been studied. In addition, Lazarus 
(Lazarus, 2000) noted the limits of the search for causal variables in coping and 
adaptation research, and called for more detailed analyses of coping and adaptation aimed 
at developing a richer understanding of a process. He acknowledged that this research 
would likely need to proceed with smaller sample sizes and a less sophisticated 
understanding of causal variables. Nevertheless, he added that these more detailed studies 
would be as valuable as traditional studies of causal variables in contributing to research 





Preliminary Analytical Procedures 
 The assumption of normal distribution of variables was evaluated for all variables 
by examining boxplots and histograms. For variables that did not exhibit a normal 
distribution, Spearman correlations were used, as opposed to Pearson correlations. 
Exploratory bivariate correlations were calculated to allow for examination of 
relationships between potential control variables and circadian disruption variables.  
 
Predictor Variables 
The IES was initially conceptualized as a measure of intrusions and avoidance, 
but subsequent studies of the factor structure of this measure have argued for alternative 
conceptualizations. In particular a three-factor model with sleep disturbance 
supplementing the two traditional factors (Larsson, 2000) suggests a 5-item version of the 
intrusions scale is more appropriate. Due to conflicting conceptualizations of items four 
and six as indicators of intrusion (Horowitz, 1979) or sleep disturbance (Witteveen, 
2006), separate calculations of intrusions scores were conducted. For all primary 
analyses, the traditional IES intrusions subscale was derived from a summary of the 
seven items on the intrusions scale of the IES (Horowitz, 1979). An alternative intrusion 
subscale was constructed with items four and six removed, and the remaining five items 
summed to yield a score that was used in secondary analyses only.  
 
Actigraphy Data Reduction 
 Dr. Ehab Dayyat, a researcher with the University of Louisville, Department of 
Pediatrics who is experienced in scoring actigraphy data, was consulted to develop 
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competency in determining cutoff points for the beginning and ending of deleted data 
periods and in setting sleep onset and awakening times. Participants were asked to 
remove the actigraphy device only if they were participating in an activity that was likely 
to get the device wet. Device removals were recorded on the daily questionnaire (see 
Appendix A “Daily Questionnaire”). These reported removals were compared against 
actigraphy data to identify episodes to be deleted from actigraphy data files and excluded 
from calculation of outcome variables. Actigraphy files were also examined to identify 
extended periods of zero values that likely indicated actigraphy device removal to be 
deleted prior to outcome variable calculation.  
 Sleep intervals were set for each participant by integrating self-reported sleep 
onset and awakening times with actigraphy data. When the reported sleep interval was 
not concordant with the sleep interval indicated by the actigraphy data, preference was 
given to actigraphy data. The participant’s typical level of activity during wake periods 
was compared with typical levels of activity during sleep to inform determinations of 
sleep onset and awakening. The sleep onset time was set at the first epoch in which a 
sustained period of time characteristic of the level of activity observed during sleep. The 
awakening time was set as the first epoch with a level of activity characteristic of waking 
levels that was followed by similar activity levels shortly afterward. 
 Actigraphy data were scored using the University of California San Diego 
(UCSD) Scoring Algorithm (G. Jean-Louis, Kripke, D., Mason, W., Elliott, J., 
Youngstedt, S., 2001) that was optimized using polysomnography as the criterion. 
Scoring of sleep/wake data was performed by the Action4 software (Ambulatory 
Monitoring, 2004).  
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 To minimize an observed bias toward over-scoring wake in the UCSD algorithm 
(Cole, 1992), rescoring rules were developed by Webster, Kripke, Messin, Mullaney, and 
Wyborney (Webster, 1982) to improve accuracy of actigraphic sleep/wake estimates. 
However, data on more recent devices have revealed that these rescoring rules increased 
the sensitivity to wake of the algorithm but decreased the specificity of wake estimates, 
resulting in considerable bias. More importantly, Webster’s rescoring rules did not 
improve the accuracy of the algorithm when compared to polysomnography (G. Jean-
Louis, Kripke, D., Cole, R., Assmus, J., Langer, R., 2001). Consequently, Webster’s 
rescoring rules were not used with the actigraphy data in this study. 
 
Data Reduction 
Reports from at least two of the four daily reports of intrusions or avoidance were 
necessary for inclusion in analyses involving one or both of these variables. Mean 
substitution was used to replace missing values if at least half of the items were 
completed for a given measure of subscale. For each participant, all daily assessment 
responses for a given measure were summed. This sum was then divided by the number 
of days for which data were available. The resulting dividend was the mean daily score 
for intrusions or avoidance across the assessment period. This dividend was used for all 
analyses. 
Saliva sample collection times were available from MEMS devices that recorded 
openings. Participants also recorded the collection times on the salivettes while providing 
the sample. The MEMS and self-reported collection times correlated very highly 
(Spearman’s r = .977), suggesting that participant reports of collection times were reliable 
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and comparable to other reports (Kraemer et al., 2006). Recent data argue the inclusion of 
MEMS caps may increase participant response burden without increasing protocol 
adherence (Kraemer et al., 2006). However, the possible response burden introduced by 
MEMS caps has already been incurred and data indicate it is possible that MEMS 
collection times are more reliable than self-reported collection times (Kirschbaum, 1994). 
As a result, MEMS collection times were given preference of self-reported collection 
times. Self-reported collection times were used when there was no MEMS time available, 
such as a series of two samples with a MEMS opening recorded for the first sample only. 
This was taken as an indication that the participant removed two cotton swabs during one 
opening (Kraemer et al., 2006) to increase the convenience of sample provision. In 
addition, no MEMS data were available for three participants due to device malfunctions. 
A total of 48 of an overall total of 528 saliva samples included in analyses used self-
reported collection times because MEMS times were not available. Collection times that 
were more than four standard deviations from the mean time for a given sample period 
(awakening, +30min, 4pm, and bedtime) were identified as outliers and examined for any 
possible confounds by considering participant comments and actigraphy data. Collection 
time outliers were limited to one patient who did have cortisol time outliers and reported 
she worked third shift sometimes, including portions of the data collection period for this 
study, and had an abnormal sleep schedule. Since it would be a threat to validity to 
exclude patients with marked circadian disruption, she was enrolled. Because she 
collected samples at unusual times due to her typical schedule, as opposed to 
nonadherence to the study protocol, her samples were included in analyses. 
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Awakening samples with MEMS times more than 10 minutes after the self-
reported awakening time were examined to explore the time lag between awakening and 
the provision of the awakening saliva sample. Actigraphy data were examined, and the 
awakening time estimated by actigraphy examination was compared with the saliva 
sample collection time. If both the self-reported awakening time and the awakening time 
estimated from actigraphy were more than 10 minutes from the sample provision time, a 
cortisol value for the awakening time estimated from actigraphy was computed. This 
value was estimated by regressing the wake and +30min cortisol values on collection 
time. When an awakening cortisol value was estimated statistically, the +30min sample 
was retained only if it was within a time window of 15-60 minutes post-awakening. If the 
wake cortisol value was estimated statistically and the +30min sample was deleted due to 
being outside the sample collection window, the wake cortisol value was used as the 
+30min sample, provided its collection time was within 15-60 minutes after the 
awakening time estimated from actigraphy. All cortisol analyses were first conducted 
using the original cortisol values, with no estimated values. All analyses were then 
repeated using the data set with estimated awakening cortisol values. 
Cortisol values more than four standard deviations from the mean for that 
collection time were identified as outliers and examined for any possible confounders 
such as sample contamination, abnormally high nicotine or caffeine intake, or deviation 
from the requested sample time. Elimination of outliers was determined depending on 





Primary Analyses: Tests of Hypotheses 
Hypothesis 1a: Cancer-related intrusions will be significantly and positively associated 
with circadian disruption, as measured by salivary cortisol and actigraphy.  
A hierarchical regression equation predicting circadian disruption was calculated 
for each of the two measures of circadian disruption, salivary cortisol and rest/activity 
rhythms as measured by actigraphy. All analyses statistically controlled for two 
theoretically-derived variables, age at diagnosis and cancer stage. A third, empirically-
derived control variable was included in regression models. This control variable was 
chosen from among demographic and medical variables that were found to be 
significantly and most strongly correlated with outcome measures in preliminary 
analyses. Control variables were entered on the first step of the regression equation. The 
mean of the daily intrusion scores was then entered on the second step. Outcome 
variables included the autocorrelation coefficient, dichotomy indices for time in bed and 
out of bed, mean log-transformed awakening cortisol, cortisol awakening response 
(CAR) slope, diurnal cortisol slope, and overall diurnal mean log-transformed cortisol. 
 
Hypothesis 1b: Avoidant coping will moderate the relationship between cancer-related 
intrusive thoughts and circadian disruption. 
If the R2 value of IES in the equation calculated for hypothesis 1a was significant, 
a similar equation was calculated for hypothesis 1b. This equation utilized methods 
recommended by Baron and Kenny (Baron, 1986). Although a more recent 
conceptualization of moderators advised alternative analytical methods, these methods 
were not available for this analysis because they would require that intrusions precede 
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avoidant coping efforts temporally (Kraemer, Stice, & Kazdin et al., 2001). Because the 
study is cross-sectional, the temporal precedence requirement was not met. 
The analytical procedure used to test hypothesis 1b includes mean-centered 
intrusion and avoidant coping scores (Baron & Kenny, 1986), as well as a cross-product 
of intrusion and avoidant coping composed of mean-centered scores. These terms are 
mean-centered to minimize collinearity with the interaction term. To limit the model to 
four predictor variables, only one additional control variable was selected by determining 
whether age at diagnosis or cancer stage was most strongly correlated with the outcome 
in a given regression equation. Due to concerns about overcontrolling noted in the 
analysis plan for hypothesis 1a, analyses were repeated using only the three predictors 
necessary to perform this test. 
 
Hypothesis 2: Diurnal salivary cortisol slope and rest-activity rhythm obtained by 
actigraphy will be significantly and positively associated.  
With conservative intent, a Spearman correlation was calculated to determine 
whether there is any association between variables yielded by two measures of circadian 
disruption, actigraphy and cortisol. Each actigraphy variable used as a measure of 
circadian disruption was correlated with each cortisol variable used as a measure of 
circadian disruption. Actigraphy variables included the 24-hour autocorrelation, the 
dichotomy indices both for time inside bed and time outside of bed. The cortisol variables 
included mean awakening cortisol, CAR slope, diurnal cortisol slope, and overall diurnal 
mean cortisol.  
Because this analysis sought to characterize the relationship between two 
measures of the same construct, variables that likely influence circadian disruption and 
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were considered possible confounds in other analyses were not considered confounds for 
testing hypothesis 2. As a result, no tests attempted to determine whether the association 
of these two measures was independent of a third variable.   
 
Secondary Analyses 
To further the aim of conducting exploratory analyses of the relationships 
between intrusions, avoidant coping, and circadian disruption, secondary analyses were 
conducted. Because a maximum of 45 participants provided enough data to be included 
in some analyses, regression equations for all secondary analyses were limited to a total 
of four predictor variables, including age at diagnosis, cancer stage, an empirically 
selected third control variable, and the predictor of interest. 
 
Modified Intrusions Analysis 
 As noted above, one factor analysis of the IES has reported that two items of the 
intrusions subscale load onto a separate sleep disturbance factor (Larsson, 2000). To 
investigate the possibility that these sleep disturbance items confound the predictor 
variable (intrusions) with the criterion variables (circadian disruption) in Hypothesis 1a 
and 1b of the primary analyses, an intrusions score without the two items that some 
researchers have conceptualized as sleep disturbance items (Larsson, 2000) was utilized 







The sleep intervals specified for each participant’s actigraphy data were used to 
calculate several sleep variables, including sleep latency, total sleep interval, total sleep 
time, time awake after sleep onset, sleep efficiency, and awakenings. These outcomes 
were tested with intrusions as a predictor, and with age at diagnosis and cancer stage as 
control variables.  
 
Avoidant Coping and Circadian Disruption 
The avoidant coping score generated by the mean of the daily assessments was 
evaluated as a predictor of circadian disruption. Analytical methods were similar to those 
used with intrusions as a predictor of circadian disruption. All regression equations were 
limited to a total of three predictor variables. 
 
Daily COPE Subscales Analysis 
The Denial, Self-Distraction, and Behavioral Disengagement subscales that 
comprised the version of the Brief COPE completed on four consecutive mornings were 
tested separately as potential moderators of the effects of intrusions on circadian 
disruption. These analyses were only conducted when significant relationships between 
intrusions and circadian disruption were observed. 
 
Secondary Cortisol Outcomes 
All of the cortisol variables included in primary analyses were re-calculated with 
replacement of awakening cortisol values that were provided outside the ten minute time 
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window for these samples. If the awakening sample was not provided within a valid time 
period, the saliva collection time was regressed on the awakening and 30 minute post-
awakening cortisol samples that had been provided. Using the slope from this linear 
regression, a cortisol value was estimated for the awakening time provided by actigraphy. 
The summary cortisol variables re-calculated with these estimated awakening values 
included in the dataset were analyzed in secondary analyses. The CAR % increase and 
CAR area under the awakening curve were also included in secondary cortisol analyses 
to supplement primary analysis of the CAR slope. 
 
Cortisol and Sleep 
Exploratory analyses explored the relationship between several diurnal cortisol 
values and the following night’s sleep. Regression analyses used age at diagnosis and 
cancer stage as control variables. Cortisol variables used in previous analyses, as well 
mean bedtime cortisol values, were tested as predictors of the sleep variables used as 
outcomes in analyses described above. The bedtime cortisol values were added to explore 
whether high bedtime cortisol was related to disrupted sleep. 
 
Removal of Patients Endorsing Depression 
 Because depression and symptoms associated with PTSD have been noted by 
some to have opposite effects on circadian cortisol rhythms (Miller, 2007), it is possible 
that the inclusion of participants experiencing depression suppressed the relationships 
between intrusions and circadian disruption tested in hypothesis 1a. To eliminate this 
possible confound, participants scoring more than 1.5 standard deviations from the mean 
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standardization sample score on the Profile of Mood States (POMS) depression subscale 
were deleted prior to repeated analyses of intrusions and circadian disruption. The 
standardization sample used was a sample of 400 participants stratified by age, gender 
and race according to United States census data (Nyenhuis et al., 1999). This 
standardization sample and method of classification was demonstrated to successfully 
classify people with HIV infection as having Major Depressive Disorder using the POMS 
depression scale (Patterson et al., 2006). The use of 1.5 standard deviations as a cut-score 
between clinical and nonclinical samples has been used with the Minnesota Multiphasic 









Demographic and medical characteristics. 
Study participants ranged in age from 21 to 79 years with an average of 53.4 years 
(SD = 13.2). Additional sociodemographic characteristics of the sample, including 
ethnicity, marital status, education, annual household income and employment status are 
presented in Table 2.  
 
Table 2. Demographic characteristics of the sample (N=45) 
_______________________________________________________________________ 




 White/Caucasian    25   56 
 African American    17   38 
 Native American     2    4 
 Asian       1    2 
 
Marital Status 
 Married     18   40 
 Divorced     12   27 
 Never Married      6   13 
 Widowed      8   18 
 
Years of Education 
 Middle School (8 years)    1    2 
 High School (12 years)   29   64 
 AA/Technical School (14 years)   5   11 
 College Degree (16 years)    4    9 
 Master’s Degree (18 years)    4    9 








 Less than $20,000    15   33 
 20,000 to 39,999    11   24 
 40,000 to 59,999     4    9 
 60,000 to 79,999     4    9 
 80,000 to 99,999     2    5 
 100,000 and Greater     5   11 
 
Currently Employed 
Yes      23   51 





All participants provided consent for medical record review. The frequencies and 
descriptive statistics for medical data obtained through chart review are presented in 
Table 3. Cancer stage provides information about disease characteristics and prognosis. 
Breast cancer stage is determined using the size of the tumor, the extent of regional 
lymph node involvement, and whether the disease has spread to other organs or tissue. 
Pathologic staging from chart review was used when available. Two patients did not have 
pathologic staging data available because surgery was not ultimately performed, and 
clinical staging based on the physical exam and imaging tests was used to determine 
staging for these two patients. Grade is a measure of the aggressiveness of the tumor as 
assigned by a pathologist. Only two patients elected to undergo lumpectomy, suggesting 
mastectomy was clearly the preferred option within the sample of women enrolled in this 
study. Due to the low frequency of lumpectomy chosen in this sample, group level 




Table 3. Staging and clinical data (N= 45)  
Variable   Range         Frequency      Percentage 
 
Stage    DCIS    3     6.7            
    Stage I   20   44.4 
    Stage IIA   4    8.9  
    Stage IIB   3    6.7 
    Stage IIIA   8   17.8 
    Stage IIIB   1    2.2 
    Stage IIIC   3    6.7 
    Stage IV   3    6.7 
     
Grade    1    3    6.7 
    2   22    48.9 
    3   17   37.8 
    Missing   3    6.7  
  
Tumor Size (T)   0    2    4.4 
    TI   20   44.4 
    T2   10   22.2 
    T3    8   17.8 
    T4    2    4.4 
    Missing   3    6.7 
 
Nodal Involvement (N)  0   26   57.8 
    NI    7   15.6 
    N2    7   15.6 
    N3    3    6.7 
    Missing   2    4.4 
 
Metastatic Status (M)  M0   19   42.2 
               M1    3    6.7 
    Undetermined  23   51.1 
 
 
Age at diagnosis (years)         53.4 (13.2) (Mean/SD)     21-79 (range) 
Time since diagnosis (days)         18.8 (21.9) (Mean/SD)     0-122 (range) 
 
 
Breast Cancer Type  Primary  43   95.6 





Variable   Range         Frequency      Percentage 
 
 
Previous Breast Surgery Yes    1    2.2 
    No   44   97.8 
 
History of Radiation*  Recent (past 2 mo.)  0     0 
Yes    2    4.4 
    No   43   95.6 
 
History of Chemotherapy Recent (past 2 mo.)  0     0 
Yes    2    4.4 
    No   43   95.6 
 
History of Cancer at   Yes   1    2.2 
Other Body Site  No   44   97.8  
  
Comorbid Medical  Yes   20   44.4 
Condition**   No   25   55.6 
 
Menopausal Status  Pre-Menopausal 18   40.0 
    Peri-Menopausal  3    6.7 
    Post-Menopausal 24   53.3 
 
Menstrual Phase  Pre-Menopausal,  7   15.6  
         Follicular Phase 
    Pre-Menopausal,  9   20.0 
         Luteal Phase 
    Pre-Menopausal,  2    4.4 
         Phase Undetermined 
    Peri-/Post-Meno.  1    2.2 
         Estrogen Therapy 
    Peri-/Post-Meno. 26   57.8 
         No Estrogen 
Oral Contraceptives  Yes    0     0 
    No   45   100 
 
Estrogen Replacement Yes    1    2.2 
    No   44   97.8 
 
Surgical Decision  Mastectomy  39   86.7 
    Lumpectomy   2    4.4 






Variable           N   Mean (SD)      Range 
_______________________________________________________________________     
Systolic blood pressure                   41 140.1 (20.4)      100-194 
Diastolic blood pressure         40  83.9 (11.2)     63-115 
Heart rate           41  83.0 (13.2)     64-120 
 
* Two participants reported receiving radiation in the past. None of the participants reported receiving 
radiation in the past year. 
** The participant endorsing a history of cancer at another site reported cervical cancer in 1985. 
Comborbid medical diagnoses included hypertension (11 participants), diabetes (9), history of myocardial 
infarction (2), arthritis (2), hypothyroidism (2), chronic obstructive pulmonary disease, scoliosis, chronic 
fatigue syndrome, seizures, skin lesions, chronic hives, scleroderma, local positive antinuclear antibody, 
supraventricular tachycardia, sarcoidosis, osteoarthritis, and asthma. 
 
 
To ensure accurate recording of medications, participants were queried as to the 
medications they were taking. Frequencies for each class of medication taken by at least 
one participant in this study or those that are important to note because of conceptual 
links with major study variables, are presented in Table 4. The participant who reported 
taking Fluticasone, a systemic steroid, was deleted from all analyses including cortisol 
due to the influence of systemic steroids on cortisol assessments. 
 
Table 4. Medications (N= 45)  
Medication          Frequency       Percentage 
 
Non-Steroidal Anti-inflammatory Agents  16   35.6 
Antihypertensive Agents    13   28.9 
Diuretics      11   24.4 
Anti-Lipidemic     10   22.2 
Antidepressants       8   17.8  
Antidiabetic Agents      8   17.8 
Cardiac Drugs       7   15.6 
Opiate Agonists      6   13.3 
Sleep Medications      5   11.1 
Antihistaminic Agents     4    8.9 
Anxiolytics       4    8.9 
Bronchodilating Agents     4    8.9 
Gastrointestinal Drugs     4    8.9 
Thyroid Agents      3    6.7 
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Medication          Frequency       Percentage 
 
Adrenergics       2    4.4 
Analgesics       2    4.4 
Antibiotics       2    4.4  
Anticonvulsants      2    4.4 
Antitussives       2    4.4 
Benzodiazepine      2    4.4 
Estrogen       2    4.4 
Potassium Replacement     2    4.4 
Sedatives/Tranquilizers      2    4.4 
Urinary Anti-Spasmodic Agents    2    4.4 
Vasodilating Agents      2    4.4  
Anticoagulants      1    2.2   
Antidiherreal Agents      1    2.2 
Anti-psychotics      1    2.2 
Antirheumatoids      1    2.2 
Anti-Spasmodics      1    2.2 
Anti-Viral Agents      1    2.2 
Cathartics/Laxatives      1    2.2 
Estrogen Replacement Therapy    1    2.2 
Iron Replacements      1    2.2 
Insulins       1     2.2 
Leucotrine Antagonists Asthma Treatment   1    2.2 
Prophylaxis (Preventive Medication)    1    2.2  
Proton Pump Inhibitors     1    2.2 
Para-Thyroid Hormones     1    2.2 
Respiratory Muscle Relaxes     1    2.2 
Skeletal Muscle Relaxants     1    2.2 
Sulfonylureas       1    2.2 
Systemic Contraceptives (Oral, patch, vaginal ring)  1    2.2 
Systemic Steroids      1    2.2 
Unclassified Therapeutic     1    2.2 
Adrenals       0      0  
Corticosteroids      0      0 
Non-Systemic Contraceptives    0      0 




 Over a period of four days, participants provided self-reports of intrusions and 
avoidant coping, wore actigraphy devices, and provided saliva samples for cortisol assay. 
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Descriptive statistics for these daily assessments are presented in Table 5. The mean for 
daily IES assessments was 9.5 (SD = 5.6). The intrusions score was lower than those 
reported (14.5) by women recently informed that they required a breast biopsy (Lebel et 
al., 2003) and those reported by women who were within 1 year of breast cancer 
diagnosis but had completed surgery (Koopman et al., 2002), but similar to the intrusions 
score (9.61) reported in breast cancer patients an average of 19 months after bone marrow 
transplant (Jacobsen et al., 1998). The mean intrusions score reported in this study was 
lower than expected given the probable salience of the diagnosis such a short time after it 
had been communicated. Previous research identified the period immediately following 
diagnosis as a time of particularly high distress, but several possible explanations exist. 
First, daily assessments may yield different results than self-report measures prompting 
participants to report retrospectively over a longer period of time. Second, patients were 
often assessed in the first few days after diagnosis in this study, and many of the previous 
studies assessed women over a larger time window. Breast cancer-related intrusions may 
increase in the weeks following diagnosis as women engage in elaborative processing. 
Focus on breast cancer after diagnosis may promote association of the diagnosis with 
more environmental cues, prompting subsequent intrusions as those environmental cues 
are encountered in daily life. Intrusion levels may also be attributable to characteristics of 
the recruitment setting. Patients in this clinic often met with their physician for 60-90 
minutes and received information related to their diagnosis and treatment. The 
communication of this information may have eased the process of deciding which 
surgical treatment to pursue and reduced concerns about outcomes that were unlikely 
given the characteristics of their illness.  
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The mean for avoidant coping assessments was 11.2 (SD = 4.1), which is 
comparable to levels observed using the same items with women seeking shelter after 
surviving domestic abuse (12.92) (Street, Gibson, & Holohan, 2005). Diagnosis of a life 
threatening illness and domestic abuse are both potentially traumatic events, so 
comparable levels of avoidant coping are not unexpected. However, potential differences 
between these events include the time of exposure to the stressor and the amenability of 
the stressor to active coping efforts. While most of the women in the current study had 
recently encountered the stressor for the first time, women suffering from domestic abuse 
may have endured this stressor for a long time before seeking shelter and could have even 
felt that the stressor was at or near its resolution because they had left the home. It is 
difficult to discern which stressor may have been perceived as more amenable to active 
coping. Although direct treatment of the tumor is largely undertaken by the patient’s 
medical team, patients could engage in active coping such as seeking information related 
to their disease, reorganizing activities to pursue treatment and choosing treatments, and 
seeking emotional support from friends and family. Similarly, women suffering from 
domestic abuse over a long period of time may have abandoned most active coping 
efforts as they have proven ineffective in the past. Conversely, the act of seeking shelter 
is an example of active coping, and sampling these women may underrepresent avoidant 







Table 5. Descriptive data for daily measures 
Variable            N   Mean (SD)      Range     
 
Intrusions 
Intrusions           45 9.5 (5.6)    0-21 
 
Coping 
Avoidant Coping          45 11.2 (4.1)       6-20.3  
Self-distraction subscale         45 5.2 (1.9)    2-8 
Denial subscale          45 3.2 (1.8)    2-7.75 
Behavioral Disengagement           
Subscale           45 2.8 (1.4)    2-7.5 
 
Sleep          
Nightly time in bed (hours)             42 7.26 (1.13)    4.35-10.02 
Nightly time spent asleep (hours)   42 6.47 (1.32)    2.75-8.34 
Nightly time spent awake after  
sleep onset (minutes)          42 48.8 (36.1)    15.67-168.75 
Overall sleep efficiency    
(% of sleep interval spent awake)   42 88.6% (9.9)    50%-97% 
Number of nightly awakenings       42 12.6 (6.0)    1.25-30 
Sleep latency (minutes)         40 41.0 (30.1)    0-128.7 
 
Circadian Disruption - Actigraphy 
24 hour autocorrelation coefficient 42           .280 (.176)               -.066-.721  
Dichotomy index % for  
time in bed (D/I)            42  97.1% (3.6)    84.5%-100% 
Dichotomy index % for  
time outside bed (D/O)         42  5.7% (5.2)   0.5%-20.05% 
 
Circadian Disruption - Cortisol 
CAR % increase (µg/dL)         40 35.8% (63.0)           -74.1%-169.1% 
CAR % increaseE (µg/dL)         40 41.1% (75.2)           -74.1%-293.5% 
 
Morning slopeL (µg/dL)         42 .012 (.181)   -.611-.586 
Morning slopeEL (µg/dL)         42 .052 (.330)   -.611-1.728 
 
Waking cortisol (µg/dL)         43 .354 (.278)   .087-1.628 
Waking cortisolE (µg/dL)         43    .360 (.278)   .087-1.605 
 
Area under the awakening curveL  
(µg/dL)              40 -1.762 (.661)           -3.693-(-0.184) 
Area under the awakening curveEL  




Variable            N   Mean (SD)      Range     
 
 
Diurnal cortisol slopeL (µg/dL)       43 -.089 (.068)   -.246-.076 
Diurnal cortisol slopeEL (µg/dL)     43 -.092 (.072)   -.246-.076 
 
Overall diurnal mean cortisol  
(µg/dL)                 43 .241 (.146)   .088-.911 
Overall diurnal mean cortisolEL  
(µg/dL)                43 .242 (.145)              .088-.904 
  
Bedtime cortisol (µg/dL)L         42 .121 (.121)   .015-.535 
 “E” subscripts are used to denote summary cortisol variables calculated with the estimated awakening 
cortisol value included. “L” subscripts are used to denoted cortisol values that are presented after log 




 Potential control variables, predictors, and outcome variables were evaluated by 
examining a histogram and boxplot for each variable to determine whether they met the 
normality assumption for Pearson correlations. For all variables that did not meet this 
assumption, Spearman correlations were used to evaluate bivariate relationships. 
 
Control variables 
Both theoretical and empirical methods were used to identify potential control 
variables. Age at diagnosis and cancer stage were adjusted in all analyses due to likely 
associations with both the predictor and outcome variables. Bivariate correlations of 
racial background, education, income, weight, systolic blood pressure, diastolic blood 
pressure, tumor size, nodal involvement, estrogen receptor status at the time of diagnosis, 
progesterone receptor status at diagnosis, human epidermal growth factor receptor 
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(her2/neu) status at diagnosis, grade at diagnosis, time since diagnosis, each class of 
medications taken by at least 5% of the sample, and all medications taken for the purpose 
of sleep. Of the variables that exhibited significant correlations with the outcome 
variable, the control variables with the highest correlations were used as covariates in the 
calculation of regression equations and partial correlations. Bivariate correlations 
between demographic variables and outcome variables can be found in Table 6. Potential 
control variables and outcome variables were evaluated to determine whether they were 
normally distributed. Non-normally distributed variables were examined using 
Spearman’s r, as noted on Table 6. Preliminary analyses of medical data as potential 
control variables are presented in Table 7. All patients included in any analysis are 
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Table 7 notes that larger tumor size was significantly correlated with more nightly 
sleep (Spearman’s r = .449, p < .01). Not only is it surprising that these variables are 
significantly correlated, but the correlation is in an unexpected direction. There is no 
obvious conceptual reason why a larger tumor should be related to increased time spent 
asleep. As a result, the distribution of nightly sleep was examined in a boxplot illustrated 
in figure 5 below. Nightly sleep is slightly negatively skewed, as two participants lie 
below the error bar. Examination of tumor size categories for these patients revealed that 
one was classified as T = 1, the modal classification for tumor sizes in this study, and the 
other was classified as T = 3, a value that would suggest a negative correlation between 
tumor size and sleep. As a result these two patients did not account for the correlation of 
tumor size and sleep. This distribution also indicates that there were no participants who 
were outliers with abnormally high levels of sleep and large tumor sizes. It is possible 
that this correlation is a spurious one due to the relatively small sample size. In any case, 
no association of tumor size with overall 24-hour rhythms was observed, so any effect of 
tumor size would be limited to sleep outcomes. Nevertheless, future studies might note 
the relationship between these variables and build on the available understanding of their 
relevance to tumors and sleep.   
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Distribution of Nightly Sleep
 
Figure 5. Distribution of mean nightly sleep in minutes for the sample. The line in the 
middle of the box represents the median, and the edges of the box represent quartiles. The 
error bars represent a 95% confidence interval. 
 
Evaluation of Missing Cortisol Data 
 One participant was excluded from all analyses involving cortisol due to 
nonadherence to the protocol. Of the 45 patients included in at least a portion of the 
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primary analyses involving cortisol variables, 86.7% of all possible cortisol samples were 
completed, judged to be provided at a valid time, without contamination, and with a valid 
value. The number of missing cortisol samples was evaluated in terms of its relationship 
with disease stage and intrusions to explore whether samples were missing for 
systematic, as opposed to random, reasons. The number of missing cortisol samples was 
not significantly correlated with disease stage (Spearman’s r = .043, p = .781) or 
intrusions (Spearman’s r = .049, p = .751).  
 Next, the number of missing cortisol samples was correlated with cortisol 
outcome variables to determine whether missing data might alter the summary variables 
used in subsequent analyses. The number of missing samples was significantly correlated 
with the diurnal cortisol slope (Spearman’s r = .375, p = .012). More missing values were 
correlated with a flatter diurnal cortisol slope. This relationship remained significant 
using the diurnal cortisol slope calculated with estimated awakening cortisol times 
included (Spearman’s r = .359, p = .017). More missing samples were also significantly 
correlated with elevated average bedtime cortisol values (Spearman’s r = .508, p = .001). 
Analyses finding a significant relationship with one of these variables as an outcome 
were followed up with analyses that controlled for the number of missing samples to 
investigate whether the number of missing samples was a confound. 
 Although the MEMS collection times and self-reported collection times were 
highly correlated (Spearman’s r = .977, p < .01), analyses sought to determine whether 
differences between these two collection time measures came about systematically. 
Correlations with disease stage (Spearman’s r = -.007, p = .965) and intrusions 
(Spearman’s r = .236, p = .143), as measured by the daily IES measure, revealed no 
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statistically significant relationship, suggesting that the differences between the two 
measures of collection time would not confound results. 
 
Primary Analysis for Testing Main Hypotheses  
 Hypothesis 1a: Cancer-related intrusions will be significantly and positively 
associated with circadian disruption, as measured by salivary cortisol and actigraphy. 
  Hierarchical regression models were utilized to examine the hypothesis that 
intrusions were significantly associated with circadian disruption. All analyses 
statistically controlled for two theoretically-derived variables, age at diagnosis and cancer 
stage. A third, empirically-derived control variable was included in regression models. 
This control variable was chosen from among demographic and medical variables that 
were found to be significantly and most strongly correlated with outcome measures in 
preliminary analyses. The mean of the daily intrusion scores was then entered on the 
second step.  
Outcome variables for primary analyses included the autocorrelation coefficient, 
dichotomy indices for time in bed and out of bed, mean awakening cortisol, cortisol 
awakening response (CAR) slope, CAR slope, diurnal cortisol slope, overall diurnal 
mean cortisol, and bedtime cortisol level. A total of nine outcome variables were 
evaluated, including three actigraphy variables and six cortisol variables.  
In the hierarchical regression model of intrusions predicting circadian disruption, 
using autocorrelation as the outcome measure, control variables entered in the first step 
(age, stage, and income) explained a significant amount of variance as a group (ΔR2 = 
.222; F(3,35) = 3.335, p = .030). The addition of intrusions (ΔR2 = .146; F(1,34) = 7.853, 
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p = .008) accounted for a significant proportion of the remaining variance, with intrusions 
being related to a lower autocorrelation (partial r = -.433), a marker of less pronounced 
circadian rhythm. The entire 4-variable model was related to the autocorrelation as well 
(F(4,34) = 4.954, p = 0.003). These statistics, as well as statistics for other circadian 
rhythm variables derived from actigraphy, are presented in Table 8. A scatterplot of the 
bivariate relationship between the 7-item version of the intrusions subscale of the IES and 
the autocorrelation is depicted in Figure 6. Regression equations with other circadian 
disruption variables as outcomes revealed no other associations of intrusions with 
circadian disruption that were independent of control variables, including both actigraphy 
and cortisol outcomes. 
In the hierarchical regression model of intrusions predicting circadian disruption, 
using the mean CAR % increase as the outcome measure, control variables entered in the 
first step (age and stage) did not explain a significant amount of variance as a group (ΔR2 
= .043; F(2,37) = 0.839, p = .440). The addition of intrusions (ΔR2 = .101; F(1,36) = 
4.245, p = .047) accounted for a significant proportion of the remaining variance, with 
intrusions being related to an elevated CAR % increase (partial r = .325), a marker of less 
pronounced circadian rhythm. The entire 4-variable model was related to the CAR % 
increase as well (F(3,36) = 2.024, p = .128). The addition of intrusions on the second step 
of a model predicting CAR % increase with estimated awakening values included also 
contributed significantly to the explanatory power of the model (ΔR2 = .134; F(1,36) = 
5.928, p = .020), with intrusions again being associated with elevated CAR % increase 




Table 8. Summary of hierarchical regression analyses entering the 7-item intrusions 
measure as a predictor of circadian disruption measured by actigraphy. 
Variable   B SE B       ß       R2         ΔR2            p of  ΔR2     N      
Autocorrelation 
Step 1            .222       .222   .030     39 
    Age            .002 .002      .147          
    Stage           .007 .011      .093 
    Income           .044 .014      .470* 
Step 2            .368       .146   .008 
    Intrusions          -.013 .004     -.414* 
 
Dichotomy Index Inside (D/I) 
Step 1            .099        .099   .262     42 
    Age               .013  .049      .048 
    Stage              .104      .271         .061 
    Anti-lipidemic agents      -3.255 1.569     -.372*      
Step 2            .024        .122          .322 
    Intrusions            -.110       .110     -.162 
 
Dichotomy Index Outside (D/O) 
Step 1             .233       .233           .017       42 
    Age            -.063   .063     -.158 
    Stage           -.054   .363     -.022 
    Opiate Agonists             7.849      2.408         .491** 
Step 2             .246       .013           .422 
    Intrusions            .064 .136       .073 
_______________________________________________________________________ 
* p < .05 




Figure 6. Illustration of the bivariate relationship between intrusions and the rest/activity 























Rest/Activity Autocorrelation as a Function of Intrusions
The regression line for the bivariate relationship illustrated in Figure 6 had the following equation: y = -
0.008x + .352. Partial r = -.233, p = .137. 
 
 
Modified Intrusions Measure  
The two items on the IES that some have argued assess sleep disturbance, as 
opposed to intrusions, were removed from the IES, and a new intrusions score for the 
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four collection days was calculated using a summary score of the remaining five items. 
This intrusions score was used to explore whether the two “sleep” items had accounted 
for the relationship between intrusions and circadian rhythms. Using this modified scale, 
results were similar to those observed with the full, 7-item scale. The addition of 
intrusions on the second step of a hierarchical regression predicting the autocorrelation 
significantly added to predictive power of the model (ΔR2 = .113; F(1,34) = 5.798, p = 
.022), such that intrusions were related to a lower autocorrelation (partial r = -.382). The 
overall, four variable model was also predictive of the autocorrelation (F(4,38) = 4.293, p 
= .006).  
In contrast to the results observed using the 7-item version of the intrusions 
subscale, addition of the 5-item intrusions subscale on the second step was not predictive 
of the CAR % increase (ΔR2 = .088; F(1,36) = 3.634, p = .065), though it was a 
significant, independent predictor of CAR % increase when estimated awakening values 
were included (ΔR2 = .112; F(1,36) = 4.816, p = .035). Other regression equations 
examining intrusions as a predictor of circadian disruption did not reveal significant, 
independent effects of the 5-item intrusions subscale on circadian disruption. 
 
Hypothesis 1b: Avoidant coping will moderate the relationship between cancer-related 
intrusive thoughts and circadian disruption. 
 To evaluate daily avoidant coping reports as potential moderators of the 
relationship between intrusions and circadian disruption, only the significant relationships 
observed in analyses from hypothesis 1a were tested. Because a significant association of 
intrusions with the autocorrelation was observed, a test of moderation was performed. 
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Age at diagnosis was used as a covariate and entered on the first step with the mean-
centered avoidant coping variable and the mean-centered intrusions variable. The 
intrusions and avoidant coping variables were moderately correlated (Pearson’s r = .554, 
p < .001). In this hierarchical regression model, age was entered on the first step with the 
mean-centered intrusions and avoidant coping variables. These variables did not explain a 
significant amount of variance as a group (ΔR2 = .188; F(3,38) = 2.704, p = .060). In 
addition, age (partial r = .009, p = .958) and mean-centered intrusions (partial r = .005, p 
= .975) covariates were not significant predictors individually. Mean-centered avoidant 
coping (partial r = -.358, p = .030) was a significant predictor individually. Using the 
mean-centered avoidant coping and intrusions scores, a cross-product of these variables 
was calculated and entered on the second step of this regression equation. This cross-
product did not account for a significant proportion of the remaining variance (ΔR2 = 
.005; F(1,34) = 2.030, p = .662). It should be noted that avoidant coping was no longer a 
significant individual predictor of the rest/activity autocorrelation (partial r = -.305, p = 
.070) after the interaction term was added to the model. In a separate model, the addition 
of a cross product between the mean-centered 5-item version of the intrusions subscale 
and the autocorrelation on the second step of a regression equation also did not contribute 
significantly to the predictive power of the model (ΔR2 = .002; F(1,37) = 0.067, p = 
.796). 
 Because intrusions were related to the CAR % increase in hypothesis 1a analyses, 
a model testing avoidant coping as a moderator of this relationship was tested. In this 
model, age (partial r = -.157, p = .348), mean-centered intrusions (partial r = .192, p = 
.247), and mean-centered avoidant coping (partial r = .155, p = .352) did not explain a 
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significant amount of variance individually or as a group (ΔR2 = .159; F(3,36) = 2.275, p 
= .096) and neither did the addition of the interaction between intrusions and avoidant 
coping (ΔR2 = .064; F(1,35) = 2.887, p = .098). Similar results were observed when using 
the interaction between intrusions and avoidant coping to predict CAR % increase with 
estimated awakening values included (ΔR2 = .036; F(1,35) = 1.597, p = .215). 
 
Hypothesis 2: Diurnal salivary cortisol slope and rest-activity rhythm obtained by  
 
actigraphy will be significantly and positively associated. 
 
 Spearman correlations between actigraphy and cortisol measures of circadian 
disruption were calculated to explore this relationship. Actigraphy measures included the 
rest/activity autocorrelation and the dichotomy indices for time in and out of bed. Cortisol 
variables included the awakening cortisol value, CAR slope, diurnal cortisol slope, mean 
diurnal cortisol, and bedtime cortisol value. All correlations are shown in Table 9. 
Significant correlations involving the diurnal cortisol slope or bedtime cortisol level were 
followed up by partial correlations controlling for the number of missing cortisol values 
because the number of missing values was correlated with these two measures and 
presented a possible confound. The results of partial correlations are presented in Table 
10.  
A higher autocorrelation was correlated with a steeper decline in the diurnal 
cortisol slope (Spearman’s r = -.613, p < .001), both indications of circadian rhythmicity. 
This effect was independent of the number of missing cortisol values (partial r = -.638, p 
< .001). A higher autocorrelation was also correlated with a lower bedtime cortisol value 
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(Spearman’s r = -.459, p = .003), an effect that was independent of the number of missing 
cortisol samples (partial r = -.476, p = .002).  
  
Table 9. Actigraphy and Cortisol Correlations (N = 41) 
           
           24 hour                   Dichotomy                   Dichotomy      
Autocorrelation                Index Inside               Index Outside                   
 
Mean Waking CortisolL         .273    .039            -.183 
 
Morning Cortisol SlopeL        -.238   -.276   .348* 
 
Diurnal Cortisol SlopeL        -.613**   -.302              .498** 
         
Mean Diurnal CortisolL        -.078    -.114                 .165 
 
Bedtime CortisolL         -.459**    -.273   .431** 
________________________________________________________________________  
 “L” subscripts are used to denoted cortisol values that are presented after log transformation to correct for 
non-normal distribution. 
* p < .05, ** p < .01 
All correlations calculated using Spearman’s r   
 
Significant correlations were noted between a higher D/O and a flatter diurnal 
cortisol slope (Spearman’s r = .498, p = .001), independent of missing cortisol samples 
(partial r = .471, p = .003). D/O was also associated with a steeper increase in the 
morning cortisol slope (Spearman’s r = .348, p = .028), and elevated bedtime cortisol 
(Spearman’s r = .431, p = .006), an effect that was also independent of missing cortisol 
values (partial r = .408, p = .011). Because D/O reflects the amount of activity when out 
of bed that falls below the median activity level for time in bed, a high D/O suggests 





Table 10. Summary of partial correlations between actigraphy and cortisol. The number 
of missing cortisol samples was statistically controlled. 
Actigraphy  Cortisol  CV   partial r    p     
Autocorrelation diurnal slopeL  missing samples -.638  <.001 
 
Autocorrelation diurnal slopeEL missing samples -.591  <.001 
   
Autocorrelation bedtime cortisolL missing samples -.476    .002 
 
D/O   diurnal slopeL  missing samples  .471    .003 
 
D/O   diurnal slopeEL missing samples  .436    .006 
 
D/O   bedtime cortisolL missing samples  .408    .011 
_______________________________________________________________________ 
 “L” subscripts are used to denoted cortisol values that are presented after log transformation to correct for 
non-normal distribution. “E” subscripts are used to denote summary cortisol variables calculated with the 
estimated awakening cortisol value included.  
* p < .05 
** p < .01 
 
Figure 7 illustrates the relationship between the rest/activity autocorrelation and 
raw cortisol values throughout the day. Solely for the purpose of illustration, the sample 
was split into “Low” and “High” autocorrelation groups using a median split. The two 











Figure 7. Contrasts between raw diurnal cortisol values for participants 
characterized by a median split of rest/activity autocorrelations (N = 20 for each group).  
 
Legend. A median split was used to divide the sample into low and high autocorrelation groups. These 
groups were created solely to aide in illustrating the relationship between the autocorrelation and cortisol 
values, and the autocorrelation median split was not used for any data analyses. All cortisol values are raw, 




Secondary Analysis #1: Sleep Variables from Actigraphy as Outcomes 
 Actigraphy data were used to calculate the mean time spent asleep each night, 
the mean amount of time awake after sleep onset, the mean sleep onset latency, the mean 
number of awakenings, and the percentage of time spent asleep each night. These 
variables were tested as outcomes in analyses similar to those used with circadian 
disruption variables in previous analyses. The intrusion score, with and without the two 
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“sleep” items was tested as a predictor of sleep outcomes. Analyses were performed with 
age and stage as control variables and a third, empirically selected control variable. The 
predictor of interest was entered on the second step. Intrusions were not significantly 
related to sleep in any of these analyses. 
 
Secondary Analysis #2: Direct Effects of Avoidant Coping on Circadian Disruption 
 Avoidant Coping Summary Scale 
 To determine whether avoidant coping was related to circadian disruption 
directly, as opposed to moderating the effects of intrusions on circadian disruption, 
regression analyses similar to those employed to test hypothesis 1a were used with 
avoidant coping as the predictor entered on the second step. Regression equations were 
calculated with a third, empirically selected control variable. Separate regression 
equations were calculated for each of the following outcomes: rest/activity 
autocorrelation, D/I, D/O, sleep time, awakenings, wake after sleep onset, sleep 
efficiency, sleep onset latency, awakening cortisol value, CAR morning slope, CAR % 
increase, area under the awakening cortisol curve, diurnal cortisol slope, and mean 
diurnal cortisol, and bedtime cortisol value. All cortisol equations were calculated with 
and without awakening values estimated using linear modeling. 
The autocorrelation was regressed on age, stage, and income on the first step of a 
hierarchical regression equation, and these control variables explained a significant 
amount of variance as a group (ΔR2 = .222; F(3,35) = 3.335, p = .030). Similarly, the 
addition of avoidant coping on the second step predicted the autocorrelaion (ΔR2 = .098; 
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F(1,34) = 4.896, p = .034), such that avoidant coping was associated with circadian 
disruption (partial r = -.355). 
 
Table 11. Summary of Regression Equations Noting a Significant Relationship Between 
Avoidant Coping and Actigraphy Measures of Circadian Disruption. 
Variable   B SE B       ß       R2         ΔR2            p of  ΔR2     N      
 
Autocorrelation 
Step 1            .222       .222   .030    39 
    Age             .002 .002      .135          
    Stage            .007 .011      .085 
    Income            .036 .014      .384* 
Step 2            .320       .098   .034 
    Avoidant Coping          -.013 .006     -.333* 
------------------------------------------------------------------------------------------------------------ 
Dichotomy/Inside (D/I) 
Step 1            .099       .099   .262    42 
    Age             .007 .045      .025          
    Stage            .123 .248      .072 
    Anti-Lipidemic Agents  -3.534     1.411     -.404* 
Step 2            .267       .168   .006 
    Avoidant Coping          -.366 .125     -.422* 
________________________________________________________________________ 
* p < .05 
 
In a hierarchical regression controlling for age, stage, and anti-lipidemic 
medication, the control variables entered on the first step did not explain a significant 
amount of variance in D/I as a group (ΔR2 = .099; F(3,38) = 1.385, p = .262). However, 
when avoidant coping was entered on the second step, it was a significant predictor of D/I 
(ΔR2 = .168; F(1,37) = 8.496, partial r = -.432, p = .006), such that avoidant coping was 
related to less time in bed in which the activity level was below the median activity level 
when not in bed. The bivariate relationship between avoidant coping and D/I is 
represented in Figure 8. A lower D/I is likely characteristic of disrupted circadian 
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rhythmicity. The entire, four variable model was not related to D/I (F(4,37) = 3.368, p = 
.019). Results for actigraphy variables can be seen in Table 11. Avoidant coping was not 
independently related to any other circadian disruption outcomes.  
 
Figure 8. Illustration of the bivariate relationship between avoidant coping and the 
dichotomy index for time in bed (D/I) (N = 41).  
 




Secondary Analysis #3: Avoidant Coping Subscales and Circadian Disruption  
Average scores on daily avoidant coping subscales were calculated and explored 
as predictors of circadian disruption. Avoidant coping subscales included self-distraction, 
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denial, and behavioral disengagement. Analytic procedures were identical to those used 
for the summary daily avoidant coping score used as a predictor in secondary analysis #2.  
 
Self-Distraction 
 With log-transformed area under the awakening cortisol curve (MAUC) as the 
outcome, age and stage did not collectively predict MAUC (R2 = .177; F(3,36) = 2.576, p 
= .069), but the addition of self-distraction on the second step did (ΔR2 = .106; F(1,35) = 
5.186, p = .029). Self-distraction was related to increased MAUC (partial r = .359). 
Similar results were observed when awakening values estimated using linear modeling 
were included in the calculation of the area under the awakening cortisol curve, as the 
addition of self-distraction was related to higher MAUC (ΔR2 = .119; F(1,35) = 6.151, 
partial r = .387, p = .018). Significant results observed in models using self-distraction as 
a predictor of circadian disruption are presented in Table 12. 
 When the log-transformed average awakening cortisol value was tested as an 
outcome, the collection of age, stage, and bronchodilating medication was not related to 
awakening cortisol (R2 = .107; F(2,40) = 2.385, p = .105), but the addition of self-
distraction on the second step was significantly associated with a higher awakening 
cortisol level (ΔR2 = .088; F(1,39) = 4.280, partial r = .314, p = .045). Similar results 
were observed when estimated awakening values were included, as the addition of self-
distraction on the second step was associated with a higher awakening cortisol level (ΔR2 
= .091; F(1,39) = 4.377, partial r = .318, p = .043). 
 No other significant relationships were observed in models using self-distraction 
as a predictor of circadian disruption, including all analyses with actigraphy outcomes. 
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Table 12. Summary of Regression Equations Showing a Significant Relationship between 
Self-distraction and Cortisol Awakening Response. 
Variable   B SE B       ß       R2         ΔR2            p of  ΔR2     N      
 
Area Under Awakening Curve (MAUC) 
Step 1            .177      .177   .069    40 
    Age             .009 .008       .187          
    Stage            .049 .056       .144 
    Benzodiazepines           .966       .471       .322* 
Step 2            .283       .106   .029 
    Self-Distraction           .115 .051       .344* 
------------------------------------------------------------------------------------------------------------ 
MAUC with Estimated Waking ValuesE 
Step 1            .203       .203   .040    40 
    Age             .011 .008       .218          
    Stage            .060 .052       .184 
    Benzodiazepines           .933       .445       .324 
Step 2            .322       .119   .018 
    Self-Distraction           .117 .047       .365* 
------------------------------------------------------------------------------------------------------------ 
Mean Awakening Cortisol 
Step 1            .107       .107   .105    43 
    Age              .014 .007       .302          
    Stage             .070      .049       .223 
Step 2            .195       .088   .045 
    Self-Distraction            .097      .047      .311* 
_ 
------------------------------------------------------------------------------------------------------------ 
Mean Awakening CortisolE 
Step 1            .101       .101   .119    43 
    Age              .015 .008       .307          
    Stage             .065      .052       .193 
Step 2            .192       .091   .043 
    Self-Distraction            .104      .050       .315* 
 
_________________________________________________________________ 
“E” subscripts are used to denote summary cortisol variables calculated with the estimated awakening 
cortisol value included.  







In a hierarchical regression exploring denial as a predictor of D/I, control 
variables including age, stage, and anti-lipidemic medication entered on the first step did 
not significantly predict D/I (ΔR2 = .099; F(3,38) = 1.385, p = .262). Denial entered on 
the second step independently predicted D/I (ΔR2 = .222; F(1,37) = 12.119, p = .001), 
such that denial was associated with a lower D/I (partial r = -.497). The entire, four 
variable model was also related to D/I (F(4,37) = 4.373, p = .005). Regression equations 
yielding a significant effect of denial on circadian disruption are summarized in Table 13. 
Table 13. Summary of Regression Equations Showing a Significant Relationship between 
Denial and D/I, D/O, and Nightly Sleep. 
Variable   B SE B       ß       R2         ΔR2            p of  ΔR2     N      
 
Dichotomy/Inside (D/I) 
Step 1            .099       .099   .262    42 
    Age             .023 .043       .083          
    Stage            .185 .239       .107 
    Anti-Lipidemic Agents  -3.363     1.348      -.385 
Step 2            .321       .222   .001 
    Denial Coping          -.933 .268     -.476* 
Dichotomy/Inside (D/O) 
Step 1            .233       .233   .017    42 
    Age            -.064 .056     -.159          
    Stage           -.143 .335     -.057 
    Opiate Agonist Agents    6.791     2.255       .424* 
Step 2            .127       .360   .010 
    Denial Coping          1.035 .382       .366* 
Nightly Sleep 
Step 1            .197       .197   .041    41 
    Age            -.766 .904      -.119          
    Stage           7.090    5.218       .191 
    Weight           -.683 .245      -.387* 
Step 2            .124       .321   .015 
    Denial Coping       -15.831    6.178      -.357* 
________________________________________________________________________ 




In a hierarchical regression controlling for age, stage, and opiate agonist 
medication, the control variables entered on the first step were related to D/O as a group 
(ΔR2 = .233; F(3,38) = 3.848, p = .017). Denial entered on the second step independently 
predicted D/O (ΔR2 = .127; F(1,37) = 7.348, p = .010), such that denial was associated 
with a higher D/O (partial r = .407). The entire, four variable model was also significantly 
associated with D/O (F(4,37) = 5.205, p = .010).  
The regression equation with mean nightly sleep as the outcome was significantly 
predicted by the group of control variables age, stage, and weight (ΔR2 = .197; F(3,37) = 
3.030, p = .041). The subsequent addition of avoidant coping to the model added to its 
predictive power (ΔR2 = .124; F(1,36) = 6.567, p = .015), with denial predicting 
decreased sleep (partial r = -.315). The resulting four variable model explained a 
significant amount of variance in nightly sleep (F(4,36) = 4.256, p = .006). 
 
Behavioral Disengagement 
Hierarchical regression equations were used to investigate the relationship 
between behavioral disengagement and circadian disruption. In a regression using 
behavioral disengagement as a predictor of the autocorrelation, control variables included 
age, stage, and income. The addition of behavioral disengagement on the second step of 
this equation explained significant variance in the autocorrelation (ΔR2 = .110; F(1,34) = 
5.620, p = .024), with behavioral disengagement being associated with a lower 
autocorrelation (partial r = -.464), indicating more behavioral disengagement was related 
to a weaker circadian activity rhythm. The entire, four variable model was also predictive 
of the autocorrelation (F(3,34) = 4.236, p = .007). Regression equations resulting in a 
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significant, independent effect of behavioral disengagement on circadian disruption are 
summarized in Table 14. 
 
Table 14. Summary of Regression Equations with Behavioral Disengagement Coping as 
a Predictor of Actigraphy Measures of Circadian Disruption. 
Variable   B SE B       ß       R2         ΔR2            p of  ΔR2     N      
 
Autocorrelation 
Step 1            .222       .222   .030    39 
    Age             .002 .002       .134          
    Stage            .012 .011       .160 
    Income            .032 .015       .338* 
Step 2            .332       .110   .024 
    Behavioral Diseng.          -.043 .018     -.373* 
 
Dichotomy/Inside (D/I) 
Step 1            .099       .099   .262    42 
    Age            -.001 .043      -.003          
    Stage            .317 .243       .184 
    Anti-Lipidemic Agents  -3.306     1.334      -.378* 
Step 2            .261       .235   .001 
    Behavioral Diseng.        -1.304 .361      -.512* 
 
Dichotomy/Outside (D/O) 
Step 1            .233       .233   .017    42 
    Age            -.039 .058      -.097          
    Stage           -.284 .344      -.114 
    Opiate Agonist Agents    6.760     2.261        .422* 
Step 2            .359       .126   .011 
    Behavioral Diseng.         1.405 .522       .382* 
________________________________________________________________________ 
* p < .05 
 
In a hierarchical regression exploring behavioral disengagement as a predictor of 
D/I, control variables included age, stage, and anti-lipidemic medication. The control 
variables entered on the first step did not significantly predict D/I (ΔR2 = .099; F(3,38) = 
1.385, p = .262). However, behavioral disengagement entered on the second step 
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independently predicted D/I (ΔR2 = .235; F(1,37) = 13.023, p = .001), such that 
behavioral disengagement was associated with a lower D/I (partial r = -.510), indicating 
more activity while in bed, likely a sign of circadian disruption. The entire, four variable 
model was also related to D/I (F(4,37) = 4.623, p = .004).  
In a hierarchical regression exploring behavioral disengagement as a predictor of 
D/O, control variables included age, stage, and opiate agonist medication. The control 
variables entered on the first step significantly predicted D/O (ΔR2 = .233; F(3,38) = 
3.848, p = .017). Behavioral disengagement entered on the second step also 
independently predicted D/O (ΔR2 = .126; F(1,37) = 7.245, p = .011), such that 
behavioral disengagement was associated with a higher D/O (partial r = .405), indicating 
more time of diminished activity while out of bed, likely a sign of circadian disruption. 
The entire, four variable model was also related to D/O (F(4,37) = 5.171, p = .002). No 
other independent relationships were observed between behavioral disengagement and 
circadian disruption.  
 In terms of sleep outcomes, behavioral disengagement was significantly and 
independently related only to increased time spent awake after sleep onset (ΔR2 = .096; 
F(1,38) = 4.179, partial r = .315, p = .048). The covariates, age and stage, were not 
significantly associated with wake after sleep onset (R2 = .029; F(2,39) = .592, p = .558). 
The final, three variable model was also not statistically significant (R2 = .126; F(3,38) = 






Secondary Analysis #4: Additional Cortisol Measures 
 To supplement primary analyses with cortisol outcomes, secondary analyses 
sought to investigate relationships previously tested in primary analyses with the addition 
of two additional CAR measures: CAR % increase and the area under the awakening 
curve. The CAR slope was used as the primary CAR outcome measure because it was 
judged to be a better indicator of the HPA response to awakening as it measures the rate 
of change from the wake sample to the +30min sample and is not as susceptible to undue 
influence from extreme awakening values. In addition, analyses of cortisol variables were 
repeated using the cortisol variables calculated with the awakening values estimated 
using linear modeling. This was done to minimize the influence of missing values on the 
cortisol outcomes.  
 In regression models using the 7-item intrusions scale as a predictor of 
secondary cortisol outcomes, a hierarchical regression model of the CAR % increase with 
estimated awakening values included was not significantly predicted by the combination 
of age and stage (ΔR2 = .051; F(2,38) = 1.022, p = .370). However, the addition of the 7-
item intrusions scale on the second step significantly explained the CAR % increase (ΔR2 
= .102; F(1,37) = 4.461, p = .041), with intrusions related to a more dramatic cortisol 
increase (partial r = .328). Other models with the 7-item version of the intrusions subscale 
as a predictor of secondary cortisol outcomes were not statistically significant. Models 
testing associations of the 5-item intrusions scale with secondary cortisol outcomes did 
not reveal and significant, independent relationships. 
 Intrusions were not significantly and independently related to other CAR 
measures. This could have been due to the error introduced by the inclusion of estimated 
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awakening values. In addition, because the awakening cortisol level is the denominator in 
the calculation of CAR % increase, low awakening values can result in high % increases 
without a large absolute difference between the awakening and +30min cortisol values. 
 Exploratory analyses similar to those employed for the evaluation of hypothesis 
2 in the primary analyses were repeated with the secondary cortisol outcomes. These 
correlations can be found in Table 15. The rest/activity autocorrelation was significantly 
correlated with the area under the awakening curve when estimated awakening values 
were included (Spearman’s r = .338, p = .035). In findings similar to those observed in 
primary analyses, both the autocorrelation (Spearman’s r = -.561, p < .001) and the D/O 
(Spearman’s r = .457, p = .003) were related to the diurnal cortisol slope with the 
estimated awakening values included. These findings were both such that disrupted 
activity rhythms were associated with a flatter diurnal cortisol slope. When the number of 
missing cortisol samples was statistically controlled, significant relationships persisted 
between the diurnal cortisol slope and both the autocorrelation (partial r = -.578, p < 
.001) and the D/O (partial r = .401, p = .011).  
 
Table 15. Actigraphy and Secondary Cortisol Variable Correlations (N = 40) 
           
           24 hour                   Dichotomy                   Dichotomy      
Autocorrelation                Index/Inside              Index/Outside                   
 
Waking CortisolEL           .273    .039            -.160 
 
Morning Cortisol SlopeEL         -.077   -.264   .228 
 
CAR % increase          -.155                         -.081                  .113 
CAR % increaseE          -.180   -.076                            .125 
 
Area under waking curveL          .191    .067                 -.148 




           
           24 hour                   Dichotomy                   Dichotomy      
Autocorrelation                Index/Inside              Index/Outside                   
 
 
Diurnal Cortisol SlopeEL         -.561**   -.273                          .457** 
         
Mean diurnal cortisolEL          .114   -.176          .194 
________________________________________________________________________  
Legend. “E” subscripts are used to denote summary cortisol variables calculated with the estimated 
awakening cortisol value included. “L” subscripts are used to denoted cortisol values that are presented 
after log transformation to correct for non-normal distribution. 
All correlations calculated using Spearman’s r.  
* p < .05 
** p < .01 
 
   
Secondary Analysis #5: Relationships between Cortisol and Sleep 
 As a final secondary analysis, the relationships between cortisol and sleep 
variables were explored. Sleep variables included total nightly sleep, awakenings, wake 
after sleep onset, sleep efficiency, and sleep onset latency. The effects of daytime and 
bedtime cortisol on sleep were explored by regressing sleep variables on the mean diurnal 
cortisol, diurnal cortisol slope, and bedtime cortisol levels with age and stage statistically 
controlled. In addition, the relationship of sleep to the cortisol awakening response was 
explored by regressing the mean awakening cortisol, morning slope, % increase, and area 
under the awakening cortisol curve on each of the sleep variables in separate equations 
and with age and stage statistically controlled. No statistically significant, independent 
associations of cortisol and sleep variables emerged from these analyses. 
  
 
Secondary Analysis #6: Removal of Patients Reporting Depression 
 Previous literature has noted hypersecretion of cortisol, especially late in the 
day, in participants reporting depression (Burke et al., 2005). It is possible that, in a 
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portion of the sample, the hypersecretion associated with symptoms of depression would 
counteract the diminished secretion of cortisol that could be expected to be associated 
with intrusions, a symptom consistent with PTSD. To reduce confounding presented by 
patients reporting high levels of depression, participants scoring more than 1.5 standard 
deviations above the mean of the standard deviation observed in a standardization sample 
receiving the POMS were removed from a repeated analysis of circadian cortisol 
outcomes. Seven participants were removed based on POMS scores. Age and stage were 
entered on the first step of a hierachical regression equation. Intrusions were entered on 
the second step. These analyses revealed no significant and independent effects of 
intrusions on cortisol. Similarly, no effects of the 5-item version of the intrusions 















Summary of Results 
 This study sought to explore relationships between breast cancer-related 
intrusions, avoidant coping, and circadian rhythms. Breast cancer-specific intrusions over 
a four day period between diagnosis and the initiation of treatment were used as an 
indication of the distress associated with breast cancer. Because detailed investigation of 
the relationships between intrusions and multiple measures of circadian disruption are not 
available, an exploratory analytical approach was employed to develop a rich 
understanding of the data collected and generate hypotheses for future research. 
  
Primary Analyses 
Hypothesis 1a: Cancer-related intrusions will be significantly and positively  
associated with circadian disruption, as measured by salivary cortisol and actigraphy. 
 Analyses of the relationship between intrusions and circadian disruption revealed 
that intrusions were significantly related to a lower autocorrelation coefficient for 
rest/activity rhythms. These effects were independent of the effects of two theoretically-
derived control variables, age at diagnosis and cancer stage, as well as one empirically-
derived variable, income. This effect persisted when items from the IES intrusions scale 
that discussed sleep were removed. Intrusions were not independently related to the 
dichotomy indices of activity while in bed and while out of bed.  
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Intrusions were also related to an increased CAR % increase, possibly indicating 
an exaggerated response of the HPA to awakening. There is no consensus interpretation 
of the cortisol awakening response, so the implications of these findings are not clear. An 
elevated CAR% increase might be the result of an absent pre-awakening cortisol rise 
characteristic of circadian disrupiton. Because this was a naturalistic study, assessment of 
pre-awakening cortisol levels that have been performed in a laboratory setting were 
unavailable. As a result, the association of intrusions with increased CAR % increase is 
consistent with circadian disruption due to an absent pre-awakening cortisol rise, and a 
pre-awakening cortisol rise is hypothesized as a mechanism, but this explanation cannot 
be confirmed based on the data available in the current study. Further, an increased CAR 
% increase could be indicative of stress appraisals in the morning, meaning such a result 
could be interpreted as being consistent with circadian rhythmicity. Evidence of a 
relationship between intrusions and circadian disruption is of clinical relevance for 
several reasons. Significant levels of intrusion have been reported in 36% of patients after 
receiving a diagnosis of breast cancer (Green, Rowland, & Krupnick, 2000), indicating 
that this is a symptom experienced by a large number of patients. Any relationship of 
intrusions with circadian disruption would apply to a notable proportion of patients who 
have breast cancer. In light of studies identifying circadian disruption as a predictor of 
shortened survival (Mormont et al., 2000; Sephton et al., 2000), it is clinically relevant to 
note that distress, specifically intrusions, associated with the diagnosis of breast cancer 
may also be related to circadian disruption.  
 It is interesting to note a possible relationship between intrusions and circadian 
disruption was largely limited to the autocorrelation coefficient, especially in light of 
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studies reporting a significant association of intrusions with cortisol (Dettenborn, 2006). 
To date, most of the studies of intrusions and cortisol have investigated the overall 
cortisol over a period of time, as opposed the circadian rhythmicity variables employed in 
this study. An alteration in total output would not necessarily be reflected in measures of 
circadian rhythmicity. However, the overall mean cortisol level was evaluated in this 
study, and intrusions did not exhibit a significant association with this measure or with 
log-transformed awakening and bedtime cortisol values. 
 The notion of allostatic load proposed by McEwen (McEwen & Stellar, 1993) is a 
useful conceptual model for the disruption of endocrine functioning, including cortisol. 
This model proposes that physiological adaptations to stress can take a toll on body 
systems over time. The wear and tear of allostatic load that could result in disrupted 
circadian rhythms may take place over a number of years. In this study, women had been 
informed of their diagnosis of breast cancer recently, often on the same day as their 
enrollment in the study. The physiological effects of stress may not have been observed 
because these effects simply do not appear in response to stressors unless exposure to 
these stressors persists over a long period of time. In fact, it has been argued that brief, 
intermittent stressors present a challenge that promotes a healthy adaptation by the 
individual (Epel & McEwen, 1998). Studies of circadian cortisol rhythms have reported 
notable interdaily instability, suggesting that circadian rhythms are sensitive to 
environmental and psychological stress. As a result, it is reasonable to expect that a 
diagnosis of breast cancer would induce sufficient distress to alter circadian cortisol 
rhythms. Still, changes in circadian cortisol rhythms may be attributable to influences 
other than psychological distress, such as medications, diet, or exercise.  
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In light of other possible explanations, interdaily variability in circadian cortisol 
rhythms does not necessarily mean that these rhythms are sensitive to changes to 
intrusions, the specific measure of psychological distress used here, but distress-induced 
disruption is evident from other studies. It is hypothesized that a longitudinal study of 
women with breast cancer would observe that post-diagnostic distress would be 
predictive of later development of disrupted circadian cortisol rhythms. The finding that 
post-diagnostic intrusions were more closely associated with disrupted rest/activity 
rhythms than with cortisol rhythms suggests a new explanation for disrupted circadian 
cortisol rhythms. It is possible that disrupted rest/activity rhythms mediate the 
relationship between distress and circadian cortisol rhythm disruption. This model 
hypothesizes that disrupted rest/activity rhythms would predict subsequent disruption of 
circadian cortisol rhythms in longitudinal studies of women with breast cancer. 
A larger sample size would be needed to appropriately test a more complex model 
of the relationships between stress, coping, and adaptation. Future research in a larger 
data set could include a self-report assessment of the degree to which patients perceived 
the relevant event as stressful. Although a diagnosis of breast cancer is likely deemed 
stressful by most patients (Rowland, 1998), the degree to which someone appraises the 
illness as stressful varies, and this variable is also of significance to the model that guided 
the design of the current study.  
 Distress was measured by the IES intrusions scale in this study because studies 
have noted that intrusions are prevalent (Jacobsen et al., 1998) and predictive of long-
term distress in patients with breast cancer (Bleiker et al., 2000). This measure also 
allowed assessment that was explicitly tied to the diagnosis of breast cancer, as opposed 
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to general distress. Future studies might benefit from a measure of general distress that 
would assess the influence of breast cancer, or another stressor, or generalized distress as 
well as measuring the influence of other significant stressors in the lives of people that 
suffer from breast cancer. It is hypothesized that breast cancer-related intrusions would 
be most strongly associated with post-diagnostic circadian disruption but that other 
measures of distress would also exhibit modest associations with circadian disruption. 
A number of studies employing daily assessments have measured dynamic 
processes over many days (Tennen & Affleck, 1996). Daily assessments over a longer 
period of time allow within-person daily fluctuations to be analyzed using advanced 
statistical techniques (Tennen, 2000). These studies are not well matched for studies that 
are conducted within a brief time window, such as between cancer diagnosis and 
treatment, but patients could be followed throughout the course of long-term treatment or 
during the remission phase of breast cancer. Alternatively, patients could be assessed 
across several phases of diagnosis and treatment. Collection of daily assessments over a 
longer time period would allow within-subjects statistical testing, using more advanced 
statistical methods such as hierarchical linear modeling. These techniques would likely be 
more sensitive to detecting the relationships hypothesized in this study. It is hypothesized 
that data collection allowing for use of advanced statistical techniques would reveal 
stronger relationships between intrusions and circadian disruption and would more 
effectively discriminate between measures of circadian disruption that are affected by 
intrusions and those that may be independent from distress. 
The aim of capturing quickly changing phenomena closer to the time of their 
occurrence is furthered by daily assessments, but a time lag between appraisals made, 
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coping efforts undertaken, and intrusions experienced remains. Assessments could be 
placed closer to the time of their occurrence using ecological momentary assessment, 
devices that prompt participants to respond immediately regarding psychological 
phenomena. Participants in this study wore actigraphy devices throughout the day and 
reported little difficulty or obtrusiveness related to actigraphy devices, so it is possible 
that these devices could be supplemented or replaced by other unobtrusive devices. These 
devices differ in that actigraphy devices require no maintenance, other than removal in 
situations in which they are likely to get wet. Despite the cost of using ecological 
momentary assessment devices, based on the results observed in the current preliminary 
study, the use of more resources to extend these findings may be merited. It is 
hypothesized that utilization of devices that allow psychosocial phenomena to be 
captured closer to their occurrence would provide more valid assessments and more 
sensitive tests that would reveal stronger relationships between intrusions and circadian 
disruption. 
Because this was an exploratory study, this finding is preliminary, and it was not 
observed with other actigraphy variables or with circadian cortisol rhythms, replication is 
essential. Based on this study, it is hypothesized that breast cancer-related intrusions 
would be related to disrupted rest/activity rhythms, but not necessarily to physiological 
rhythms, in the period immediately following diagnosis. Replication of a relationship 
between intrusions and disrupted rest/activity rhythms as well as extension of these 
findings in a longitudinal study, would support the importance of available resources and 
intervention to address distress associated with a breast cancer diagnosis. It is important 
to address this distress primarily because of the clinical relevance of distress as a clinical 
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outcome. However, an association of intrusions with the rest/activity autocorrelation, a 
variable predictive of survival in one study (Mormont et al., 2000), would suggest the 
possible presence of poor physical health outcomes influenced by intrusion levels. 
 
Hypothesis 1b: Avoidance as a moderator of intrusion and circadian disruption 
The relationship between intrusions and autocorrelation was carried forward to a 
test of avoidant coping as a possible moderator of this relationship. Tests using the 
overall avoidant coping score as well as the self-distraction, denial, and behavioral 
disengagement subscales revealed no significant moderation of the effect of intrusions on 
circadian rhythms. 
The lack of moderation is reasonable given the low statistical power for tests with 
an interaction term and the modest sample size for this study. Considering the modest 
relationships often observed between psychosocial variables and physiological variables, 
a number of factors could explain the lack of a moderation finding. In addition, the 
intrusions and avoidant coping predictors were moderately correlated (Pearson’s r = .554, 
p < .001), compromising the interpretability of the interaction term. Baron & Kenny 
(1986) indicated that these conditions are not ideal for testing moderation effects. This 
correlation may have influenced the absence of a finding with the interaction term tested 
in this model. 
The transactional model illustrated in the introduction places the appraisal of 
threat, harm, or challenge before the onset of coping and distress (Lazarus, 1984). Based 
on this conceptualization, it might be expected that coping could moderate the effects of 
perceived stress on the resulting distress but can not moderate the effects of distress on 
153
physiology or behavior. However, the transactional character of the model means that the 
variables interact extensively with one another. Lazarus (2000) has emphasized the 
potential for any of these variables to act as predictors, moderators, and outcomes and has 
called for richer investigation of the interrelationships between these variables. In 
keeping with that goal, this study investigated avoidant coping both as a moderator and as 
a predictor in models exploring circadian disruption. 
It should also be noted that the stress, coping, and adaptation process renews as 
distress continues and stressors persist. Thus, even if coping initially precedes distress in 
response to the first exposure to a stressor, it is likely that coping will also follow distress 
and influence the effects of distress on variables such as the physiology, sleep, and 
rest/activity rhythms explored in this study. The figure illustrating the transactional model 
of stress, coping and adaptation is shown on page 19. Still, it is interesting to note that 
avoidant coping was predictive of circadian disruption when it was specified as a 
predictor but not when it was specified as a moderator in models in this study. 
 
Hypothesis 2: Diurnal salivary cortisol slope and rest-activity rhythm obtained by 
actigraphy will be significantly and positively associated. 
One of the strengths of this study is the use of multiple measures of circadian 
rhythmicity. Consequently, exploration of the type and strength of the relationship 
between these two measures is of interest. Generally, the expected relationships were 
evident. A higher 24-hour autocorrelation generated from actigraphy data was related to a 
steeper diurnal decrease in the cortisol slope. The relationship between these measures 
suggests they will yield similar indications concerning circadian rhythmicity. The 
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autocorrelation was related to a lower bedtime cortisol level, a result that is consistent 
with stronger circadian rhythmicity, as cortisol is typically at its nadir in the evening. 
This finding informs comparison of the two studies reporting that circadian rhythms were 
predictive of cancer survival because one study used the rest/activity autocorrelation 
(Mormont et al. 2000), and the other study used the diurnal cortisol slope (Sephton et al., 
2000). Preliminary evidence from the current study suggests these two variables measure 
similar phenomena, as they were moderately to highly correlated in a sample of women 
with breast cancer in this study. The correlation in this study (r = -.614) was such that 
there appears to be a meaningful amount of independent variance between the 
rest/activity autocorrelation and the diurnal cortisol slope, indicating that the inclusion of 
multiple measures of circadian disruption would be a useful methodological characteristic 
of future studies. 
More frequent activity while in bed (D/I) was related to a flattened diurnal 
cortisol slope in this sample, the sole significant, independent relationship of D/I with a 
primary cortisol outcome. Because D/I is a measure of activity while in bed, typically at 
night, it is interesting that D/I would be related to the diurnal decrease in cortisol. Due to 
their proximity to getting into and out of bed, it might be expected that bedtime cortisol 
or CAR variables would be more strongly associated with D/I. Due to the small sample 
size of this study, relationships of D/I with CAR and bedtime cortisol cannot be 
discounted, but they were not evident in the current sample.  
 The relationship of D/I to the diurnal cortisol slope is interpretable in that they are 
both taken to be indicators of circadian disruption. It is interesting to note that inactivity 
while out of bed (D/O) was also related to a flattened diurnal cortisol slope, meaning all 
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of the actigraphy measures of circadian rhythms were related, in the expected direction, 
to the diurnal cortisol slope. This lends further support to the comparability of these two 
measures and the utility of the diurnal cortisol slope in characterizing circadian rhythms. 
While abnormality in a given measure of circadian rhythmicity is noteworthy, weak 
circadian rhythms would theoretically be expected to be evident in disrupted rhythmicity 
throughout the day. The relationship between the diurnal cortisol slope and an overnight 
measure of circadian disruption (D/I) is consistent with the idea of a stable circadian 
rhythm, rather then transitory disruptions. Based on the robust relationship of the diurnal 
cortisol slope with measures of circadian disruption obtained using a different modality, 
actigraphy in this study, it is hypothesized that the diurnal cortisol slope would be related 
to other indicators of circadian rhythmicity such as body temperature and brain wave 
activity.  
 A higher D/O was also associated with higher bedtime cortisol levels. It is 
noteworthy that frequent inactivity while out of bed is related to increased cortisol levels 
in the bedtime. It might be expected that increased availability of glucose would be 
related more activity, so this relationship is in need of further exploration. Conceptualized 
from the perspective of circadian rhythms, inactivity during the day and elevated bedtime 
cortisol levels are consistent with circadian disruption. In this case, circadian disruption 
offers an explanation for a relationship that is otherwise counterintuitive, suggesting that 
circadian rhythms are an important tool in understanding activity and physiology in 
patients with breast cancer. 
  Finally, a higher D/O was related to a steeper morning cortisol slope. It is 
interesting to note that frequent inactivity while out of bed is correlated with increased 
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cortisol availability in saliva in the morning, similar to the results observed between D/O 
and the bedtime cortisol level. A stronger CAR might otherwise be interpreted as a 
mobilization of physiological resources for daytime activity, but these patients ultimately 
exhibited decreased activity as indicated by the D/O. This could be explained by the 
absence of a pre-awakening cortisol rise in patients with disrupted circadian rhythms, and 
that a subsequent spike in post-awakening cortisol secretion was then observed.It is 
possible that psychological states, such as stress appraisals, could have elevated cortisol 
levels in the morning, though the intrusions measure employed in this study was not 
related to the CAR measures. It is reasonable to hypothesize that future studies measuring 
stress perceptions or additional measures of distress might find a relationship between 
psychological states and the CAR in women with breast cancer. As with other 
associations between measures of circadian disruption, the correlation between D/O and 
the morning cortisol slope could be explained by their conceptual link as measures of 
circadian rhythms.  
 Findings of a relationship between actigraphy and cortisol measures of circadian 
rhythmicity are consistent with a study of patients with metastatic colorectal cancer 
noting that patients within the upper quartile of the rest/activity autocorrelation had a 
higher ratio of 8 a.m. to 4 p.m. serum cortisol samples than patients in the lower quartile 
of the rest/activity autocorrelation (Rich et al., 2005). Similar to the results presented in 
the current study, patients in the Rich et al., (2005) study also exhibited no relationship 
between the autocorrelation and mean diurnal cortisol levels. The rest/activity 
autocorrelation was also related to the difference between 8 a.m. and 4 p.m. serum 
cortisol levels in a previous report on this sample of patients with metastatic colorectal 
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cancer patients (Mormont et al., 2000). Similarities in the findings of the current study 
and that of Rich et al. (2005) are noteworthy because of significant differences in 
methods, including serum vs. salivary cortisol assessment, different calculations of the 
cortisol rhythm, and differences in cancer site and timing within the disease course.  
Overall, the data presented in this study support the conceptualization of these 
two measures as circadian rhythms. Nevertheless, correlations between these two 
measures were typically moderate, suggesting that while there is considerable conceptual 




 To further the aim of hypothesis generation that is essential to exploratory data 
analysis, secondary analyses were conducted. These analyses explored additional 
relationships among major study variables.  
 
Sleep Outcomes 
Sleep variables calculated from rest/activity data were examined as outcomes with 
the same analysis plan as that used for the examination of other circadian rhythm 
variables for hypothesis 1a. Sleep is a process characterized by the lack of consciousness, 
presenting an obvious barrier to self-report as an assessment method. Consequently, the 
availability of an alternative measure of sleep through actigraphy is valuable.  
Intrusions were not significantly associated with sleep outcomes in any of the 
regression models employed. This result contradicts recent research suggesting a 
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significant relationship between the distress associated with breast cancer and sleep 
disturbance in women receiving chemotherapy (Roscoe et al., 2007) and in another 
sample of women with metastatic breast cancer (Palesh et al., 2007). However, caution is 
merited due to the small sample size. While intrusions were not related to sleep 
disturbance in this sample, other measures of distress may influence sleep, including 
depression (Palesh et al., 2007). In addition, the sample from the current study was not 
receiving treatment and most of the patients did not have metastatic disease. It is possible 
that these factors in particular accounted for the sleep disturbance observed in previous 
studies of women with breast cancer and explain the absence of findings in the current 
study. 
Each morning, participants completed a questionnaire assessing the prior night’s 
sleep and actiwatch removals. The final question invited participants to provide 
qualitative data on their sleep, and stated “do you have any other comments regarding last 
night’s sleep”. Selected comments regarding the cancer diagnosis and sleep are presented 
below. 
“I couldn't stop thinking - so much was taking in a day and still not understanding if there 
will be a tomorrow” 
 
“nightmares about dying”                                                                                                                               
 
“first time to dream about cancer”  
 
“just before sleep is when I have a deep sense of facing my mortality and dealing with the 
prospect of physical pain to come”  
 
“Kept coughing, had to get up and get drink. Kept worrying about that. Mind started 
racing that cancer had spread to lungs”                                                                                                          
 
“Dreamed about reading to make decision on type of cancer surgery”               
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Qualitative data provide detailed self-reports regarding sleep. The statements 
about intrusions regarding the diagnosis and treatment of breast cancer that appear 
immediately prior to sleep suggest that these are relevant to the intrusions construct and 
that it is important to include items that discuss sleep in the 7-item version of the IES 
intrusions scale, as opposed to the 5-item version suggested by a more recent factor 
analysis (Witteveen, 2006). In addition to breast cancer-related thoughts and dreams, 
other life stressors and dreams were reported in response to the question about the prior 
night’s sleep. It is important to keep in mind that although a diagnosis of breast cancer is 
often a source of significant distress, pre-existing and co-occurring life stressors certainly 
contribute to elevated distress. These sources of distress were not targeted by the 
intrusions measure employed in this study. It follows that the absence of a significant 
relationship between intrusions and sleep in this study does not rule out the possibility 
that general distress was related to sleep disturbance in these patients.                                                         
 
Direct Effects of Avoidant Coping on Circadian Disruption 
The transactional model of stress, coping, and adaptation allows for a number of  
relationships among these variables (Lazarus, 2000), so avoidant coping was investigated 
as a predictor of circadian disruption in an exploratory analysis. The analytical approach 
for the evaluation of avoidant coping was similar to the one employed in the evaluation 
of intrusions as a predictor in hypothesis 1a. In addition to the summary score for 
avoidant coping, the self-distraction, denial, and behavioral disengagement subscales of 
the avoidant coping measure were investigated as predictors of circadian disruption.  
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The summary avoidant coping score was related to a lower autocorrelation, an 
indication of circadian disruption. In follow-up analyses of the avoidant coping subscales, 
only behavioral disengagement was significantly and independently related to the 
autocorrelation, suggesting behavioral manifestations of avoidance have the most direct 
influence on disruptions in the circadian activity rhythms. This finding is intuitive in that 
activity levels are a behavioral variable as well, but the items of the behavioral 
disengagement scale of the brief COPE does not refer to inactivity specifically. Rather, 
the items refer to “giving up trying to deal with it” and “giving up the attempt to cope”, 
which could possibly be interpreted as giving up cognitive and emotional coping efforts 
in addition to behavioral efforts. 
Avoidant coping is often characterized as a maladaptive way of coping with a 
stressor, but it could alternatively be conceptualized as an adaptive means of maintaining 
a life that is as normal as possible in spite of the stressor. This might be especially useful 
over a short period of time. In the current sample, this did not appear to be the case, as 
avoidant coping was related to disrupted rest/activity rhythms, suggesting that avoidant 
coping failed to eliminate the stressor from awareness or failed to ameliorate the effects 
of the stressor in terms of circadian rhythmicity. This informs models of avoidant coping 
and contributes to a substantial literature linking avoidant coping with undesirable 
outcomes. If further research supports the conceptualization of avoidant coping as 
predictive of circadian disruption and other clinically relevant adverse outcomes, coping 
techniques such as distraction could be viewed as potentially problematic, even during 
short-term efforts to cope with a breast cancer diagnosis. Results suggesting avoidant 
coping has an effect on a measure of circadian rhythmicity support conceptualization of 
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influences of avoidant coping on circadian disruption, as opposed to models proposing 
avoidant coping as a moderator of the effects of stress or intrusions on circadian 
disruption.  
In the model testing avoidant coping as a moderator of the association of 
intrusions with the rest/activity autocorrelation, the mean-centered avoidant coping 
variable entered as a covariate on the first step was significantly related to the 
rest/activity autocorrelation. This is consistent with the significant association of avoidant 
coping with a lower rest/activity autocorrelation observed in secondary analyses.  
Avoidant coping was also related to more frequent high activity levels during time 
spent in bed (D/I). Subsequent analyses of individual subscales of the COPE revealed that 
the denial and behavioral disengagement subscales of this measure were related to 
circadian disruption indicated by D/I, but the self-distraction subscale was not. While 
avoidant coping was related to high activity levels in the time spent in bed, it is surprising 
that avoidant coping was not related to sleep variables in this sample. Consistent with the 
interpretations of other similar findings in this dataset, this finding may be taken as 
support for the distinction between general circadian disruption and sleep, which 
accounts for part of the circadian rhythm. 
Although many of the analyses exploring relationships between avoidant coping 
and circadian disruption did not result in significant, independent associations, no 
analyses revealed a relationship between avoidant coping and improved circadian 
rhythmicity. It follows that this study’s results suggest any link between avoidant coping 
and circadian disruption is limited, but negative to the extent that a relationship exists. 
There are several possible clinical implications of these results. Primarily, they are 
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consistent with the idea of offering psychological treatment, emotional support, and 
medical and psychosocial information. It is likely ill-advised to restrict a patient’s 
autonomy by pressuring the patient to adopt a given view or coping style, but promoting 
awareness of available resources might encourage engagement of the stressor without 
carrying a negative connotation for the patient. Fears about interfering with avoidant 
coping strategies that are successful for short-term coping are not furthered by the results 
of the current study. In addition, within the limits of the circadian disruption outcome 
investigated by this study, increased availability of outlets for expression, overt 
discussion of matters related to the breast cancer diagnosis, and treatment of distress 
makes sense in terms of health care policy. 
Although there were no other analyses revealing an association of the summary 
avoidant coping score with measures of circadian disruption that was independent of the 
covariates in this study, additional analyses explored relationships of avoidant coping 
subscales with circadian disruption. Elevation of the self-distraction subscale was 
independently related to an increase in a secondary cortisol outcome, the area under the 
awakening cortisol curve, a finding that was not observed with either of the other two 
avoidant coping subscales. This finding remained when awakening values estimated 
using linear modeling were included. Perhaps not coincidentally, elevation of the self-
distraction subscale was also independently related to a higher awakening cortisol level. 
This finding was also not altered by the inclusion of estimated awakening values.  
In considering the CAR, the pattern of findings observed with self-distraction 
offers further insight. Because the area under the awakening cortisol curve includes the 
awakening and 30 minute post-awakening values, an elevated awakening cortisol value 
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has a heavy influence on the area under the awakening cortisol curve, even if the post-
awakening increase is not dramatic. The lack of a significant, independent relationship 
between self-distraction and the other two CAR measures, slope and % increase, suggests 
that the increased area under the awakening curve was primarily driven by elevated 
awakening values. As a result, it is not hypothesized that self-distraction would be related 
to CAR in future studies of women with breast cancer studied between the times of 
diagnosis and initiation of treatment. However, relationships with the awakening cortisol 
level would be hypothesized to be evident. Because the interpretation of the CAR as it 
relates to self-distraction is not straightforward, it would be interesting to note the 
longitudinal effects of an elevated awakening cortisol level during the post-diagnostic 
period. A study designed to test whether post-diagnostic awakening cortisol levels are 
predictive of subsequent indicators of circadian disruption would be useful in clarifying 
the interpretation of awakening cortisol levels in women with breast cancer. Until studies 
like these are conducted, the clinical implications of this finding are unclear. 
The denial and behavioral disengagement subscale of the avoidant coping 
measure were independently related to increased D/O, meaning these patients exhibited 
more time out of bed in which activity levels fell below the median activity levels for 
time in bed. This is likely an indicator of disrupted circadian activity rhythms. In support 
of this inference, a higher D/O was related to cortisol measures of circadian disruption, 
including a more dramatic increase in the morning cortisol slope, a flattened diurnal 
cortisol slope, and elevated bedtime cortisol levels. It is perhaps unsurprising that self-
distraction was not related to daytime inactivity, as self-distraction is consistent with 
activity during waking hours that might occupy the patient and divert attention from 
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reminders of breast cancer. It is possible that patients attempt to avoid reminders of breast 
cancer by restricting activities that might bring them into contact with other people who 
might ask about their health condition or experience reduced enjoyment of activities due 
to distress, especially cancer-related intrusions. It is hypothesized that these factors would 
be evident in studies designed to assess them. This finding may offer preliminary support 
for interventions increasing exercised for women with breast cancer, as daytime activity 
could be particularly sensitive to avoidant coping in response to the cancer diagnosis. 
In terms of sleep outcomes, a model of denial as a predictor of decreased nightly 
sleep. Additionally, behavioral disengagement was related to increased time spent awake 
after sleep onset. It is possible that cognitive avoidance strategies are more difficult to 
enact when patients try to go to sleep because their attention is not taken up by other 
activities. Consistent with findings in other analyses from this study, psychosocial factors 
appeared to be more strongly related to circadian rhythms generally, as opposed to sleep 
specifically. To the extent that denial is related to nightly sleep, ready availability of 
resources and treatments that encourage engagement of stressors and expression 
regarding the diagnosis of breast cancer may be supported. Brief behavioral treatments 
and medications for addressing sleep problems are available, and these treatments may 
promote improved circadian rhythmicity. Future research could utilize ecological 
momentary assessment or brief questionnaires in the morning to assess the content of 
thoughts experienced by women with breast cancer as they go to bed. It is hypothesized 
that attempts to avoid or deny the presence of breast cancer would be linked with sleep 
disruption. 
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In modeling the variables studied, the cross-sectional nature of the study inhibits 
causal inferences. Therefore, relationships between avoidant coping and circadian 
disruption may both be caused by a third variable not included in analyses. The 
pathophysiological processes associated with cancer are one possibility. This potential 
confound was addressed by including cancer stage as a covariate in analyses. 
Nevertheless, cancer stage as an estimate of disease severity may not fully capture the 
physiological processes affecting psychosocial variables such as intrusions and avoidant 
coping as well as circadian variables as indicated by actigraphy and cortisol. This study 
also emphasized generalizability in applying relatively few exclusion criteria. However, 
future studies might consider eliminating other potential confounds such as substance 
abuse problems and psychological and medical diagnoses by conducting diagnostic 
interviews or controlling for them statistically.  
Longitudinal studies that begin at the time of initial breast cancer screening, such 
as at the time of the mammogram, could track avoidant coping and circadian disruption 
over time and contribute to understanding of whether avoidant coping precedes the 
development of circadian disruption or speak to the possibility of the opposite temporal 
relationship. 
 
Secondary Cortisol Outcomes 
In testing secondary cortisol outcomes, the seven item versions of the intrusions 
subscale of the IES predicted increased CAR %. Ambiguities in CAR interpretation 
reviewed above do not permit strong conclusions to be draw from this finding. In 
addition, when awakening values estimated using linear modeling replaced values that 
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were missing due to nonadherence to the protocol, intrusions were not related to CAR %. 
Finally, no other CAR outcomes were significantly and independently associated with 
intrusions. Despite these limits, a relationship between intrusions and a higher CAR % is 
consistent with an interpretation of a more dramatic CAR as an indicator of distress. 
Given the association of psychosocial stressors, including PTSD, with a diminished CAR, 
it is certainly possible that an increased CAR indicates a healthy response of the HPA 
axis. At this point, it seems reasonable to hypothesize that the CAR would be interpreted 
differently depending on sample and situational characteristics. 
Aside from interpretation issues, it is noteworthy that previous research has 
reported a relationship between PTSD and a diminished CAR (Rohleder, Joksimovic, 
Wolf, & Kirschbaum, 2004). It should be noted that intrusions are only one part of PTSD, 
so elevated intrusions can not be equated with PTSD. This distinction is especially 
relevant to the current sample, in which participants provided data shortly after being 
confronted with the stressor of being diagnosed with breast cancer. As a result, the 
observed results are in line with expectations. It is possible that the heightened cortisol in 
response to awakening associated with cancer-specific intrusions in this study were part 
of responsivity in the acute phase of coping with a stressor. 
In repeats of hypothesis 2 using secondary cortisol outcomes, an elevated 
rest/activity autocorrelation was related to increased area under the awakening cortisol 
curve, but only when estimated awakening cortisol values were included in the 
calculation. Cautious interpretation of this finding is needed because it was only observed 
with estimated awakening values included. In this analysis, a more exaggerated CAR is 
related to a measure indicating increased circadian rhythmicity, adding to the difficulty 
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interpreting CAR findings. Longitudinal investigations into the outcomes predicted by 
CAR variables would improve the interpretability of these results. Longitudinal studies 
could also note relationships of CAR variables with other indicators of circadian rhythms 
over time.  
A higher rest/activity autocorrelation was related to a steeper diurnal cortisol 
decline with estimated awakening values included. This is consistent with a finding 
linking these two variables in hypotheses two analyses with no estimated awakening 
values. An increased D/O, meaning more frequent inactivity during the day, was related 
to a flatter diurnal cortisol slope with estimated awakening values included. This was also 
consistent with results obtained in testing of primary cortisol outcomes in hypothesis two 
analyses. These findings add to the robustness of the relationships between these 
variables but do not alter the interpretation.  
 
Cortisol and Sleep 
Secondary analyses of the association between cortisol and sleep revealed no 
significant, independent associations of circadian cortisol variables and sleep outcomes. 
Because sleep is a component of circadian rhythms, it is surprising that circadian cortisol 
variables and sleep outcomes would not be related more strongly. However, because type 
II error is a clear possibility in a small sample, retention of the null hypothesis is in need 
of cautious interpretation. It is hypothesized that in larger data sets, relationships among 
more of the measures of circadian rhythms would be observed, based on their overt 
conceptual links. Still, other interpretations are possible. There is a meaningful distinction 
between 24-hour rhythms and sleep. Disrupted circadian rhythms may not ultimately 
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manifest in sleep disturbance. The SCN is crucial in the regulation of circadian rhythms, 
but sleep outcomes are influenced by a number of other variables, ranging from 
behavioral variables targeted by sleep hygiene interventions to physiological variables 
such as melatonin secretion. 
 
Depression as a Potential Confound 
The final of the secondary analyses sought to determine whether the effects of 
depression influenced results obtained in previous analyses. Patients were removed from 
analysis based on elevated scores on the depression subscale of the POMS, and 
procedures employed in hypothesis 1a were repeated. No significant relationships 
emerged from these analyses, possibly because the elimination of eight additional 
participants limited the statistical power of an already small sample. Nevertheless, no 
support was found for the notion that depression masked relationships in previous 
analyses. 
 
Strengths and Limitations 
Multiple Measures of Circadian Disruption 
Data collection for this study allowed for extensive analysis of two measures of 
circadian disruption. Measures of physiological rhythms and activity rhythms, as well as 
sleep assessment that did not rely on self-reported sleep, yielded interesting and 
surprising results. Detailed analysis of multiple measures of circadian disruption sheds 
some light on previous studies using different measures. Circadian disruption has been 
predictive of cancer survival in two studies, but circadian rhythms have been measured 
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with the diurnal cortisol slope (Sephton et al., 2000) and the 24-hour rest/actigraphy 
autocorrelation yielded by actigraphy (Mormont et al., 2000). This is of particular interest 
in cancer patients because circadian disruption can take many forms in this population 
and increases with advanced illness. As a result, different measurement modalities may 
be needed to fully capture the circadian disruption in cancer patients, and multiple types 
of circadian disruption may need to be assessed. 
Although it would be reasonable to speculate that measures of circadian 
disruption would be associated, this hypothesis has not previously been formally tested. 
As a result, the degree of concordance of these two findings in cancer patients, for whom 
extensive dysregulation of circadian rhythms is evident, was unknown. Results from this 
study indicate that these measures are related and in the expected direction. In light of 
this finding, the idea that circadian disruption is a conceptual variable linking the diurnal 
cortisol slope and rest/activity rhythm is supported. Circadian disruption can reasonably 
be proposed as predictive of survival in two studies of patients with cancer. 
 
Data on Homogeneous Group of Women 
Generalization from these data are limited by the homogeneity of the sample in 
that all participants were diagnosed with breast cancer of various stages and were 
between the time of diagnosis and the initiation of treatment. These results may not 
generalize to patients during the diagnostic testing, treatment, or post-treatment remission 
phases of cancer. Results may have also have limited applicability to men and patients 
suffering from cancer at other bodily sites. There was substantial diversity in race within 
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this sample, as only 55% of the sample was Caucasian, so generalizability of results is 
not expected to be limited to one racial group. 
The common timing with respect to diagnosis, in particular, is not frequently seen 
in studies of psychosocial aspects of patients’ experience of cancer. Because reactions to 
cancer are likely to vary over time, patient similarities in the course of diagnosis and 
treatment reduce variance in the illness as a stressor for participants in this study. 
However, the stressors that patients are experiencing at the time of diagnosis, or that 
confront patients during data collection, could not be held constant and likely influence 
patients’ stress levels, intrusions, and possibly circadian rhythms. 
Patients that enrolled in this study had recently been diagnosed with cancer and 
were anticipating treatment. Many were likely considering several treatment options and 
experiencing significant time constraints. As a result, coping, intrusions, and activity 
rhythms were expected to change rapidly. Because of these features of the sample, 
multiple assessments were deemed worthwhile to increase the reliability of self-report 
variables, a practice that is commonly employed in assessments of circadian cortisol 
rhythms. The collection of daily self-reports also promoted concordance among the spans 
of time over which data were collected for cortisol, actigraphy, and self-report data. 
While daily assessments are appealing from a conceptual perspective, results may have 
limited generalizability to trait-oriented measures of intrusions and coping. 
 
Sample Size 
 Collection of detailed data in a specific sample within a brief time window has the 
potential to limit accrual. In this study, a total of 44 participants enrolled and provided 
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enough data to be included in some analyses. Possibly due to the demands of being 
recently diagnosed with cancer, complete data could not be collected for all participants. 
The saliva samples that were missing, insufficient for assay, or collected outside the 
specified time window presented a threat to validity to the extent that they might have 
been missing in a nonrandom pattern. Analyses attempted to adjust for this problem by 
controlling for the number of missing samples with the diurnal slope or bedtime cortisol 
level as an outcome because the number of missing samples was correlated with these 
outcomes.  
While the sample size was expected to provide sufficient statistical power to 
detect the effects proposed for primary analyses, the sample size was relatively small. 
This small sample size likely limited the ability of this study to detect effect sizes in some 
of the secondary analyses. The limits of a small sample size were ameliorated somewhat 
because the study was exploratory in nature in an effort to capitalize on the rich data 
provided by patients who participated in this study. None of the results from this study 
are intended to present confirmatory conclusions regarding population relationships 
among study variables. Relationships that were not statistically significant in this analysis 
should not be discounted. The small sample size should also be considered in evaluating 
relationships that were not statistically significant. 
 
Comments and Implications 
 Because this was an exploratory study, the results observed do not determine 
whether the relationships exist, but rather indicate the types of relationships that are 
particularly interesting for more focused, confirmatory studies. Daily assessments of 
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intrusions and avoidant coping prompted participants to tie responses to the experience of 
having breast cancer, meaning the effects of psychosocial variables on circiadian 
disruption are conceptually tied to the stress of breast cancer diagnosis specifically. Daily 
psychosocial assessments at the same time as physiological and activity data collection 
also allowed for increased reliability through multiple assessments.  
Actigraphy and cortisol measures of circadian rhythmicity are likely to provide 
unique variance simply as a function of the mode of assessment. While actigraphy 
assesses rest/activity behavior, cortisol provides information on physiological rhythms. 
They might also be expected to be distinct because cortisol rhythms are so responsive to 
the regulation of the SCN. Rest/activity rhythms are almost certainly influenced by the 
SCN, but they are also likely to be more responsive to fluctuations in daily occupational, 
social, and recreation routines. It was interesting to note that a relationship between 
circadian cortisol rhythms and sleep was often absent in this sample, but sleep is clearly 
altered if environmental factors such as noise or the availability of appealing activities is 
strong. Aside from environmental factors, cognitions often alter sleep outcomes, as well 
as rest/activity pattern. Perhaps biofeedback could allow someone to learn to exert a 
degree of conscious influence on cortisol secretion, but sleep can reliably be intentionally 
delayed, and an individual can transition from rest to activity almost effortlessly. In this 
way, it makes sense to conceptualize rest/activity circadian rhythms as being influenced 
by a fairly balanced contribution of endogenous, exogenous, and psychological  factors. 
In contrast, circadian cortisol rhythms, while certainly influenced by exogenous and 
psychological factors, are more often determined by endogenous rhythms. 
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 The unique variance in circadian rhythms provided by dual assessment of 
actigraphy and cortisol is clearly useful in a study of primarily circadian rhythms, but 
these measures may be differentially effective depending on the aim of the study. For 
instance, a study of the influence of rhythms on cancer incidence or survival might favor 
collection of cortisol rhythms if only one measure of circadian rhythmicity could be 
completed, as cortisol is expected to be more closely linked with biology. However, a 
study of the influence of psychological or behavioral variables on circadian disruption 
might favor the use of actigraphy as a measure of circadian rhythms because rest/activity 
patterns are expected to be more closely related to psychosocial variables.  
There are also clinical reasons for determining which circadian rhythm measure to 
use if only one can be chosen. The study of rest/activity rhythms could be more useful in 
the context of psychosocial interventions because these rhythms could be directly 
addressed by cognitive-behavioral interventions. These could include established 
interventions targeting behavioral activation and sleep hygiene treatments, as well as 
other interventions that could easily be developed with the aim of producing more 
reliable circadian rest/activity rhythms. Given the results of the current study, rest/activity 
rhythms might be of more interest to studies of patients early in the course of disease.  
Cortisol rhythms could be of interest to studies aiming to develop better medical 
intervention such as chronomodulated chemotherapy or medications addressing cortisol 
irregularities associated with cancer. 
 In speculating that psychosocial variables are more strongly related with 
rest/activity rhythms and cortisol rhythms are more strongly related to biological 
outcomes, a larger model can also be conceived. The disruption of circadian cortisol 
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rhythms by psychosocial variables may be mediated by rest/activity rhythm disruption. 
The results from the current study are consistent with this conceptualization, as intrusions 
were related to disrupted rest/activity rhythms, but few relationships with disrupted 
cortisol rhythms were observed. As this study included only women who had been 
recently diagnosed with breast cancer, perhaps disruption of the cortisol rhythm would be 
present only after prolonged exposure to abnormal rest/activity patterns. 
 The reason rest/activity rhythms might influence subsequent disruption of 
circadian cortisol rhythms is not known, but several possibilities exist. One possibility is 
that the body might adjust to disrupted rest/activity rhythms with less pronounced 
physiological rhythms as a means of adaptation to environmental demands. Strong 
circadian cortisol rhythms are less useful if physiological resources are not reliably 
needed at specific times of the day, but are rather needed sporadically throughout the day 
and night. Another possibility is suggested by epidemiological studies of cancer 
incidence in people working third shifts. Decreased melatonin secretion has often been 
proposed as a mechanism for this effect because melatonin suppresses estrogen and 
increased exposure to estrogen is a risk factor for breast cancer. People who work third 
shift are exposed to light at night more often than people who sleep at night, and this light 
inhibits secretion of melatonin. Similarly, people with disrupted rest/activity rhythms 
would not be expected to be inactive or sleep at night as regularly as most people and 
could have increased exposure to light. Disruption of melatonin secretion rhythms likely 
alters other biological circadian rhythms, including cortisol. These relationships are 
worthy of further study. It would be interesting to follow patients longitudinally to 
determine whether the initial disruption of activity rhythms is related to subsequent 
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disruption of circadian cortisol rhythms that were not observed in the period immediately 
after diagnosis. Such a study would extend the findings of the current study and inform a 
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Home-Based Data Collection: 






 Sandra Sephton, Ph.D., Director 
Biobehavioral Research Laboratory 
University of Louisville  









Thank you for providing saliva samples and activity data for three full days. We 
appreciate your careful attention to the details necessary for good data collection in this 
study! This set of instructions will guide you through each part of the study over the next 
three days. If you have any questions or difficulties, please call the study Project Director 
Elizabeth Lush: (502) 298-4561. 
 
NOTE: If you have any bleeding in your mouth you should wait until after it heals to 
complete the study. Even a tiny amount of blood in the saliva will interfere with cortisol 
measurement.  
 
I. You received a black plastic box to store saliva samples after you complete each 
collection. Please place the empty box in your refrigerator.  
 
II. Please assemble the following items, and place them at your bedside: 
♦ This instruction packet   
♦ The white “trackcap” bottle containing cotton swabs for saliva collection. 
The purpose of the trackcap is to record the exact time you collect saliva 
samples. This information is needed to study your cortisol rhythm. Never 
open the trackcap before you are ready to take a sample! 
♦ The small black case containing “salivettes” (tubes for holding saliva 
samples) 
♦ The black “Sharpie” pen provided in the case (for you to write on the tubes). 
III. During the next three days you will collect four saliva samples at set times during the 
day. You will also complete questionnaires each morning just after you provide your 
first saliva sample in the morning. Open the black case and take out the salivettes 




TIME of SAMPLE 
 
LABEL COLOR 
IMMEDIATELY after you wake up in the morning YELLOW 
EXACTLY 30 minutes after you wake up  GREEN 
4 PM GRAY 
Just before going to bed PINK 
 
IV. Prepare to provide saliva samples for early tomorrow morning: 
 
 





If you are not wearing the actiwatch, please put it on your 
non-dominant wrist now
♦ From the black case, take out two tubes and put them where you can easily reach 
them from your bed when you first wake up in the morning: 
 
  Day 1: WAKING (yellow) 
 
  Day 1: 30 minutes after awakening (green) 
 
♦ Set out the white “trackcap” bottle containing cotton swabs for saliva collection. 
♦ Take out the marking pen and set it next to the tubes. 
 
V. Please wear the actiwatch all the time during the next three days and nights---except 
when showering, bathing, swimming, or doing anything else that would immerse the 
watch in water (it is NOT waterproof!). Please note the time you remove the watch 
and the time you put it back on. The watch will continuously record your level of 







COLLECTING SALIVA SAMPLES  
 
VI. How to collect saliva samples: 
♦ Open the “trackcap” bottle. Remove one cotton swab. Close the cap again, tightly.  
♦ Place swab in your mouth and gently move it around with your tongue to soak up 
saliva.  Keep the cotton in your mouth until it feels full like a wet sponge. This 
usually takes a minute or two, but can take longer. If you have trouble getting 
enough saliva, try imagining the smell of a lemon.  
♦ While the cotton is in your mouth, use the black “Sharpie” pen to write the date, 
your ID number and the exact time on the correct salivette tube.  Please record the 
time to the minute (e.g., 5:06). Circle “AM” or “PM” accordingly. 
♦ When the cotton swab feels full of saliva, open the salivette. Spit the cotton swab 
into the small plastic holder that rests inside the tube, and cap the tube very tightly 
again. 
♦ Place the salivette in the black plastic box in your refrigerator. Sometimes it may be 
inconvenient to immediately refrigerate your sample. For example, if you are away 
from home when you take the 4 pm sample you may refrigerate it later that evening. 
Samples should not be left out for more than a day.  




Waking sample. For the next three mornings, the moment you wake up in the morning—
when you are ready to arise for the day—provide the “WAKING (yellow) sample. After 
you collect this sample you may get out of bed and continue your usual routine for the 
next 30 minutes.  
 
NOTE: Please do not eat, drink, brush teeth, use mouthwash, chew gum, or smoke for 
30 minutes before providing any saliva sample. These things can interfere with the 
measurement. Please do not put anything in your mouth until after you have completed 
the waking sample, the short questionnaire, and the 30 minutes post-waking sample.   
 
30 Minutes after Waking. Exactly 30 minutes after waking—please provide the 30 
minute (green) sample each morning.  
 
4 p.m. At 4p.m. each day, please provide the (gray) sample.  
 
Bedtime. Just before going to bed each night, please provide the (pink) sample. You 











♦ Plan to note the exact times you remove and the activity watch to shower or bathe as 
well as the exact times you get into bed and begin trying to fall asleep. We’ll need to 
know both the time you take it off and the time you put it back on, to the minute.  
Please record this information, along with any problems during saliva collection, in 
the Saliva and Activity Watch Log (located at the end of this packet). 
 
♦ Plan on completing the Daily Questionnaires and Cortisol Questionnaire just after 

































If you have any questions please do not hesitate to call us: 
Study Telephone Number:  852-5562 
Elizabeth Lush Telephone Number: 298-4561 
 
If we are not available, please leave a message and we will call you back as soon as 
possible.  




YOUR SALIVA AND ACTIVITY WATCH DATA 
 
SALIVA SAMPLES  
 
Please provide saliva samples when you wake in the morning (#1 in 
the figure below), 30 minutes after waking (#2), at 4 pm (#3), and at 
bedtime (#4) on three consecutive days. We will measure the levels of 
the stress hormone, cortisol, in these samples. The graph below shows 
the usual daily rhythm of cortisol, which may be disrupted by stress, 




Please wear the “actigraph” on your wrist during the three day period 
that you provide saliva samples. This device records physical 
movement to characterize your sleep-wake rhythm. The black and 





























   
   


















ID _____          DATE ___/___/___ 
 
Daily Data Collection Schedule  
DAY ONE 
Sample 1: Awakening 
___ Take your waking saliva sample immediately. Refer to Saliva Collection 
Instructions. 
___ Label the correct tube and place it in the plastic box in your refrigerator. 
___ Your Activity Watch should still be on your wrist since it is on for 3 days, 
24 hours per day. Only take the Activity Watch off during activities in which 
it may be immersed in water. Record the time duration in which you take 
the Activity Watch off on the Saliva and Activity Watch Log (one log for 
all days located at the end of the packet). 
___ Fill out the Day One Daily Questionnaires. 
 
Sample 2: 30 minutes post-waking  
___ Take your 30-minute post-waking saliva sample at EXACTLY 30 minutes 
after your wake time. 
___ Place the salivette fully labeled in the plastic box in your refrigerator. 
 
Sample 3: 4:00pm  
___ Take your 4:00pm saliva sample.  
___ Place the salivette fully labeled in the plastic box in your refrigerator. 
 
Sample 4: Bedtime 
___ Take your Bedtime saliva sample immediately before you go to sleep.  
___ Place the salivette fully labeled in the plastic box in your refrigerator. 






Don’t forget to let us know of any comments about saliva samples, as well as 
exact times you take off your Activity Watch (temporarily) during the day on 
the Saliva and Activity Watch Log sheet. 
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ID _____       DATE ___/___/___ 
Daily Questionnaire for DAY ONE 
(to be completed immediately after awakening) 
Below is a list of comments made by people after stressful life events. Please fill in each 
item, indicating how frequently the comments were true for you YESTERDAY regarding your 




















 0 1 2 3 
I thought about it when I didn't mean to. O O O O 
I had trouble falling asleep or staying asleep, because of pictures 









I had waves of strong feelings about it. O O O O 
I had dreams about it. O O O O 
Pictures about it popped into my mind O O O O 
Other things kept making me think about it. O O O O 
Any reminder brought back feelings about it. O O O O 
 We are interested in how people respond when they confront the experience of having 
breast cancer in their lives. There are lots of ways to try to deal with having breast cancer. This 
questionnaire asks you to indicate what you did and felt yesterday, when you experienced 
stressful events related to having breast cancer. Obviously, different events bring out somewhat 
different responses, but think about what you usually did yesterday when you were under a lot of 
stress related to having breast cancer. 
 Then respond to each of the following items by filling in one number for each, using the 
response choices listed just below. Please try to respond to each item separately in your mind 
from each other item. Choose your answers thoughtfully, and make your answers as true FOR 
YOU as you can. Please answer every item. There are no "right" or "wrong" answers, so choose 
the most accurate answer for YOU-- not what you think "most people" would say or do. Indicate 













































 1 2 3 4 
I've been turning to work or other activities to take my mind off 
things. 
O O O O 
I've been saying to myself "this isn't real". O O O O 
I've been giving up trying to deal with it. O O O O 
I've been refusing to believe that it has happened. O O O O 
I've been giving up the attempt to cope. O O O O 
I've been doing something to think about it less, such as going to 












ID _____          DATE ___/___/___ 
 
ACTIVITY WATCH LOG - DAY ONE 
 
UPON AWAKENING (Please complete as soon as possible after waking)  
 
1. Time you got into bed last night:  ___:___ am/pm (circle one) 
2.   Time you began trying to fall asleep:  ___:___ am/pm (circle one) 
3. Time you woke up for the last time this morning:  ___:___ am/pm (circle 
one) 




 For the question below, please fill one bubble on the scale from 0 – 100 
that best describes your answer. For example, if you slept just as well as you 
have usually slept in the past few months, you would fill in the bubble = 50.  If 
worse, you would fill in 60, 70, or 80, etc.  
 
5.   How well did you sleep last night? 
O O O O O O O O O O O 
 
much better 
than usual 0 10 20 30 40 50 60 70 80 90 100 
 

















Remember to take saliva samples 30 minutes after you awoke and 
at 4pm this afternoon. 
 
Please note any times you remove the activity watch. 
 
The questionnaire continues tomorrow morning. 





Daily Data Collection Schedule 
DAY TWO 
Sample 1: Awakening 
___ Take your waking saliva sample immediately. Refer to Saliva Collection 
Instructions. 
___ Label the correct tube and place in the plastic box in your refrigerator. 
___ Your Activity Watch should still be on your wrist since it is on for 3 days 24 
hours per day. Only take the Activity Watch off during activities in which it 
may be immersed in water. Record the time duration in which you take the 
Activity Watch off on the Saliva and Activity Watch Log (one log for all 
days located at the end of the packet). 
___ Fill out the Day Two Daily Questionnaires and Cortisol Questionnaire. 
 
Sample 2: 30 minutes post-waking  
___ Take your 30-minute post-waking saliva sample at EXACTLY 30 minutes 
after your wake time. 
___ Place the salivette fully labeled in the plastic box in your refrigerator. 
 
Sample 3: 4:00pm  
___ Take your 4:00pm saliva sample.  
___ Place the salivette fully labeled in the plastic box in your refrigerator. 
 
Sample 4: Bedtime 
___ Take your Bedtime saliva sample immediately before you go to sleep.  
___ Place the salivette fully labeled in the plastic box in your refrigerator. 







Don’t forget to let us know of any comments about saliva samples, as well as 
exact times you take off your Activity Watch (temporarily) during the day on 
the Saliva and Activity Watch Log sheet. 
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ID _____          DATE ___/___/___ 
Daily Questionnaire for DAY TWO 
(to be completed immediately after awakening) 
Below is a list of comments made by people after stressful life events. Please fill in each 
item, indicating how frequently the comments were true for you YESTERDAY regarding your 




















 0 1 2 3 
I thought about it when I didn't mean to. O O O O 
I had trouble falling asleep or staying asleep, because of pictures 









I had waves of strong feelings about it. O O O O 
I had dreams about it. O O O O 
Pictures about it popped into my mind O O O O 
Other things kept making me think about it. O O O O 
Any reminder brought back feelings about it. O O O O 
 We are interested in how people respond when they confront the experience of having 
breast cancer in their lives. There are lots of ways to try to deal with having breast cancer. This 
questionnaire asks you to indicate what you did and felt yesterday, when you experienced 
stressful events related to having breast cancer. Obviously, different events bring out somewhat 
different responses, but think about what you did yesterday when you were under a lot of stress 
related to having breast cancer. 
 Then respond to each of the following items by filling in one number for each, using the 
response choices listed just below. Please try to respond to each item separately in your mind 
from each other item. Choose your answers thoughtfully, and make your answers as true FOR 
YOU as you can. Please answer every item. There are no "right" or "wrong" answers, so choose 
the most accurate answer for YOU-- not what you think "most people" would say or do. Indicate 













































 1 2 3 4 
I've been turning to work or other activities to take my 
mind off things. 
O O O O 
I've been saying to myself "this isn't real". O O O O 
I've been giving up trying to deal with it. O O O O 
I've been refusing to believe that it has happened. O O O O 
I've been giving up the attempt to cope. O O O O 
I've been doing something to think about it less, such as 
going to movies, watching TV, reading, daydreaming, 











 ID _____          DATE ___/___/___ 
 
ACTIVITY WATCH LOG - DAY TWO 
 
UPON AWAKENING (Please complete as soon as possible after waking)  
 
1. Time you got into bed last night:  ___:___ am/pm (circle one) 
2.   Time you began trying to fall asleep:  ___:___ am/pm (circle one) 
3. Time you woke up for the last time this morning:  ___:___ am/pm (circle 
one) 
4. Time you got out of bed this morning:  ___:___ am/pm (circle one) 
 
For the question below, please fill one bubble on the scale from 0 – 100 
that best describes your answer. For example, if you slept just as well as you 
have usually slept in the past few months, you would fill in the bubble = 50.  If 
worse, you would fill in 60, 70, or 80, etc.  
 
5.   How well did you sleep last night? 











   


















Please continue to the next page 
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ID _____          DATE ___/___/___ 
 
Cortisol Questionnaire for DAY TWO 
(to be completed immediately after awakening) 
 
Please choose the number that best describes your experience or 
activities yesterday.  Please answer by comparing yesterday with “your average 
day” over the last few months. Rate your experience yesterday by filling in a 
bubble from 0 – 100 on the scale below each statement. For example, for 
question 1 if you were just about as physically active yesterday as you have 
usually been in the past few months, you would fill in the bubble = 50. If you 
exercised more than usual, you would fill in 60, 70, or 80, etc.  
 
1. How much physical activity or exercise did you have yesterday? 






0 10 20 30 40 50 60 70 80 90 100
 
 
2. If you exercised yesterday, please fill in the following: 
a) Exercise activity (e.g., walking, running, etc.) ____________________ 
b) Duration ___________ minutes 
c) Level of exertion (darken one):         O HIGH        O  MEDIUM      O LOW 
d) Time you began to exercise (hour:minutes)  _____:_____ 
 
3. How would you rate your health yesterday (how generally well you felt). 
O O O O O O O O O O O 
 
much better 
than usual 0 10 20 30 40 50 60 70 80 90 100
 
 
4. How stressful was your day yesterday? 









5. If yesterday was MORE stressful than usual, what events during the day, and/or  
what times of day were particularly stressful?  
 
Event: _____________________________________________________________ 
               Time it began to be stressful: ____:____ (hour:minutes) 
 
Event: _____________________________________________________________ 




6.  How much pain did you experience yesterday? 
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7. How well did you sleep the night before last night? 
O O O O O O O O O O O 
 
much better 




8. If you smoke, how many cigarettes (cigars, or pipes) did you smoke yesterday?  
 
PLEASE LEAVE THIS QUESTION BLANK IF YOU DON’T SMOKE 
O O O O O O O O O O O much less 




9. If you drink alcoholic beverages, how many drinks did you have yesterday?  
 
PLEASE LEAVE THIS QUESTION BLANK IF YOU DON’T DRINK ALCOHOL 
O O O O O O O O O O O much less 
than usual 0 10 20 30 40 50 60 70 80 90 100
 
 
10. If you drink caffeinated beverages, how many did you have yesterday?  
 































Remember to take saliva samples 30 minutes after you awoke and 
at 4pm this afternoon. 
 
Please note any times you remove the activity watch. 
 
The questionnaire continues tomorrow morning. 
 





Daily Data Collection Schedule 
DAY THREE 
Sample 1: Awakening 
___ Take your waking saliva sample immediately. Refer to Saliva Collection 
Instructions. 
___ Label the correct tube and place it in the plastic box in your refrigerator. 
___ Your Activity Watch should still be on your wrist since it is on for 3 days 24 
hours per day. Only take the Activity Watch off during activities in which it 
may be immersed in water. Record the time duration in which you take the 
Activity Watch off on the Saliva and Activity Watch Log (one log for all 
days at the end of the packet). 
___ Fill out the Day Three Daily Questionnaires. 
 
Sample 2: 30 minutes post-waking  
___ Take your 30-minute post-waking saliva sample at EXACTLY 30 minutes 
after your wake time. 
___ Place the salivette fully labeled in the plastic box in your refrigerator. 
 
Sample 3: 4:00pm  
___ Take your 4:00pm saliva sample.  
___ Place the salivette fully labeled in the plastic box in your refrigerator. 
 
Sample 4: Bedtime  
___ Take your Bedtime saliva sample immediately before you go to sleep.  
___ Place the salivette fully labeled in the plastic box in your refrigerator. 







Don’t forget to let us know of any comments about saliva samples, as well as 
exact times you take off your Activity Watch (temporarily) during the day on 
the Saliva and Activity Watch Log sheet. 
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ID _____          DATE ___/___/___ 
Daily Questionnaire for DAY THREE 
(to be completed immediately after awakening) 
Below is a list of comments made by people after stressful life events. Please fill in each 
item, indicating how frequently the comments were true for you YESTERDAY regarding your 




















 0 1 2 3 
I thought about it when I didn't mean to. O O O O 
I had trouble falling asleep or staying asleep, because of 









I had waves of strong feelings about it. O O O O 
I had dreams about it. O O O O 
Pictures about it popped into my mind O O O O 
Other things kept making me think about it. O O O O 
Any reminder brought back feelings about it. O O O O 
 We are interested in how people respond when they confront the experience of having 
breast cancer in their lives. There are lots of ways to try to deal with having breast cancer. This 
questionnaire asks you to indicate what you did and felt yesterday, when you experienced 
stressful events related to having breast cancer. Obviously, different events bring out somewhat 
different responses, but think about what you did yesterday when you were under a lot of stress 
related to having breast cancer. 
 Then respond to each of the following items by filling in one number for each, using the 
response choices listed just below. Please try to respond to each item separately in your mind 
from each other item. Choose your answers thoughtfully, and make your answers as true FOR 
YOU as you can. Please answer every item. There are no "right" or "wrong" answers, so choose 
the most accurate answer for YOU-- not what you think "most people" would say or do. Indicate 





























































































I've been doing something to think about it less, such as going to movies, 












ID _____          DATE ___/___/___ 
 
ACTIVITY WATCH LOG - DAY THREE 
 
UPON AWAKENING (Please complete as soon as possible after waking)  
 
1. Time you got into bed last night:  ___:___ am/pm (circle one) 
2.   Time you began trying to fall asleep:  ___:___ am/pm (circle one) 
3. Time you woke up for the last time this morning:  ___:___ am/pm (circle 
one) 




For the question below, please fill one bubble on the scale from 0 – 100 that best 
describes your answer. For example, if you slept just as well as you have usually 
slept in the past few months, you would fill in the bubble = 50.  If worse, you 
would fill in 60, 70, or 80, etc.  
 
5.   How well did you sleep last night? 
 
O O O O O O O O O O O 
 
much better 
than usual 0 10 20 30 40 50 60 70 80 90 100 
 
 














Please continue to the next page 
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 ID _____          DATE ___/___/___ 
 
Cortisol Questionnaire for DAY THREE 
(to be completed immediately after awakening) 
 
Please choose the number that best describes your experience or 
activities yesterday. Please answer by comparing yesterday with “your average 
day” over the last few months. Rate your experience yesterday by filling in a 
bubble from 0 – 100 on the scale below each statement. For example, for 
question 1 if you were just about as physically active yesterday as you have 
usually been in the past few months, you would fill in the bubble = 50.  If you 
exercised more than usual, you would fill in 60, 70, or 80, etc.  
 
1. How much physical activity or exercise did you have yesterday? 






0 10 20 30 40 50 60 70 80 90 100
 
 
2. If you exercised yesterday, please fill in the following: 
a) Exercise activity (e.g., walking, running, etc.) _______________________ 
b) Duration ___________ minutes 
c) Level of exertion (darken one):         O HIGH           O  MEDIUM      O LOW 
d) Time you began to exercise (hour:minutes)  _____:_____ 
 
3. How would you rate your health yesterday (how generally well you felt). 
O O O O O O O O O O O 
 
much better 
than usual 0 10 20 30 40 50 60 70 80 90 100
 
 
4. How stressful was your day yesterday? 









5. If yesterday was MORE stressful than usual, what events during the day, and/or  
what times of day were particularly stressful?  
 
Event: _____________________________________________________________ 
               Time it began to be stressful: ____:____ (hour:minutes) 
 
Event: _____________________________________________________________ 




6.  How much pain did you experience yesterday? 
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7. How well did you sleep the night before last night? 
O O O O O O O O O O O 
 
much better 




8. If you smoke, how many cigarettes (cigars, or pipes) did you smoke yesterday?  
 
PLEASE LEAVE THIS QUESTION BLANK IF YOU DON’T SMOKE 
O O O O O O O O O O O much less 
than usual 0 10 20 30 40 50 60 70 80 90 100
 
  
9. If you drink alcoholic beverages, how many drinks did you have yesterday?  
 
PLEASE LEAVE THIS QUESTION BLANK IF YOU DON’T DRINK ALCOHOL 
O O O O O O O O O O O much less 
than usual 0 10 20 30 40 50 60 70 80 90 100
 
 
10. If you drink caffeinated beverages, how many did you have yesterday?  
 

































Remember to take saliva samples 30 minutes after you awoke and 
at 4pm this afternoon. 
 
Please note any times you remove the activity watch. 
 
The questionnaire continues tomorrow morning. 
 










___ Fill out the Day Four Daily Questionnaires, Activity Watch 
Questionnaire, and  
Cortisol Questionnaire. 
___ You may take off the Activity watch. Keep them with the supplies (but not in 
the plastic box with the saliva samples) to return to the research staff. 
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ID _____          DATE ___/___/___ 
Daily Questionnaire for DAY FOUR 
(to be completed immediately after awakening) 
Below is a list of comments made by people after stressful life events. Please fill 
in each item, indicating how frequently the comments were true for you YESTERDAY 
regarding your diagnosis and treatment of BREAST CANCER. If they did not occur, 



















 0 1 2 3 
I thought about it when I didn't mean to. O O O O 
I had trouble falling asleep or staying asleep, because of 









I had waves of strong feelings about it. O O O O 
I had dreams about it. O O O O 
Pictures about it popped into my mind O O O O 
Other things kept making me think about it. O O O O 
Any reminder brought back feelings about it. O O O O 
 We are interested in how people respond when they confront the experience of having 
breast cancer in their lives. There are lots of ways to try to deal with having breast cancer. This 
questionnaire asks you to indicate what you did and felt yesterday, when you experienced 
stressful events related to having breast cancer. Obviously, different events bring out somewhat 
different responses, but think about what you did yesterday when you were under a lot of stress 
related to having breast cancer. 
 Then respond to each of the following items by filling in one number for each, using the 
response choices listed just below. Please try to respond to each item separately in your mind 
from each other item. Choose your answers thoughtfully, and make your answers as true FOR 
YOU as you can. Please answer every item. There are no "right" or "wrong" answers, so choose 
the most accurate answer for YOU-- not what you think "most people" would say or do. Indicate 













































 1 2 3 4 
I've been turning to work or other activities to take 
my mind off things. 
O O O O 
I've been saying to myself "this isn't real". O O O O 
I've been giving up trying to deal with it. O O O O 
I've been refusing to believe that it has happened. O O O O 
I've been giving up the attempt to cope. O O O O 
I've been doing something to think about it less, such 
as going to movies, watching TV, reading, 












ID _____          DATE ___/___/___ 
 
ACTIVITY WATCH LOG - DAY FOUR 
UPON AWAKENING 
 
1. Time you got into bed last night:  ___:___ am/pm (circle one) 
2.   Time you began trying to fall asleep:  ___:___ am/pm (circle one) 
3. Time you woke up for the last time this morning:  ___:___ am/pm (circle 
one) 
4. Time you got out of bed this morning:  ___:___ am/pm (circle one) 
 
For the question below, please fill one bubble on the scale from 0 – 100 that best 
describes your answer. For example, if you slept just as well as you have usually 
slept in the past few months, you would fill in the bubble = 50.  If worse, you 
would fill in 60, 70, or 80, etc.  
 
 
5.   How well did you sleep last night? 
O O O O O O O O O O O 
 
much better 



















Please continue to the next page 
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 ID _____          DATE ___/___/___ 
 
Cortisol Questionnaire for DAY FOUR 
(to be completed immediately after awakening) 
 
Please choose the number that best describes your experience or 
activities yesterday. Please answer by comparing yesterday with “your average 
day” over the last few months. Rate your experience yesterday by filling in a 
bubble from 0 – 100 on the scale below each statement. For example, for 
question 1 if you were just about as physically active yesterday as you have 
usually been in the past few months, you would fill in the bubble = 50.  If you 
exercised more than usual, you would fill in 60, 70, or 80, etc.  
 
 
1. How much physical activity or exercise did you have yesterday? 






0 10 20 30 40 50 60 70 80 90 100
 
 
2. If you exercised yesterday, please fill in the following: 
a) Exercise activity (e.g., walking, running, etc.) _______________________ 
b) Duration ___________ minutes 
c) Level of exertion (darken one):         O HIGH           O  MEDIUM      O LOW 
d) Time you began to exercise (hour:minutes)  _____:_____ 
 
3. How would you rate your health yesterday (how generally well you felt). 
O O O O O O O O O O O 
 
much better 
than usual 0 10 20 30 40 50 60 70 80 90 100
 
 
4. How stressful was your day yesterday? 





0 10 20 30 40 50 60 70 80 90 100
 
 
5. If yesterday was MORE stressful than usual, what events during the day, and/or  
what times of day were particularly stressful?  
 
Event: _____________________________________________________________ 
               Time it began to be stressful: ____:____ (hour:minutes) 
 
Event: _____________________________________________________________ 
               Time it began to be stressful: ____:____ (hour:minutes) 
 
 
6.  How much pain did you experience yesterday? 
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0 10 20 30 40 50 60 70 80 90 100
 
 
7. How well did you sleep the night before last night? 
O O O O O O O O O O O 
 
much better 
than usual 0 10 20 30 40 50 60 70 80 90 100
 
 
8. If you smoke, how many cigarettes (cigars, or pipes) did you smoke yesterday?  
 
PLEASE LEAVE THIS QUESTION BLANK IF YOU DON’T SMOKE 
O O O O O O O O O O O much less 
than usual 0 10 20 30 40 50 60 70 80 90 100
 
  
9. If you drink alcoholic beverages, how many drinks did you have yesterday?  
 
PLEASE LEAVE THIS QUESTION BLANK IF YOU DON’T DRINK ALCOHOL 
O O O O O O O O O O O much less 
than usual 0 10 20 30 40 50 60 70 80 90 100
 
 
10. If you drink caffeinated beverages, how many did you have yesterday?  
 






























Saliva and Activity Watch Log Sheet 
 
 Saliva  Watch  
 
Please write about any 
problems with saliva 
collection 
Please write down any  
times the Actiwatch is  
removed 












     
DAY 1     
     
     
     
DAY 2     





Saliva and Activity Watch Log Sheet 
 
 Saliva  Watch  
 
Please write about any 
problems with saliva 
collection 
Please write down any  
times the Actiwatch is  
removed 





4 p.m.  
sample 
1/1/06 




DAY 3        
         
         
         













You Are Finished! 
 
















 Sandra Sephton, Ph.D., Director 
Biobehavioral Research Laboratory  
University of Louisville  
2301 S. Third Street, 427 Lutz Hall 
Louisville, KY 40208 
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Stress, Coping, and Sleep in Breast Cancer 







Dear Research Participant.    
We greatly appreciate your willingness to take part in this study of the effects of 
stress, coping, and sleep in women with breast cancer. It may take you about one hour 
to complete this packet. Please complete it in a quiet place, alone, at a time when you 
can be free from interruption.  
 
• Please be sure to write the date that you answer each questionnaire at the top 
of the page on which it begins.   
• Please fill in the bubbles so that the entire circle is blackened (do NOT make 
check marks) 
• Do not skip any items 
• Please use a dark pen and write clearly DO NOT USE PENCIL 
• If you make any mistakes, please put an “X” through the incorrect answer and 
fill in the correct answer.  
 
By completing this questionnaire, you will help us understand much about stress 
in cancer. We hope this will be a valuable experience for you as well as for us. We are 
very grateful to you for making the commitment to participate. Your role in this research 
is vital. You may feel as though you are answering the same question more than once; 
however, your answer on each item is needed. 
The timing of your menstrual cycle, your physical condition, and some of the 
medications you may be taking are likely to influence the stress hormones we will be 
measuring in your blood, urine and saliva samples. Thus, please be as accurate as 
possible when recording your medical information. To maintain the confidentiality of the 
information you provide, all data will be secured in locked files and will be accessed only 
by research staff. In some of the enclosed questionnaires you will be asked to answer 
questions about past stressful experiences. This may bring up painful feelings or 
memories. If you experience so much distress that you would benefit from personal 
counseling, the investigators can refer you to the Behavioral Medicine Clinic at Norton 
Hospital, although the study cannot provide payment for such treatment. If you have 
concerns or questions that come up in the process of completing these questionnaires, 
you may contact Sandra Sephton.  
 
With our sincere thanks, 
 
 







The packet contains the following questionnaires:  
 
Page 
1. Background 4 
2. Medications 8 
3. KAR 8 
4. IES 9 
5. COP 9 
6. QOL 11 
7. ISEL 13 
8. POM 15 
9. PFS 17 













Please answer the following questions about your background and medical history. 
 
1.  Name:______________________________________________________________ 
 
2.  Nickname:___________________________________________________________ 
 
3.  Age:__________ 
 
4.  Gender: Male  O   Female  O 
 
5.  Date of Birth:    Month: _______     Day: _______     Year: _______ 
 
6.  Address: 
Street ______________________________   Apt. # ___________ 
 




 7.  Family/Friend Caregiver Support?  O Yes     O    No 
 
 Name ______________________________  
 
Phone Number _______________________   
 





Location (practice, clinic or hospital, 
city):________________________________ 
          
  
9.  Date of first breast cancer diagnosis (mm/dd/yy):   
__________________________________ 
 
10.  On which side was your cancer? _____________________________________ 
 
11.  Stage at diagnosis: : _____________________________________ 
 
12. Have you EVER had radiation therapy?   O Yes O   No 
 
13.  Are you currently receiving radiation therapy?    O Yes     O    No 
 








14.  When was the last date of your radiation therapy? (mm/dd/yy):   
_______________________ 
 
15.  Have you EVER had chemotherapy treatment?  O Yes     O    No 
 
DATE STARTED?    (mm/dd/yy):   _______________________ 
 
 
16.  Are you currently receiving chemotherapy treatment? O Yes     O    No 
 
DATE STARTED?    (mm/dd/yy):   _______________________ 
 
17.  When was the last date of your chemotherapy treatment?  (mm/dd/yy):   
_____________________ 
 
18.  Have you had a breast or part of a breast removed surgically?  (mm/dd/yy):   
_________________ 
 
 Which breast or part of your breast?________________________________ 
 
19.  Have you been diagnosed with any other type of cancer?: 
 
When?   (mm/dd/yy):   
_______________________________________________ 
 




20.  Have you been diagnosed with other ongoing medical conditions (diabetes, 
cardiovascular disease, high blood pressure, renal disease, etc.)?  
 
            
  
 
21.  Do you have children?      O Yes      O    No 
If so, how many children have you had?  
Number of children you have had: _____ 
Number of children living with you: _____ 
Number of elderly parents living with you: _____ 












22. What is your marital status?  O Single, never married 
      O Single, divorced 
      O Single, living with partner 
O Married 
O Divorced and remarried 
O Widowed 
O Widowed and remarried 
O Separated 
      O Other 
 




24. What is your racial-ethnic background?  O Asian 
       O Black 
       O Hispanic 
       O Native American 
       O White/Caucasian 
       O Other 
 
25.  How many years of education have you completed?  
       Use the following numbers as a guide to your answer: 
O Grade School = K-6 
O Middle School = 7-8  
 O High School = 12 
O AA/Technical = 14 
O BA/BS = 16 
       O MA = 18 
       O PhD, MD, JD = 20 
 
26.  Are you currently employed?   O Yes  O No  
 
27.  If currently employed: Hours per week? (enter 0 if not applicable) :      
 
  Occupation:  _____________________________________________ 
 
28.  If not currently employed, which of the following best describes your situation? 
  O Not looking for work 
  O Looking for work 
  O Leave of Absence 
  O Retired 
  O Medical leave or temporary disability 
  O Permanently disabled 






29.  If not currently employed, what was your previous occupation, if any? 
___________________ 
 
30.  What is your total annual household income before taxes?  
O Less than $20,000 
O $20,000 - $39,999 
O $40,000 - $59,999 
O $60,000 - $79,999 
O $80,000 - $99,999 
O $100,000 and above 
 
31.  What is your current living situation?    
(Do not include temporary visitors.) O Live alone 
     O Live with spouse/partner only 
     O Live with spouse/partner and child only 
     O Live with child or children only 
     O Live with other relatives 
     O Live with other non-relatives 
     O Other 
 
32.  Do you own or rent your place of residence?  O Own  O Rent 
 
33.  What is the total number of people living in your household, including yourself?    
_______ 
 
34.  What is your religious affiliation? O Protestant 
(darken one)    O Jewish 
      O Catholic 
      O None 
      O  Other____________(please specify) 
 
35. Insurance:   Private O 
    Public  O 
Other  O 
    None  O 
 
36.  Do you consider yourself to be? 
O pre-menopause (you have a menstrual period on a regular cycle) 
O peri-menopause (you have begun to experience symptoms of 
menopause, but have not completed this transition) 
O post-menopause (you no longer menstruate, and have completed the 









37. If you currently experience a regular menstrual period, what was the first day of your 
last menstrual period?   
(mm/dd/yy):   _____________________ 
 
38. If you currently experience a regular menstrual period, how many days is your usual 
cycle (days from the beginning of one period to the beginning of the next one, for 
example, 28 days, 31 days, etc.). 
 
_______ # days 
 
39. Do you currently use oral contraceptive pills?   O Yes  O No 
 




Please list all medications you have taken in the past month. Please include prescription 
medications and non-prescription (over-the-counter) medications, as well as any herbal 
supplements. You may find it helpful to have your medications at hand while completing this form.  
Please use the back of this page if you need additional room. 
 
Medication Dosage Number of 
times per day 
Number of days per 
week 
Reason taken 
     
     
     
      
     
     


































100 Normal, no complaints, no evidence of disease 
 
90 Able to carry on normal activity: minor symptom of disease 
 
80 Normal activity with effort: some symptoms of disease 
 
70 Cares for self: unable to carry on normal activity or active work 
 
60 Requires occasional assistance but is able to care for needs 
 
50 Requires considerable assistance and frequent medical care 
 
40 Disabled: requires special care and assistance 
 
30 Severely disabled: hospitalization is indicated, death not imminent 
 
20 Very sick, hospitalization necessary; active treatment necessary 
 
10 Moribund, fatal processes progressing rapidly 
 




Below is a list of comments made by people after stressful life events. Please fill in each 
item, indicating how frequently the comments were true for you DURING THE CURRENT DAY 
regarding your diagnosis and treatment of BREAST CANCER. If they did not occur, please mark 





















 0 1 2 3 
1. I thought about it when I didn't mean to. O O O O 
2. I avoided letting myself get upset when I thought about it or 
was reminded of it. O O O O 
3. I tried to remove it from memory. O O O O 
4. I had trouble falling asleep or staying asleep, because of 
pictures of thoughts about it that came into my mind. O O O O 
5. I had waves of strong feelings about it. O O O O 
6. I had dreams about it. O O O O 
7. I stayed away from reminders of it. O O O O 
8. I felt as if it hadn't happened or it wasn't real. O O O O 
9. I tried not to talk about it. O O O O 
10. Pictures about it popped into my mind. O O O O 
11. Other things kept making me think about it. O O O O 
12. I was aware that I still had a lot of feelings about it, but I didn't 
deal with them. O O O O 
13. I tried not to think about it. O O O O 
14. Any reminder brought back feelings about it. O O O O 
15. My feelings about it were kind of numb. O O O O 
We are interested in how people respond when they confront difficult or stressful events 
in their lives that are related to the experience of having breast cancer. There are lots of ways to 
try to deal with this stress. This questionnaire asks you to indicate what you generally do and feel, 
when you experience stressful events related to breast cancer. Obviously, different events bring 
out somewhat different responses, but think about what you usually do when you are under a lot 
of stress related to breast cancer. 
Then respond to each of the following items by filling in one number for each, using the 
response choices listed just below. Please try to respond to each item separately in your mind 
from each other item. Choose your answers thoughtfully, and make your answers as true FOR 
YOU as you can.  Please answer every item.  There are no "right" or "wrong" answers, so choose 
the most accurate answer for YOU-- not what you think "most people" would say or do.  Indicate 




























































1. I've been concentrating my efforts on 
doing something about the situation I'm 
in. 
O O O O 
2. I've been trying to come up with a 































































3. I've been trying to see it in a different light, 
to make it seem more positive.  O O O O 
4. I've been accepting the reality of the fact 
that it has happened. O O O O 
5. I've been making jokes about it. O O O O 
6. I've been trying to find comfort in my religion 
or spiritual beliefs.  O O O O 
7. I've been getting emotional support from 
others. O O O O 
8. I've been trying to get advice or help from 
other people about what to do. O O O O 
9. I've been turning to work or other activities 
to take my mind off things. O O O O 
10. I've been saying to myself "this isn't real." O O O O 
11. I've been saying things to let my unpleasant 
feelings escape. O O O O 
12. I've been using alcohol or other drugs to 
make myself feel better. O O O O 
13. I've been giving up trying to deal with it. O O O O 
14. I've been criticizing myself. O O O O 
15. I've been learning to live with it. O O O O 
16. I've been taking action to try to make the 
situation better. O O O O 
17. I've been thinking hard about what steps to 
take. O O O O 
18. I've been looking for something good in 
what is happening. O O O O 
19. I've been making fun of the situation. O O O O 
20. I've been praying or meditating. O O O O 
21. I've been getting comfort and understanding 
from someone. O O O O 
22. I've been getting help and advice from other 
people. O O O O 
23. I've been doing something to think about it 
less, such as going to movies, watching TV, 
reading, daydreaming, sleeping, or 
shopping. 
O O O O 
24. I've been refusing to believe that it has 
happened. O O O O 
25. I've been expressing my negative feelings. O O O O 
26. I've been using alcohol or other drugs to 
help me get through it. O O O O 
27. I've been giving up the attempt to cope. O O O O 
28. I've been blaming myself for things that 




Below is a list of statements that other people with your illness have said are 
important.  By circling one number per line, please indicate how true each statement has 
































 0 1 2 3 4 
1. I have a lack of energy. O O O O O 
2. I have nausea. O O O O O 
3. Because of my physical condition, I have trouble meeting 
the needs of my family. O O O O O 
4. I have pain. O O O O O 
5. I am bothered by side effects of treatment. O O O O O 
6. I feel ill. O O O O O 
7. I am forced to spend time in bed. O O O O O 
 
       Not at all           
Very much so 
8. Looking at the above 7 questions, 
how much would you say your 
PHYSICAL WELL-BEING affects 
























Regardless of your current level of sexual activity, please answer the following 
questions: 
             No      
Yes  

































 0 1 2 3 4 
9. I feel distant from my friends. O O O O O 
10. I get emotional support from my family. O O O O O 
11. I get support from my friends and neighbors. O O O O O 
12. My family has accepted my illness. O O O O O 
13. Family communication about my illness is poor. O O O O O 
14. I feel close to my partner (or the person who is my 
main support). 
O O O O O 
247
  
               Not at all                
Very much so 
16. Looking at the above 7 questions, 
how much would you say your 
SOCIAL/FAMILY WELL-BEING 

























               Not at all             
Very much so 
19. Looking at the above 7 questions, 
how much would you say your 
RELATIONSHIP WITH THE 
























Not at all           
Very much so 
26. Looking at the above 6 questions, 
how much would you say your 
EMOTIONAL WELL-BEING affects 























































 0 1 2 3 4 

































 0 1 2 3 4 
17. I have confidence in my doctor(s). O O O O O 

































 0 1 2 3 4 
20. I feel sad. O O O O O 
21. I am proud of how I'm coping with my illness. O O O O O 
22. I am losing hope in the fight against my illness. O O O O O 
23. I feel nervous. O O O O O 
24. I worry about dying. O O O O O 




                  Not at all          
Very much so 
34. Looking at the above 7 questions, 
how much would you say your 
FUNCTIONAL WELL-BEING affects 
























                 Not at all           
Very much so 
44. Looking at the above 9 questions, 
how much would you say these 
ADDITIONAL CONCERNS affect 





























































 0 1 2 3 4 
27. I am able to work (include work in home). O O O O O 
28. My work (include work in home) is fulfilling. O O O O O 
29. I am able to enjoy life. O O O O O 
30. I have accepted my illness. O O O O O 
31. I am sleeping well. O O O O O 
32. I am enjoying the things I usually do for fun. O O O O O 

































 0 1 2 3 4 
35. I have been short of breath. O O O O O 
36. I am self-conscious about the way I dress. O O O O O 
37. One or both of my arms are swollen or tender. O O O O O 
38. I feel sexually attractive. O O O O O 
39. I am bothered by hair loss. O O O O O 
40. I worry about the risk of cancer in other family 
members. 
O O O O O 
41. I worry about the effect of stress on my illness. O O O O O 
42. I am bothered by a change in weight. O O O O O 




This scale is made up of a list of statements each of which may or may not be 
true about you.  Choose “definitely true” if you are sure it is true about you and “probably 
true” if you think it is true but are not absolutely certain.  Similarly, you should choose 
“definitely false” if you are sure the statement is false and “probably false” if you think it 




































 0 1 2 3 
1. There are several people that I trust to help solve my 
problems. O O O O 
2. If I needed help fixing an appliance or repairing my car, 
there is someone who would help me. O O O O 
3. Most of my friends are more interesting than I am. O O O O 
4. There is someone who takes pride in my 
accomplishments. O O O O 
5. When I feel lonely, there are several people I can talk to. O O O O 
6. There is no one that I feel comfortable to talking about 
intimate personal problems. O O O O 
7. I often meet or talk with family or friends. O O O O 
8. Most people I know think highly of me. O O O O 
9. If I needed a ride to the airport very early in the morning, 
I would have a hard time finding someone to take me. O O O O 
10. I feel like I’m not always included by my circle of friends. O O O O 
11. There really is no one who can give me an objective 
view of how I’m handling my problems. O O O O 
12. There are several different people I enjoy spending time 
with. O O O O 
13. I think that my friends feel that I’m not very good at 







































 0 1 2 3 
14. If I were sick and needed someone (friend, family member, 
or acquaintance) to take me to the doctor, I would have 
trouble finding someone. 
O O O O 
15. If I wanted to go on a trip for a day (e.g., to the mountains, 
beach, or country), I would have a hard time finding 
someone to go with me. 
O O O O 
16. If I needed a place to stay for a week because of an 
emergency (for example, water or electricity out in my 
apartment or house), I could easily find someone who 
would put me up. 
O O O O 
17. I feel that there is no one I can share my most private 
worries and fears with. O O O O 
18. If I were sick, I could easily find someone to help me with 
my daily chores. O O O O 
19. There is someone I can turn to for advice about handling 
problems with my family. O O O O 
20. I am as good at doing things as most other people are. O O O O 
21. If I decide one afternoon that I would like to go to a movie 
that evening, I could easily find someone to go with me. O O O O 
22. When I need suggestions on how to deal with a personal 
problem, I know someone I can turn to. O O O O 
23. If I needed an emergency loan of $100, there is someone 
(friend, relative, or acquaintance) I could get it from. O O O O 
24. In general, people do not have much confidence in me. O O O O 
25. Most people I know do not enjoy the same things that I do. O O O O 
26. There is someone I could turn to for advice about making 
career plans or changing my job. O O O O 
27. I don’t often get invited to do things with others. O O O O 
28. Most of my friends are more successful at making changes 
in their lives than I am. O O O O 
29. If I had to go out of town for a few weeks, it would be 
difficult to find someone who would look after my house or 
apartment (the plants, pets, garden, etc.). 
O O O O 
30. There really is no one I can trust to give me good financial 
advice. O O O O 
31. If I wanted to have lunch with someone, I could easily find 
someone to join me. O O O O 
32. I am more satisfied with my life than most people are with 
theirs. O O O O 
33. If I was stranded 10 miles from home, there is someone I 
could call who would come and get me. O O O O 
34. No one I know would throw a birthday party for me. O O O O 
35. It would me difficult to find someone who would lend me 
their car for a few hours. O O O O 
36. If a family crisis arose, it would be difficult to find someone 
who could give me good advice about how to handle it. O O O O 
37. I am closer to my friends than most other people are to 







































 0 1 2 3 
38. There is at least one person I know whose advice I 
really trust. O O O O 
39. .  If I needed some help in moving to a new house or 
apartment, I would have a hard time finding someone 
to help me. 
O O O O 











































Below is a list of words that describe feelings people have. Please read each one 
carefully. Then circle ONE number under the answer to the right which best describes 
HOW YOU HAVE BEEN FEELING DURING THE PAST WEEK INCLUDING TODAY. 





























 0 1 2 3 4 
1. Friendly O O O O O 
2. Tense O O O O O 
3. Angry O O O O O 
4. Worn out O O O O O 
5. Unhappy O O O O O 
6. Clear-headed O O O O O 
7. Lively O O O O O 
8. Confused O O O O O 
9. Sorry for things done O O O O O 
10. Shaky O O O O O 
11. Listless O O O O O 
12. Peeved O O O O O 
13. Considerate O O O O O 
14. Sad O O O O O 
15. Active O O O O O 
16. On edge O O O O O 
17. Grouchy O O O O O 
18. Blue O O O O O 
19. Energetic O O O O O 
20. Panicky O O O O O 
21. Hopeless O O O O O 
22. Relaxed O O O O O 
23. Unworthy O O O O O 
24. Spiteful O O O O O 
































 0 1 2 3 4 
26. Uneasy O O O O O 
27. Restless O O O O O 
28. Unable to concentrate O O O O O 
29. Fatigued O O O O O 
30. Helpful O O O O O 
31. Annoyed O O O O O 
32. Discouraged O O O O O 
33. Resentful O O O O O 
34. Nervous O O O O O 
35. Lonely O O O O O 
36. Miserable O O O O O 
37. Muddled O O O O O 
38. Cheerful O O O O O 
39. Bitter O O O O O 
40. Excited O O O O O 
41. Anxious O O O O O 
42. Ready to fight O O O O O 
43. Good-natured O O O O O 
44. Gloomy O O O O O 
45. Desperate O O O O O 
46. Sluggish O O O O O 
47. Rebellious O O O O O 
48. Helpless O O O O O 
49. Weary O O O O O 
50. Bewildered O O O O O 
51. Alert O O O O O 
52. Deceived O O O O O 
53. Furious O O O O O 
54. Efficient O O O O O 
55. Trusting O O O O O 
56. Full of pep O O O O O 
57. Bad-tempered O O O O O 
58. Worthless O O O O O 
59. Forgetful O O O O O 
60. Carefree O O O O O 
61. Terrified O O O O O 
62. Guilty O O O O O 
63. Vigorous O O O O O 
64. Uncertain about things O O O O O 






 For each of the following questions, circle the number that best describes the fatigue you are 
experiencing now.  Please make every effort to answer each question to the best of your ability.  Thank you 
very much. 






O Other (please describe): ___________________ 
 
0 1 2 3 4 5 6 7 8 9 10 2.  To what degree is the fatigue you are feeling now causing you 
distress? 
None 
O O O O O O O O O O O 
A great deal 
0 1 2 3 4 5 6 7 8 9 10 
3.  To what degree is the fatigue 
you are feeling now interfering 
with your ability to complete 
your work or school activities? 
None O O O O O O O O O O O A great deal 
0 1 2 3 4 5 6 7 8 9 10 
4.  To what degree is the fatigue 
you are feeling now interfering 
with your ability to visit or 
socialize with your friends? 
None 
O O O O O O O O O O O 
A great deal 
0 1 2 3 4 5 6 7 8 9 10 
5.  To what degree is the fatigue 
you are feeling now interfering 
with your ability to engage in 
sexual activity? 
None 
O O O O O O O O O O O 
A great deal 
0 1 2 3 4 5 6 7 8 9 10 
6. Overall how much is the 
fatigue, which you are 
experiencing now, interfering 
with your ability to engage in the 
kind of activities you enjoy 
doing? 
None O O O O O O O O O O O A great deal 
0 1 2 3 4 5 6 7 8 9 10 7.  How would you describe the degree of intensity or severity of 
the fatigue which you are 
experiencing now? 
Mild O O O O O O O O O O O Severe 
0 1 2 3 4 5 6 7 8 9 10 
8.  To what degree would you 
describe the fatigue which you 
are experiencing now as being: 
Pleasant 
O O O O O O O O O O O 
Unpleasant 
0 1 2 3 4 5 6 7 8 9 10 
9.  To what degree would you 
describe the fatigue which you 
are experiencing now as being: 
Agreeae 
O O O O O O O O O O O 
Disagree- 
able 
0 1 2 3 4 5 6 7 8 9 10 
10.  To what degree would you 
describe the fatigue which you 
are experiencing now as being: 
Protective 
O O O O O O O O O O O 
Destructive 
0 1 2 3 4 5 6 7 8 9 10 
11.  To what degree would you 
describe the fatigue which you 
are experiencing now as being: 
Positive 
O O O O O O O O O O O 
Negative 
0 1 2 3 4 5 6 7 8 9 10 
12.  To what degree would you 
describe the fatigue which you 
are experiencing now as being: 
Normal 
O O O O O O O O O O O 
Abnormal 
0 1 2 3 4 5 6 7 8 9 10 13. To what degree are you now 




0 1 2 3 4 5 6 7 8 9 10 14. To what degree are you now 
feeling:  Awake O O O O O O O O O O O Sleepy 
 
0 1 2 3 4 5 6 7 8 9 10 15. To what degree are you now 
feeling: Lively O O O O O O O O O O O Listless 
0 1 2 3 4 5 6 7 8 9 10 16. To what degree are you 
now feeling: 
Refreshe
d O O O O O O O O O O O Tired 
0 1 2 3 4 5 6 7 8 9 10 17. To what degree are you 
now feeling: Energetic O O O O O O O O O O O Unenergetic 
0 1 2 3 4 5 6 7 8 9 10 18. To what degree are you 
now feeling: Patient O O O O O O O O O O O 
Impatient 
0 1 2 3 4 5 6 7 8 9 10 19. To what degree are you 
now feeling: Relaxed O O O O O O O O O O O Tense 
0 1 2 3 4 5 6 7 8 9 10 20. To what degree are you 
now feeling: Exhilarated O O O O O O O O O O O Depressed 
0 1 2 3 4 5 6 7 8 9 10 21. To what degree are 
you now feeling: 
Able to 
concentrate O O O O O O O O O O O 
Unable to  
concentrate 
0 1 2 3 4 5 6 7 8 9 10 22. To what degree are 
you now feeling: 
Able to 
remember O O O O O O O O O O O 
Unable to  
remember 
0 1 2 3 4 5 6 7 8 9 10 23. To what degree are 
you now feeling: 
Able to 
think clearly O O O O O O O O O O O 
Unable to  
think clearly 
 

















27.  Are you experiencing any other symptoms right now?   
O  No  O Yes (please describe)______________________ 
 ______________ 
 





We have listed 24 symptoms below. Please read each one carefully. If you had the 
symptom during the past week, let us know how OFTEN you had it, how SEVERE it was usually 
and how much it DISTRESSED OR BOTHERED you by circling the appropriate number. If you 
DID NOT HAVE the symptom, make an X in the box marked "DID NOT HAVE". 
IF YES 
How OFTEN did 




was it usually? 
 
IF YES 







Did you have any 


























































































concentrating O O O O O O O O O O O O O O 
Pain O O O O O O O O O O O O O O 
Lack of energy O O O O O O O O O O O O O O 
Cough O O O O O O O O O O O O O O 
Feeling nervous O O O O O O O O O O O O O O 
Dry mouth O O O O O O O O O O O O O O 
Nausea O O O O O O O O O O O O O O 
Feeling drowsy O O O O O O O O O O O O O O 
Numbness/tingling 
in hands/feet O O O O O O O O O O O O O O 
Difficulty sleeping O O O O O O O O O O O O O O 
Feeling bloated O O O O O O O O O O O O O O 
Problems with 
urination O O O O O O O O O O O O O O 
Vomiting O O O O O O O O O O O O O O 
Shortness of 
breath O O O O O O O O O O O O O O 
Diarrhea O O O O O O O O O O O O O O 
Feeling sad O O O O O O O O O O O O O O 
Sweats O O O O O O O O O O O O O O 
Worrying O O O O O O O O O O O O O O 
Problems with 
sexual interest or 
activity 
O O O O O O O O O O O O O O 
Itching O O O O O O O O O O O O O O 
Lack of appetite O O O O O O O O O O O O O O 
Dizziness O O O O O O O O O O O O O O 
Difficulty  
Swallowing O O O O O O O O O O O O O O 




We have listed 8 symptoms below. Read each one carefully. If you have had the 
symptom during this past week, let us know how SEVERE it was usually and how much 
it DISTRESSED or BOTHERED you by circling the appropriate number. If you DID NOT 
HAVE the symptom, make an "X" in the box marked "DID NOT HAVE." 
IF YES 




How much did it DISTRESS or 
BOTHER you? 
 
DURING THE PAST 
WEEK 
 











































































































Weight loss O O O O O O O O O O 
Hair loss O O O O O O O O O O 
Constipation O O O O O O O O O O 
Swelling of arms or legs O O O O O O O O O O 
"I don't look like myself" O O O O O O O O O O 
Changes in skin O O O O O O O O O O 
 
 
IF YOU HAD ANY OTHER SYMPTOMS DURING THE PAST WEEK, PLEASE LIST BELOW 



































Other:     
 
 
O O O O O 
Other:       
  
 
O O O O O 
Other:        
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1105 W NC Highway 54 Bypass Apt. A4 Department of Psychiatry 
Chapel Hill, NC 27516   Duke University  






University of North Carolina     Aug. 2006-Aug. 2007 
Chapel Hill, NC 
Clinical Psychology Intern – Behavioral Medicine emphasis 
 
University of Louisville      Aug, 2001- present  
Louisville, KY 
Doctoral Student Clinical Psychology program 
 
Indiana University       Aug. 1995-Dec. 1998 
Bloomington, IN 




Purdue University       Aug. 1994-Dec.1994 
West Lafayette, IN 
 
EMPLOYMENT 
Duke University       Aug. 2007-present 
Department of Psychiatry 
Position: Postdoctoral Research Fellow 
Responsibilities: Conduct research into optimizing smoking cessation interventions and 
provide clinical service 
 
University of North Carolina Hospitals    Aug. 2006-Aug. 2007 
Department of Psychiatry 
Position: Clinical Psychology Intern – Behavioral Medicine emphasis 
 
University of Louisville      July 2006-Aug. 2006 
Department of Psychological and Brain Sciences    
Position: Instructor 
Responsibilities: Taught undergraduate course in statistics and research design. Prepared 
lesson plan, lecture materials, homework problems, and exams. 
CURRICULUM VITAE
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University of Louisville      Aug. 2001-May 2002 
Department of Psychological and Brain Sciences   Aug. 2005-May 2006 
Position: Graduate Teaching Assistant 
Responsibilities:  Taught introduction to psychology classes to undergraduate students. 
Prepared lesson plan for lab sections. 
 
Brown Cancer Center       Aug. 2003-June 2005 
Louisville, KY       
Position: Project Director 
Responsibilities: Directed project investigating psychosocial issues in patients with lung 
cancer. My duties included the preparation of measures for data collection, statistical 
consultation on grant submission, recruitment, interviewing participants, data 
management, training of other research personnel, and preparation of human subjects 
reports and proposals. This project is currently in the results dissemination phase. 
 
Central State Hospital      Aug. 2002-May 2003 
Louisville, KY 
Position: Research Assistant 
Responsibilities: Addressed clinical questions by designing archival studies of patient 
charts, and writing reports based on data collected. Chart reviews ensuring compliance 
with documentation guidelines. 
 
Indiana University       Feb. 2001-May 2001 
Social Psychology Research Laboratory 
Bloomington, IN 
Position: Research Assistant 
Responsibilities: Contacted research participants, collected data, entered data. 
 
Stone Belt Center       Mar. 1999-July 2001 
Bloomington, IN 
Position: Behavior Technician 
Responsibilities: Provided active treatment to developmentally disabled adolescent 
males. Initiated behavior tracking forms in charts and ensured reliable tracking by staff. 
Met with house staff regarding behavior plan revisions and submitted proposed revisions 




Transplant Outcomes Research     Aug. 2006-present 
Intern for Dr. Eileen Burker working clinically with patients being evaluated as 
candidates for heart and lung transplants. This research focuses on psychosocial 
predictors of medical and quality of life outcomes in transplant recipients. My 
responsibilities include human subjects proposals, recruitment, chart review, and 
manuscript preparation. I am currently collaborating with Dr. Burker and other 
researchers on a review of post-transplant employment in heart transplant recipients and 
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an analysis of pre-transplant depression as a predictor of post-transplant survival in lung 
transplant recipients. 
 
Biobehavioral Research Group     Aug. 2001-present 
Research Assistant for Dr. Sandra Sephton, Dr. Paul Salmon, and Dr. Jamie Studts. A 
project investigating a Mindfulness-Based Stress Reduction (MBSR) intervention and 
psychosocial factors in the adjustment of women with fibromyalgia has been completed. 
My duties have included data management, data analysis, and preparations of portions of 
the study results for journal publication.  
 
A project investigating psychosocial factors in the adjustment of patients with lung 
cancer is currently in the data analysis and dissemination of results phase. My duties have 
included the preparation of measures for data collection, recruitment, interviewing 
participants, data management, training of other research personnel, and preparation of 
human subjects reports and proposals. 
 
My dissertation is investigating the effects of distress and coping on circadian 
physiological rhythms in women with breast cancer. This project is in the data collection 
phase. 
 
Cognitive Psychology Research Lab    Aug. 1998-Dec. 1998 
Undergraduate Research Assistant for Dr. Jerome Busemeyer at Indiana University.  The 
primary research was in decision field theory.  My duties included scheduling 





PRACTICA/PREDOCTORAL CLINICAL EXPERIENCE 
 
Psychological Services Center     Aug. 2001-May 2006 
Department of Psychological & Brain Sciences  
University of Louisville 
Louisville, KY  
Supervisors: Abbie Beacham, PhD, Tamara Newton, PhD, Amy Buckley, PhD, Paul 
Bock, PhD, & Bernadette Walter, PhD 
Provided cognitive-behavioral therapy (CBT) to primarily low-income clients. Clinical 
team concentrations included problem-focused health psychology and women with a 
history of trauma. Provided assessment including Attention Deficit/Hyperactivity 
Disorder (ADHD), developmental disability, advanced placement, and full diagnostic 
cases. 
 
Ambulatory Internal Medicine Clinic    Jan. 2003-May 2005 
Department of Psychological & Brain Sciences    
University of Louisville 
Louisville, KY     
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Supervisors: Abbie Beacham, PhD & Amy Buckley, PhD 
            
     
Provided cognitive-behavioral therapy (CBT) to primarily low-income clients in a 
primary care setting. Services included brief assessments and interventions focused on 
behavioral health, medical regimen adherence, pain management, and depression and 
anxiety reduction.  
 
Christopher East Health Care Facility    Aug. 2003-July 2004 
Louisville, KY   
Supervisor: D. Bradley Burton, PhD 
 
Provided neuropsychological assessments of patients in acute rehabilitation from 
traumatic brain injury.  
 
AWARDS AND MEMBERSHIPS 
 
"Distress and Immune Activation in Lung Cancer" cited by the Society of Behavioral 
Medicine as a Meritorious Student Poster at 2005 meeting.  
 
Society of Behavioral Medicine, Student Member, 2002 - 2003, 2004-present 
 
Grawemeyer Summer Research Stipend, 2002, 2003, 2005 
 
International Congress on Psychosomatic Medicine, Student Member, 2003-2004 
  
“Sense of coherence in women with fibromyalgia is enhanced by a Mindfulness-Based 
Stress Reduction Program” cited in Clinician’s Research Digest: Briefings in Behavioral 
Science 21(7), July 2003. Paper selected as among those representing the “most critical 
research to bring to the attention of clinicians”. 
 
 
GRANT PROPOSALS SUMITTED 
 
Intramural Research Incentive Grants, Research on Women Grant awarded to fund 
dissertation, June 2005. 
 
Department of Defense Breast Cancer Research Program Predoctoral Grant, submitted 
May 2004 and not funded. 
 
JOURNAL PEER REVIEW 
 
Journal of Psychosomatic Medicine 
Nicotine & Tobacco Research 
Journal of Clinical Psychopharmacology 
Journal of Traumatic Stress 
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Weissbecker, I, Floyd, A, Dedert, E, Salmon, P, and Sephton, S. Childhood 
trauma and diurnal cortisol disruption in fibromyalgia syndrome (2006). 
Psychoneuroendocrinology, 31, 312-324. 
 
Dedert, E., Studts, J., Weissbecker, I., Salmon, P., Banis, P., & Sephton, S. (2004).  
Religiosity may help preserve the cortisol rhythm in women with stress-related illness. 
International Journal of Psychiatry in Medicine, 34(1), 61-77. 
 
Weissbecker, I., Salmon, P., Studts, J., Floyd, A., Dedert, E., & Sephton, S. 
(2002). Sense of coherence in women with fibromyalgia is enhanced by a Mindfulness-





Martin, M., E. Lush, E. Dedert, A. Chagpar, P. Rhodes, S. Sephton (2007). 
Avoidant coping styles: Associations with physiological stress markers among recently 
diagnosed breast cancer patients. Poster presented at Louisville Breast Cancer Update, 
Louisville, KY. 
 
Dedert, E., Ghate, S., Floyd, A., Banis, P., Weissbecker, I., Hermann, C. Studts, 
J., Salmon, P. and Sephton, S. (2005). Distress and Immune Activation in Lung Cancer. 
Poster presented at the meeting of the Society of Behavioral Medicine, March 2005, cited 
as Meritorious Student Poster. 
 
Sephton, S.E., Weissbecker, I., Floyd, A., Dedert, E., and Salmon, P. Childhood 
trauma and diurnal cortisol disruption in fibromyalgia syndrome. Poster presented at the 
annual meeting of the American Psychosomatic Society, Vancouver, British Columbia, 
Canada, March 2-5, 
2005. 
 
Dedert, E., Ghate, S., Floyd, A., Banis, P., Weissbecker, I., Hermann, C. Studts, 
J., Salmon, P. and Sephton, S. Spirituality Buffers Symptom Distress in Patients with 
Lung Cancer. Poster presented at the 17th World Congress on Psychosomatic Medicine, 
Waikoloa, HI, August 23-28, 2003. 
 
Weissbecker, I., Ghate, S., Studts, J., Floyd, A., Dedert, E., and Sephton, S. 
Gender Differences in the relationship between social support and psychological distress 
in lung cancer patients. Psychosomatic Medicine 66(1), A-36. Poster presented at the 
17th World Congress on Psychosomatic Medicine, Waikoloa, HI, August 23-28, 2003. 
 
Weissbecker, I., Dedert, E., Studts, J., Salmon, P., and Sephton, S. (2003). 
Traumatic Events and Health in Women with Fibromyalgia. Poster presented at the 17th 
World Congress on Psychosomatic Medicine, Waikoloa, HI, August 23-28, 2003. 
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Weissbecker, I., Ghate, S., Dedert, E., Floyd, A., Studts, J., Salmon, P., Banis, P., 
& Sephton, S. Gender Differences in the relationships between psychological distress and 
social support in lung cancer patients. Poster presented at the Conference of the American 
Psychosomatic Society (APS), March 2003. 
 
Beacham, A., Stetson, B., Newton, T., Ulmer, C., Dedert, E., Weissbecker, I., 
Mitchell, C. & Woodruff-Borden, J. Are we adequately fostering medically underserved 
patients’ interest in health-enhancing information and self-management? Poster presented 
at the meeting of the Society of Behavioral Medicine, March 2003. 
 
Dedert, E., Banis, P.,  Weissbecker, I., Salmon, I., Studts, J., & Sephton, S. 
Spiritual Expression is Linked with and Immune Function Among Women with 
Fibromyalgia. Annals of Behavioral Medicine, 24 (2002 Suppl.), S080, March, 2002 
 
DESCRIPTION 
I am a postdoctoral research fellow at Duke University. My doctoral degree will be 
conferred from the University of Louisville in December of 2007. My clinical training 
has focused on brief, problem-focused mental and behavioral health interventions in 
underserved groups with chronic illness. I plan to do clinical research in these groups and 
am currently an active researcher with the Nicotine Research Lab at Duke University and 
the Durham, NC VA and the Biobehavioral Research Lab at the University of Louisville. 
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